syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
CHILDHOOD ABSENCE EPILEPSY	2.52074085	94.56849242888448
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	75.80774728761048
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	75.03230046744748
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.31953969	49.504049249401255
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	45.741009207701296
DIGEORGE SYNDROME; DGS	1.2132820729999998	45.51767252655177
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
NORRIE DISEASE	1.0536243989999998	39.52793124280088
ISOTRETINOIN-LIKE SYNDROME	1.03301453	38.754728301099526
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.019834649	38.26026990544092
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	1.0119048	37.96277249902617
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
BROWN SYNDROME	1.0	37.51615023372374
EHLERS-DANLOS SYNDROME, TYPE I	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
STRABISMUS, SUSCEPTIBILITY TO	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
LAFORA DISEASE	0.77152896	28.944796373028638
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.7621951	28.59462587900809
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.083800875229276
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.58878041260787
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.701565914	26.320052228483714
W SYNDROME	0.618698804	23.211197280289202
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
PALLISTER-HALL SYNDROME	0.586854744	22.01653074127749
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.558315284	20.94584007232814
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.842307352786534
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.550936494	20.66901627814504
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5509259599999999	20.668621083018476
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.5424316290000001	20.349946485087504
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.53954418	20.241620514611284
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.533870354	20.02876040599528
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
GABRIELE-DE VRIES SYNDROME	0.5233586400000001	19.63440136435734
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.52282005	19.614195541002957
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.39011210088303
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	19.215588320577158
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.50969036	19.121620118440738
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.50969036	19.121620118440738
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.50740741	19.03597262326466
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
PAROXYSMAL HEMICRANIA	0.50621118	18.99109467887057
SSR4-CDG	0.504375733	18.922235773472536
RESTRICTIVE DERMOPATHY	0.50297619	18.86973030802598
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.501790884	18.825262190057046
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.501086973	18.798854159229876
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.500541419	18.778387073405263
CREST SYNDROME	0.5	18.75807511686187
FRAXE INTELLECTUAL DISABILITY	0.5	18.75807511686187
BRANCHIOOTORENAL SYNDROME 1	0.5	18.75807511686187
INHALATIONAL ANTHRAX	0.5	18.75807511686187
613241 PSEUDOPILI ANNULATI	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
LEBER CONGENITAL AMAUROSIS, TYPE II	0.5	18.75807511686187
LEBER CONGENITAL AMAUROSIS, TYPE I	0.5	18.75807511686187
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.48168830000000007	18.071090628626997
21Q22.11Q22.12 MICRODELETION SYNDROME	0.46584713899999997	17.47679125267439
C SYNDROME	0.453780829	17.0241097539477
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.45362051999999997	17.018095577419885
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.443672114	16.644869683337806
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.43830405	16.443480587849564
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.4346148040000001	16.305074280664403
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.43355804899999995	16.265428901324157
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728000000003	15.812955279585921
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.417133064	15.6492266964775
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.413742579	15.522028751852316
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062606
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.39775455	14.92221945394718
PLACENTAL INSUFFICIENCY	0.3887161	14.583131605867184
ELSAHY-WATERS SYNDROME; ESWS	0.37703802399999997	14.145015152210338
CANAVAN DISEASE	0.37037	13.894856562064263
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.369922354	13.878062607476737
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.35371573	13.270052466711265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.352174819	13.212243418138467
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.352121464	13.210241743942747
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.35148571	13.186390701367056
COG4-CDG	0.349340884	13.10592508692586
PSEUDOAMINOPTERIN SYNDROME	0.348584454	13.077546745404565
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34755226399999994	13.038822950294815
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.346659854	13.005343162664737
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.3459912	12.98025783874636
OROFACIODIGITAL SYNDROME TYPE 3	0.3455281	12.962884109573123
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489327
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34249279	12.849010963607196
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.34113168	12.797947356362574
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
CONGENITAL ENTEROVIRUS INFECTION	0.33532646000000005	12.580157850702758
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.335165554	12.574121277033246
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.33462	12.553654191208638
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	12.5520908932284
PALLISTER-HALL SYNDROME	0.334419973	12.546149948225837
EPIDERMAL NEVUS SYNDROME	0.333878554	12.525837991682446
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333874419	12.525682862401228
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
NON-INVOLUTING CONGENITAL HEMANGIOMA	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.333333	12.505370905857834
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.333333	12.505370905857834
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	0.333333	12.505370905857834
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.333333	12.505370905857834
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	12.505370905857834
NEUROMYELITIS OPTICA	0.333333	12.505370905857834
CHROMOSOME 16P13.3 DELETION SYNDROME	0.315486733	11.83584767197469
PEHO SYNDROME	0.30483668399999997	11.43629883369417
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.3035874	11.389430507465583
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252718
AL KAISSI SYNDROME; ALKAS	0.294901293	11.063561212307384
CHROMOSOME 17Q12 DELETION SYNDROME	0.29488410000000004	11.062916197136417
INFANTILE MYOFIBROMATOSIS	0.29346490000000003	11.009673276724715
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.28834590000000004	10.817628103678285
HYPERTRICHOSIS CUBITI	0.288338984	10.817368641983267
MILLER-DIEKER SYNDROME	0.285768719	10.720942194102784
WEST SYNDROME	0.2822581	10.58923728428542
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.281718684	10.569000472590945
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.27791268399999997	10.426214004801391
TUFTED ANGIOMA	0.27633168	10.366900821217277
TUBEROUS SCLEROSIS COMPLEX	0.2734533	10.258915084707528
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27066968	10.154484378593931
MARFAN SYNDROME; MFS	0.27066968	10.154484378593931
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.267678154	10.04225383974984
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.26676428399999996	10.007968955535745
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.266062384	9.981636369686695
ROBERTS SYNDROME	0.265199854	9.949277564625604
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.26385092	9.898670754026224
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.2611111	9.795883255292862
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.258465073	9.696614508838373
SLC35A2-CDG	0.258351184	9.692341832004406
ALLAN-HERNDON-DUDLEY SYNDROME	0.25816384	9.685313406355018
CHROMOSOME 1P36 DELETION SYNDROME	0.255429073	9.58271547672879
ROBERTS SYNDROME; RBS	0.25373261999999996	9.519071091116336
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.252584849	9.476011141846426
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.252332303	9.4665365881695
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.25184340299999997	9.448194942320232
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.251086973	9.419816600798937
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.25106438000000003	9.418968998416707
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	9.399504644255545
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	9.379037558430936
SEVERE HEMOPHILIA A	0.25	9.379037558430936
TERMINAL OSSEOUS DYSPLASIA; TOD	0.25	9.379037558430936
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430936
AMERICAN TRYPANOSOMIASIS	0.25	9.379037558430936
DYSTONIA 6, TORSION	0.25	9.379037558430936
HYPERPARATHYROIDISM 2	0.25	9.379037558430936
HEMOPHILIA B	0.25	9.379037558430936
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430936
CONGENITAL FACTOR II DEFICIENCY	0.25	9.379037558430936
ASCHER SYNDROME	0.25	9.379037558430936
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	9.379037558430936
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	9.379037558430936
TETANUS	0.25	9.379037558430936
TRICHOTHIODYSTROPHY	0.246813564	9.25949474674479
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.24554200299999998	9.211790673237445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042523
JUVENILE MYOCLONIC EPILEPSY	0.2427134	9.105672378137884
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.234508329	8.797849701823514
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
POLYARTERITIS NODOSA	0.2208333	8.284815259408985
JUVENILE HYALINE FIBROMATOSIS	0.22	8.253553051419225
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.217977493	8.177676374958464
CRI-DU-CHAT SYNDROME	0.21634583000000002	8.116462660719657
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.21422171	8.036773855685201
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.21391433	8.025242141426359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.21282421899999998	7.984345373378922
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.212177863	7.960096584578453
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.211050643	7.917807629711997
SAY-BARBER-MILLER SYNDROME	0.20870939400000002	7.829972980493441
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.818491762972814
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.20740741000000001	7.781127553147536
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.20621118000000002	7.736249608753449
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.697875089002378
BROOKE-SPIEGLER SYNDROME	0.203704	7.642189867210461
TRANSALDOLASE DEFICIENCY	0.203521744	7.635352323733464
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20128700000000002	7.551513332095553
6P22 MICRODELETION SYNDROME	0.20124533	7.549950034115311
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.20054555400000001	7.5236971325693585
ROMANO-WARD SYNDROME	0.200541419	7.523542003288142
EPISODIC ATAXIA, TYPE 4	0.2	7.50323004674475
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.50323004674475
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.50323004674475
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.50323004674475
BENIGN SCHWANNOMA	0.2	7.50323004674475
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.2	7.50323004674475
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	7.50323004674475
BETA-THALASSEMIA	0.2	7.50323004674475
MALARIA	0.2	7.50323004674475
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.50323004674475
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.50323004674475
UNILATERAL POLYMICROGYRIA	0.19654492	7.373608746395215
AICARDI SYNDROME; AIC	0.19611683000000002	7.357548457641661
PHACE SYNDROME	0.19564093299999996	7.339694634293879
ESOPHAGEAL ATRESIA	0.18909610000000002	7.09415769621125
SMITH-LEMLI-OPITZ SYNDROME	0.184226223	6.911458659059493
PITYRIASIS RUBRA PILARIS	0.18333370000000002	6.877974632104439
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.182697903	6.854121976334287
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.18264054899999999	6.851970275053783
PHELAN-MCDERMID SYNDROME	0.182255733	6.837533460185442
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.181657503	6.815090173631122
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266899
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266899
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.181236073	6.799279742438123
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.18112029899999998	6.794936347660964
RETT SYNDROME, CONGENITAL VARIANT	0.180907019	6.786934903139116
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.180126834	6.757665365469018
SCALP-EAR-NIPPLE SYNDROME	0.17777810000000002	6.669549907865964
WRINKLY SKIN SYNDROME	0.17562958399999998	6.588945858830403
MUCOLIPIDOSIS TYPE II	0.17536141	6.578885002757624
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17416518	6.534007058363538
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.174074183	6.53059320124072
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.172472984	6.470522379002632
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.17219307399999997	6.460021233390709
WAARDENBURG SYNDROME	0.17204334000000002	6.454403790151614
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.17142993899999998	6.431391346082097
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.17072376	6.404898228626196
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.16996733	6.376519887104901
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.169797403	6.370144880244136
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.16954730999999998	6.360762353683731
HYPOPHOSPHATASIA, INFANTILE	0.168495419	6.32129945289823
LAMB-SHAFFER SYNDROME	0.168457884	6.3198912841992065
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	6.273016167547428
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.167208419	6.273016167547428
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.273016167547428
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.252704211004036
SOLAR URTICARIA	0.166667	6.252704211004036
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.166667	6.252704211004036
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.252704211004036
CEREBROOCULONASAL SYNDROME	0.166667	6.252704211004036
OROMANDIBULAR DYSTONIA	0.166667	6.252704211004036
PEMPHIGUS VULGARIS	0.166667	6.252704211004036
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.166667	6.252704211004036
DERMATOLEUKODYSTROPHY	0.166667	6.252704211004036
PHLEBECTASIA OF LIPS	0.166667	6.252704211004036
PFAPA SYNDROME	0.166667	6.252704211004036
247150 LIP PRINTS	0.166667	6.252704211004036
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.166667	6.252704211004036
XANTHOMA DISSEMINATUM	0.166667	6.252704211004036
MAXILLONASAL DYSPLASIA	0.166667	6.252704211004036
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.166667	6.252704211004036
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.16636041399999998	6.2412022845684785
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1658174	6.220830489765464
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16415611399999996	6.15850543460828
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.161277634	6.050515946483513
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.98403980433527
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.15856221399999998	5.948643841815853
DE BARSY SYNDROME	0.15838815399999998	5.942113780706172
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.15732748999999996	5.902321750734668
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.15633160000000001	5.864959791878407
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.15543832999999996	5.831447740359127
COFFIN-SIRIS SYNDROME 1; CSS1	0.15471535299999997	5.8043244266116005
RESTRICTIVE DERMOPATHY, LETHAL	0.15423654999999997	5.786361581331242
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.15290563999999998	5.736430961823678
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.582763309820337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14829852	5.563589555758885
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.14675665300000001	5.505744641746465
EHLERS-DANLOS SYNDROME, TYPE VI	0.14664487999999998	5.501551349086389
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.146394944	5.492174712561574
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.146189729	5.48447583579136
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14470040299999998	5.428602057828369
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.143709469	5.391426029012665
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14361343	5.387823015460367
GANGLIONEUROMA	0.14285699999999998	5.3594446739390715
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.3594446739390715
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.3594446739390715
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.1424031	5.342416093347985
AICARDI SYNDROME	0.14091214	5.2864810139955125
PETERS-PLUS SYNDROME; PTRPLS	0.13979623299999996	5.244616479336647
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.13905376299999997	5.216761863272615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.138613184	5.200233035318792
YUNIS-VARON SYNDROME	0.13793471000000002	5.174779302805117
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.160973134422204
COG8-CDG	0.13404542899999997	5.028868452507948
SCHINZEL-GIEDION SYNDROME	0.13375360000000003	5.017920151901393
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.13187475	4.947432933034761
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.131064923	4.917051341639434
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.13076914	4.905954702174853
LISSENCEPHALY, X-LINKED, 2	0.130296759	4.888232785611297
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.129079114	4.8425514328599535
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.128027384	4.803094572174639
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.12683255400000001	4.75826915039088
PHENYLKETONURIA	0.126297849	4.738209077280155
DILATED CARDIOMYOPATHY WITH ATAXIA	0.125541419	4.709830735758859
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.125541419	4.709830735758859
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.12536701	4.703287581512747
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	4.689518779215468
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.125	4.689518779215468
CENTRAL PRECOCIOUS PUBERTY	0.125	4.689518779215468
THORACOLARYNGOPELVIC DYSPLASIA	0.125	4.689518779215468
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	4.689518779215468
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.12315085399999999	4.620145940075378
YUNIS-VARON SYNDROME	0.12233505400000001	4.589540264714707
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.12203601899999998	4.578321622729565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12091581399999998	4.536295843656997
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.119047944	4.466220552119931
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.118471824	4.444606747647279
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.118333664	4.4394235163309865
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.11778423999999998	4.418811243004972
ZIMMERMANN-LABAND SYNDROME	0.11714692899999998	4.394901787783368
INTESTINAL LYMPHANGIECTASIA	0.11666670000000001	4.376885444472778
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1166667	4.376885444472778
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.116254733	4.361430028609441
COG1-CDG	0.11511466	4.31865887866403
STEINERT MYOTONIC DYSTROPHY	0.11492704000000001	4.311620098557178
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.11476995000000001	4.305726686516962
RAMOS-ARROYO SYNDROME	0.11438209	4.29117567248731
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.114199733	4.2843343398791385
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.113443303	4.255955998357843
WARBURG MICRO SYNDROME 1	0.11315442999999999	4.245118595491376
BILATERAL POLYMICROGYRIA	0.113135344	4.244402562248016
FEMORAL-FACIAL SYNDROME	0.11267177	4.227011050419568
OKAMOTO SYNDROME	0.112412984	4.217302395965183
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.112412984	4.217302395965183
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11186742999999999	4.196835310140574
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11186742999999999	4.196835310140574
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11165241899999999	4.188768925162671
8Q22.1 MICRODELETION SYNDROME	0.111446984	4.1810617948394055
FACIAL HYPERTRICHOSIS	0.11111099999999999	4.168456968619278
PORPHYRIA CUTANEA TARDA	0.11111099999999999	4.168456968619278
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	4.168456968619278
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	4.168456968619278
DYSTONIA 16; DYT16	0.11111099999999999	4.168456968619278
TURCOT SYNDROME WITH POLYPOSIS	0.11111099999999999	4.168456968619278
HENNEKAM-BEEMER SYNDROME	0.10999225900000001	4.126486113190653
ADNP SYNDROME	0.10936712900000001	4.103033642195045
TRISOMY 8P	0.10830225900000001	4.0630838192956595
TRICHOHEPATOENTERIC SYNDROME 1	0.1076219	4.037559368838794
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.10711848400000001	4.0186731385527334
GITELMAN SYNDROME	0.10684260000000001	4.008323032961653
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.106758864	4.005181580605681
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.10367890000000002	3.889633188467221
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.101287	3.799898308723177
KAPOSIFORM LYMPHANGIOMATOSIS	0.1011629	3.7952425544791715
BEHÇET DISEASE	0.100541419	3.771926979915767
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.100541419	3.771926979915767
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.10005725000000001	3.753762822973256
ACQUIRED ICHTHYOSIS	0.1	3.751615023372375
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	3.751615023372375
DRACUNCULIASIS	0.1	3.751615023372375
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.1	3.751615023372375
DISTAL MONOSOMY 17Q	0.09997898999999999	3.7508268090559636
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.09989778	3.747780122495483
NEUROFIBROMATOSIS TYPE 1	0.09957531900000001	3.735682627174967
PACHYDERMOPERIOSTOSIS	0.09903390000000001	3.7153706706315743
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.6811540658109063
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.09628854300000002	3.6123754449743695
JUVENILE ABSENCE EPILEPSY	0.09540435	3.579203927550761
MICROFORM HOLOPROSENCEPHALY	0.094590439	3.5486691201978817
WOLF-HIRSCHHORN SYNDROME	0.094271993	3.536722252220553
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.092998703	3.488953313289455
17Q23.1Q23.2 MICRODELETION SYNDROME	0.09268974999999999	3.4773625861262945
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.09260879000000002	3.474325278603374
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.092360884	3.4650247998635315
DUANE RETRACTION SYNDROME 1	0.09180788000000001	3.444278218719682
SCHAAF-YANG SYNDROME; SHFYNG	0.090934153	3.411499345324421
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.09063145300000001	3.400143206648673
DIABETIC EMBRYOPATHY	0.09042503	3.3923990103689765
RHEUMATOID ARTHRITIS	0.0901315	3.381386894790871
DUANE-RADIAL RAY SYNDROME; DRRS	0.08755482000000002	3.2847197808066406
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08746936000000001	3.2815136506076668
PROTEUS SYNDROME	0.087355049	3.277225141958299
DDOST-CDG	0.08722609900000002	3.272387434385661
8Q12 MICRODUPLICATION SYNDROME	0.08685504400000002	3.258466879260687
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.086750349	3.2545391259119665
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08663363000000002	3.250160278372837
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08645022000000001	3.2432794412584696
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.08567275400000002	3.2141119100008573
BECKWITH-WIEDEMANN SYNDROME	0.08532646	3.2011202922718196
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.08516585400000001	3.195094973447383
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.08478268	3.180719760097725
TOWNES-BROCKS SYNDROME 1; TBS1	0.08463528400000002	3.1751900296178763
CONGENITAL ANALBUMINEMIA	0.08413976000000001	3.15659987678946
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.08412700000000001	3.156121170712477
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08408973000000002	3.154722943793267
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.083159349	3.119818630422664
DISTAL TRISOMY 6P	0.082748404	3.104401556064867
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.08245	3.0932065867705227
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.08243804899999999	3.092758231259079
MYASTHENIA GRAVIS; MG	0.0820434	3.077952520085491
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.08174838400000001	3.066884655508139
ACRORENAL-MANDIBULAR SYNDROME	0.0815508	3.0594720644803584
EMANUEL SYNDROME	0.080886883	3.034564454565635
WILLIAMS SYNDROME	0.08071515	3.028121693537547
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.080705203	3.0277485203911723
WILLIAMS-BEUREN SYNDROME; WBS	0.08069420000000001	3.027335730190151
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07950794900000001	2.9828321594592455
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07906479999999999	2.966206914999321
ETHYLMALONIC ENCEPHALOPATHY	0.078751519	2.95445381793795
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07870984900000001	2.952890519957711
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.07835228400000001	2.9394760576993892
DISTAL MONOSOMY 12Q	0.07812761399999998	2.931047304226378
LEPRECHAUNISM	0.07767953000000001	2.914236917565051
274210 THYMIC APLASIA WITH FETAL DEATH	0.0776316	2.912438768484348
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.077574294	2.9102888679790544
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.9063256618683644
ISOLATED BILIARY ATRESIA	0.07746451900000001	2.9061705325871476
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07711513	2.8930628023731373
SRD5A3-CDG	0.077070183	2.891376563968582
DOORS SYNDROME	0.07695389400000001	2.8870138483740524
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.07692310000000001	2.885858576043755
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.885858576043755
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.885858576043755
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.885858576043755
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.07664749900000001	2.8755190875231906
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.07641948	2.8669646924630467
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002488
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.07627231000000001	2.86144344063315
PIERPONT SYNDROME	0.07587871300000001	2.8466771964496074
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.07569283	2.8397035818957117
WHITE-SUTTON SYNDROME; WHSUS	0.075502224	2.8325527785642626
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.075371959	2.8276657372540663
KABUKI SYNDROME	0.07531187900000001	2.825411766948025
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.07507006	2.816339649014655
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.07475133300000002	2.804382238999112
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.07407411	2.778975439189378
VACTERL/VATER ASSOCIATION	0.07369316000000001	2.764683661757841
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07366436	2.76360319663111
NEU-LAXOVA SYNDROME	0.07291763999999999	2.7355891369285836
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0726316	2.7248580173157295
CAMPOMELIC DYSPLASIA	0.07216120999999999	2.707210795407288
NEUROFACIODIGITORENAL SYNDROME	0.07216120999999999	2.707210795407288
CAMPOMELIA, CUMMING TYPE	0.07216120999999999	2.707210795407288
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
8Q24.3 MICRODELETION SYNDROME	0.07141473300000001	2.679205852129269
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.07128905	2.6744907098194437
NON-DISTAL MONOSOMY 20Q	0.071164689	2.6698251638602275
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.07105861399999999	2.665845638224185
SCHWARTZ-JAMPEL SYNDROME	0.07057316	2.6476332730286227
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0705412	2.646434256867153
YOU-HOOVER-FONG SYNDROME; YHFS	0.069274384	2.598908197492668
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.069270249	2.598753068211452
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.069214014	2.5966433475030586
KEUTEL SYNDROME; KTLS	0.06901971900000001	2.5893541470933976
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.068999003	2.5885769625251553
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.06863431	2.574895085147968
ELLIS VAN CREVELD SYNDROME	0.06847153	2.5687882062129224
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.068331244	2.563525215561234
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06795369999999999	2.549361218137393
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06795369999999999	2.549361218137393
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06791203	2.5477979201571537
CROSSED POLYSYNDACTYLY	0.06791203	2.5477979201571537
URBAN-ROGERS-MEYER SYNDROME	0.06791203	2.5477979201571537
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.06791203	2.5477979201571537
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.06791203	2.5477979201571537
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.06791203	2.5477979201571537
RHIZOMELIC SYNDROME, URBACH TYPE	0.06780633	2.5438324630774494
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.067572879	2.535074280289236
LATHOSTEROLOSIS	0.06752875900000001	2.5334190677409247
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.06752204	2.533166996727504
MENTAL RETARDATION, X-LINKED 98; MRX98	0.067425273	2.529536671417837
OROFACIODIGITAL SYNDROME TYPE 5	0.06742313	2.5294562743078863
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	2.5294562743078863
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.067327604	2.5258725065406598
ROSSELLI-GULIENETTI SYNDROME	0.067212254	2.5215450186111994
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.5215450186111994
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.066977264	2.512729098467777
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0666667	2.5010779327865906
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
MEIGE DISEASE	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
NIEVERGELT SYNDROME	0.0666667	2.5010779327865906
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.0666667	2.5010779327865906
MECKEL SYNDROME, TYPE 1; MKS1	0.06604623	2.477800287051072
NOONAN SYNDROME	0.0657295	2.4659177967875445
15Q OVERGROWTH SYNDROME	0.065659989	2.4633100116686486
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.06537123	2.452476885643309
9Q33.3Q34.11 MICRODELETION SYNDROME	0.065333689	2.4510684918473844
SILVER-RUSSELL SYNDROME	0.06529217000000001	2.449510858805831
AMISH INFANTILE EPILEPSY SYNDROME	0.06514384000000001	2.4439460882416624
CORNELIA DE LANGE SYNDROME 3	0.065017963	2.4392236677986916
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.06448417000000001	2.419197809416982
JOHANSON-BLIZZARD SYNDROME	0.06439111	2.415706556476231
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.064376203	2.415147303224697
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.06436751	2.4148211753307156
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.4127236473711475
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME	0.0641259	2.4057568982727453
H SYNDROME	0.06406828	2.4035952176962785
KNIEST-LIKE DYSPLASIA, LETHAL	0.06401115	2.4014519200334257
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06384318	2.395150332278667
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.063101674	2.367331881783459
1P36 DELETION SYNDROME	0.06292049300000001	2.3605346681679635
SECKEL SYNDROME 10; SCKL10	0.06252321000000001	2.345630139454659
SMITH-MAGENIS SYNDROME; SMS	0.062123982999999994	2.3306526793452997
DIPHALLIA	0.061799690000000004	2.318486454437555
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.06176678000000001	2.317251797933363
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.06176678000000001	2.317251797933363
HEMOCHROMATOSIS, TYPE 1	0.06176678000000001	2.317251797933363
ISOLATED KLIPPEL-FEIL SYNDROME	0.06156017	2.3095005861335736
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.061205303	2.2961873424485826
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0611888	2.295568213421275
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.289796728869319
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.289796728869319
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.2779693873466353
3MC SYNDROME 2	0.060663884	2.27587538590519
RUBINSTEIN-TAYBI SYNDROME	0.060326143	2.2632046438091016
MICROPHTHALMIA WITH LIMB ANOMALIES	0.060188710000000006	2.2580486867340306
MICROPHTHALMIA, SYNDROMIC 3	0.060125484	2.255676690619353
HAMAMY SYNDROME; HMMS	0.05931858999999999	2.2254051340926626
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	2.224512624878603
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.05918063	2.2202294060064185
SHPRINTZEN OMPHALOCELE SYNDROME	0.05902681	2.214458671777467
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.058884754	2.209129277539865
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.05888254	2.2090462167832476
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.058873	2.208688312710018
3P25.3 MICRODELETION SYNDROME	0.05885298999999999	2.2079376145438405
ACRO-RENAL-MANDIBULAR SYNDROME	0.0588235	2.2068312632734486
PHAVER SYNDROME	0.0588235	2.2068312632734486
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.0588235	2.2068312632734486
ULNAR HEMIMELIA	0.0588235	2.2068312632734486
SPONDYLOCOSTAL DYSOSTOSIS 5	0.0588235	2.2068312632734486
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05840336	2.191069227914252
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.05838522	2.190388684949012
FONTAINE PROGEROID SYNDROME; FPS	0.05813389	2.1809597509107705
RENAL AGENESIS, BILATERAL	0.05812611	2.1806678752619524
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.05803860399999999	2.1773849870195994
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.057826813000000005	2.169439404045449
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
ULBRIGHT-HODES SYNDROME	0.057407410000000006	2.153705018088975
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.057407410000000006	2.153705018088975
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.150778383209242
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05725402	2.147950415804624
HAND-FOOT-GENITAL SYNDROME	0.05722363000000001	2.1468102999990215
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0571896	2.1455336254065673
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.05717591	2.145020029309868
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.05684260000000001	2.1325155212754656
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.05684260000000001	2.1325155212754656
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.05684260000000001	2.1325155212754656
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05684260000000001	2.1325155212754656
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.05684260000000001	2.1325155212754656
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.056452209999999996	2.1178695913857215
PYGMY	0.05641948	2.116641687788572
SPONDYLO-OCULAR SYNDROME	0.05633598000000001	2.1135090892440567
NIJMEGEN BREAKAGE SYNDROME	0.056312030000000006	2.1126105774459587
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.1046993217492718
OBESITY DUE TO SIM1 DEFICIENCY	0.056101154	2.1046993217492718
MEIER-GORLIN SYNDROME 1; MGORS1	0.05592036	2.097916626883916
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.055861100000000004	2.0956934198210657
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.055632623	2.0871218423641147
LETHAL KNIEST-LIKE DYSPLASIA	0.055607790000000004	2.0861902038053612
TRICHO-DENTO-OSSEOUS SYNDROME	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
HEMOCHROMATOSIS, TYPE 4; HFE4	0.055555600000000004	2.084232235924663
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.055555600000000004	2.084232235924663
ANIRIDIA	0.055555600000000004	2.084232235924663
ESTROGEN RESISTANCE; ESTRR	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.055555600000000004	2.084232235924663
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.055555600000000004	2.084232235924663
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.055555600000000004	2.084232235924663
ARGININOSUCCINIC ACIDURIA	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
X-LINKED SIDEROBLASTIC ANEMIA	0.055555600000000004	2.084232235924663
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.055555600000000004	2.084232235924663
DERMATOMYOSITIS	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
HYPERLIPOPROTEINEMIA, TYPE IV	0.055555600000000004	2.084232235924663
BAMFORTH-LAZARUS SYNDROME	0.055555600000000004	2.084232235924663
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.055555600000000004	2.084232235924663
ESTROGEN RESISTANCE SYNDROME	0.055555600000000004	2.084232235924663
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.055555600000000004	2.084232235924663
CAUDAL REGRESSION SEQUENCE	0.055494510000000004	2.0819403743068845
PGM3-CDG	0.05539991899999999	2.078391684140126
PRIMARY CILIARY DYSKINESIA	0.055383100000000005	2.0777607000093457
CHRISTIANSON SYNDROME	0.05529573	2.074482913963425
KBG SYNDROME	0.055243703000000005	2.0725310612152152
ROTHMUND-THOMSON SYNDROME	0.055178914	2.0701004273577226
POTOCKI-LUPSKI SYNDROME	0.055160293	2.06940183912422
GORLIN SYNDROME	0.05494903	2.061476064677393
KASABACH-MERRITT SYNDROME	0.0548941	2.0594153025450543
ISOLATED CEREBELLAR AGENESIS	0.054832548999999994	2.0571061459820186
PERLMAN SYNDROME	0.054823984	2.0567848201552668
HYPOPLASMINOGENEMIA	0.0545894	2.047984131568839
FASCIAL DYSTROPHY, CONGENITAL	0.0545894	2.047984131568839
CRANIOLENTICULOSUTURAL DYSPLASIA	0.054559039999999996	2.046845141247743
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.054460019	2.0431302545354493
COG2-CDG	0.05426045399999999	2.035643344014056
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.05406267299999999	2.0282233623046797
CROUZON DISEASE	0.05387693	2.021255000011818
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.05342888900000001	2.00444622654495
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.053177154	1.9950020984658634
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.053177154	1.9950020984658634
HYPOPLASTIC LEFT HEART SYNDROME	0.052976190000000006	1.9874627028502936
PENILE AGENESIS	0.052976190000000006	1.9874627028502936
CLEIDOCRANIAL DYSPLASIA	0.0526316	1.9745350126412546
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	1.9745350126412546
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	1.9745350126412546
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	1.9745350126412546
BIEMOND SYNDROME II	0.0526316	1.9745350126412546
PERINEURAL CYST	0.0526316	1.9745350126412546
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412546
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.9745350126412546
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	1.9745350126412546
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	1.9745350126412546
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.0526316	1.9745350126412546
POLYEMBRYOMA	0.0526316	1.9745350126412546
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9745350126412546
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	1.9745350126412546
MYXOPAPILLARY EPENDYMOMA	0.0526316	1.9745350126412546
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	1.9745350126412546
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.052427214	1.9668672367595847
SLC39A8-CDG	0.052206949	1.9586037419283535
AMYLOIDOSIS	0.052139099999999994	1.9560583086511454
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052037643999999994	1.9522520701130326
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0517429	1.9411944099285445
XQ12-Q13.3 DUPLICATION SYNDROME	0.051682389999999995	1.9389243076779015
ABLEPHARON MACROSTOMIA SYNDROME	0.051431264000000004	1.9295030269343076
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.051327884000000004	1.9256246073231453
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.05124131900000001	1.922377021778163
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
TRIOPIA	0.0511111	1.9174917062108776
FOIX-CHAVANY-MARIE SYNDROME	0.051086973	1.9165865540541887
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.051066104	1.915803629514961
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.05104609399999999	1.9150529313487838
16Q24.3 MICRODELETION SYNDROME	0.051012179000000005	1.9137805711136076
FETAL HYDANTOIN SYNDROME	0.050869884	1.9084422105160994
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05059527	1.8981397504358157
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.05045762299999999	1.8929757649045944
16P13.11 MICRODELETION SYNDROME	0.050362633999999996	1.889412143310043
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.050273330000000005	1.886061801029571
CRANIOLENTICULOSUTURAL DYSPLASIA	0.05019154000000001	1.8829933551019549
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.05015248900000001	1.8815283119191777
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.050015589	1.8763923509521805
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.05	1.8758075116861874
SYMBRACHYDACTYLY OF HANDS AND FEET	0.05	1.8758075116861874
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	1.8758075116861874
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	1.8758075116861874
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	1.8758075116861874
FRASER SYNDROME	0.04972924000000001	1.8656496388489046
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.04960590300000001	1.8610225094275277
DISTAL TRISOMY 18Q	0.049518364	1.8577383831522174
PYRIDOXINE-DEPENDENT EPILEPSY	0.049331164	1.8507153598284642
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.841174627662526
SMITH-MAGENIS SYNDROME	0.049009343	1.8386418748440971
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.04896773	1.8370807152844213
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.04893246	1.8357575206656775
LICHTENSTEIN SYNDROME	0.048854640000000005	1.8328380138544895
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.048849473000000004	1.832644167906232
7Q11.23 MICRODUPLICATION SYNDROME	0.048837179	1.8321829443552584
TARP SYNDROME	0.048828463	1.8318559535898213
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.048750749	1.8289404234905575
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.048456250000000006	1.8178919547628762
TRISOMY 13	0.047962019	1.7993503103167126
WHITE FORELOCK WITH MALFORMATIONS	0.047699820000000004	1.7895136132415805
PSEUDOTRISOMY 13 SYNDROME	0.04721092	1.771171967392313
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.046964	1.761908479576602
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.04687735899999999	1.7586580428042016
DYSKERATOSIS CONGENITA	0.046756734	1.7541326571822589
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7522953412407127
ZELLWEGER SYNDROME	0.046702509	1.7520983439358353
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.046528904	1.7455853526745095
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04648261	1.7438485800155896
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.7241184614461718
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.045891573	1.7216751471299
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.7187198874275393
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.045807524	1.7185219522189061
POEMS SYNDROME	0.04580738	1.7185165498932724
MICROHYDRANENCEPHALY; MHAC	0.045729990000000005	1.7156131750266848
NEVUS COMEDONICUS SYNDROME	0.045688049	1.714039710169732
PRIMARY BASILAR INVAGINATION	0.0456668	1.7132425294934153
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.045605179999999995	1.7109307843160133
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.045553108999999994	1.7089772808571928
OCULODENTODIGITAL DYSPLASIA	0.045539149	1.7084535553999303
MESOMELIA-SYNOSTOSES SYNDROME	0.04549451	1.7067788719696473
ALG13-CDG	0.045416	1.7038334790147973
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.045321703000000005	1.700295818596208
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.045317009	1.700119717787011
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0452381	1.697159355888218
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.04520084	1.6957615041305094
22Q11.2 MICRODUPLICATION SYNDROME	0.045011493	1.6886579336322045
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.044894592999999997	1.6842722956698821
BRADDOCK SYNDROME	0.04476530000000001	1.679421720057714
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.04472363000000001	1.6778584220774744
ALLAN-HERNDON-DUDLEY SYNDROME	0.044444410000000004	1.667383162609214
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.044419559000000004	1.6664508487597558
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.6618886973105835
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.04423473000000001	1.6595167762282068
RING CHROMOSOME 1 SYNDROME	0.04423473000000001	1.6595167762282068
XP22.13P22.2 DUPLICATION SYNDROME	0.044209878999999994	1.6585844623787482
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.044120203	1.6552201640903887
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.04406995	1.6533348649926936
HYDROXYKYNURENINURIA	0.044023854	1.65160552053152
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.6514503912503038
LASSA FEVER	0.044019719000000006	1.6514503912503038
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.6514503912503038
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6514503912503038
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814000000001	1.6461388922163633
20Q13.33 MICRODELETION SYNDROME	0.043878049	1.646135478246692
CHARGE SYNDROME	0.043776914	1.6423412823928043
PENTASOMY X	0.043776914	1.6423412823928043
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.043763244	1.6418284366191094
SOTOS SYNDROME	0.043561903	1.6342748974149008
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0435606	1.6342260138711464
PREPAPILLARY VASCULAR LOOPS	0.0435606	1.6342260138711464
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.043518509999999996	1.632646959107809
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.043495753000000005	1.6317932040769405
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.04348908	1.6315428588064305
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.6311384347069111
YELLOW FEVER	0.043478300000000004	1.6311384347069111
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.6311384347069111
RINGED HAIR DISEASE	0.043478300000000004	1.6311384347069111
OCULOTRICHOANAL SYNDROME	0.043478300000000004	1.6311384347069111
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.6311384347069111
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.6311384347069111
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.6311384347069111
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.6311384347069111
HYDATIDIFORM MOLE	0.043478300000000004	1.6311384347069111
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	1.6311384347069111
ASHERMAN SYNDROME	0.043478300000000004	1.6311384347069111
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.6311384347069111
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.043478300000000004	1.6311384347069111
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.6311384347069111
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.6311384347069111
JUVENILE XANTHOGRANULOMA	0.043478300000000004	1.6311384347069111
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.6311384347069111
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.6311384347069111
WERNER SYNDROME	0.043478300000000004	1.6311384347069111
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6225267524853606
FETAL ALCOHOL SYNDROME	0.043142363999999996	1.6185354092619946
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.04296454899999999	1.611864475008185
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.04296454899999999	1.611864475008185
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.04296454899999999	1.611864475008185
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042778383999999996	1.604880280899924
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
MOWAT-WILSON SYNDROME	0.042543179	1.596056294784201
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	1.5915525184647925
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.042250359	1.5850708156727622
FRONTOOCULAR SYNDROME	0.041804074	1.5683279205657046
184705 STEINFELD SYNDROME	0.04178951	1.5677815353537006
ANDROGEN INSENSITIVITY SYNDROME	0.0416667	1.5631741769434973
49,XXXYY SYNDROME	0.041666699999999994	1.5631741769434968
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5631741769434968
49,XYYYY SYNDROME	0.041666699999999994	1.5631741769434968
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.5631741769434968
HISTIDINEMIA	0.041666699999999994	1.5631741769434968
MERRF	0.041517359999999996	1.5575715150675926
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.041412723	1.5536459376555865
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.041287000000000004	1.5489292946997524
ACRODERMATITIS ENTEROPATHICA	0.041287000000000004	1.5489292946997524
SARCOSINEMIA	0.041091234	1.541584908033097
GRISCELLI SYNDROME	0.041086973	1.5414250517169512
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.041086973	1.5414250517169512
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.04095251	1.5363805176080738
611426 TENTED EYEBROWS	0.0408333	1.5319082173387117
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.04082213	1.531489161940601
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.040817744	1.5313246161056762
1Q44 MICRODELETION SYNDROME	0.040778644	1.5298577346315374
9P13 MICRODELETION SYNDROME	0.04073268	1.5281333423021946
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.040693980000000005	1.5266814672881495
TRANSALDOLASE DEFICIENCY	0.040681449999999994	1.5262113899257206
SHORT SYNDROME	0.0405229	1.520263204306164
TETRASOMY 9P	0.040487973000000003	1.5189528777269508
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.040250143999999995	1.510030449233014
ACRODYSOSTOSIS	0.040065699999999996	1.5031108204193053
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.040065699999999996	1.5031108204193053
BÖÖK SYNDROME	0.04	1.5006460093489498
CENTRAL CONGENITAL HYPOTHYROIDISM	0.04	1.5006460093489498
MONILETHRIX	0.04	1.5006460093489498
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.04	1.5006460093489498
ACROMICRIC DYSPLASIA	0.04	1.5006460093489498
VOGT-KOYANAGI-HARADA DISEASE	0.04	1.5006460093489498
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.04	1.5006460093489498
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.04	1.5006460093489498
ULERYTHEMA OPHRYOGENESIS	0.04	1.5006460093489498
ROMBO SYNDROME	0.04	1.5006460093489498
PILI TORTI	0.04	1.5006460093489498
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.04	1.5006460093489498
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.04	1.5006460093489498
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.039972900000000006	1.499629321677616
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	1.499471753846634
FILIPPI SYNDROME; FLPIS	0.03972025900000001	1.4901512039664178
HOLOPROSENCEPHALY	0.039631123000000004	1.4868071643991847
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.039264363	1.4730477411394638
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.03924148400000001	1.4721894091382668
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.039238	1.4720587028708523
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.038937113	1.4607705809754779
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.03892543400000001	1.4603324298568985
STURGE-WEBER SYNDROME	0.038823749000000005	1.4565176001203821
GALLOWAY-MOWAT SYNDROME	0.038818162999999996	1.4563080349051762
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143658
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143658
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143658
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143658
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143658
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143658
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143658
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143658
MAL DE MELEDA	0.0384615	1.4429274122143658
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143658
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4429274122143658
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143658
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143658
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4429274122143658
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143658
PHEOCHROMOCYTOMA	0.038405800000000004	1.4408377626463476
LISSENCEPHALY 2; LIS2	0.038338984	1.4383310835523309
CLAPO SYNDROME	0.038324	1.4377689415572286
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.038299149000000005	1.4368366277077707
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.038253430000000005	1.435121426835235
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.038204969000000005	1.4333033566787585
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.038123973	1.4302646985744276
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.4284161653039615
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.03779343	1.417863997727722
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.03779343	1.417863997727722
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.037779183	1.417329505135342
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.037640329	1.4121202376107886
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03763444	1.411899305002062
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.037582554	1.4099527420310352
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.037578419	1.4097976127498186
HYPOPARATHYROIDISM, X-LINKED	0.037578419	1.4097976127498186
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.037578419	1.4097976127498186
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.037578419	1.4097976127498186
TREACHER-COLLINS SYNDROME	0.037560684000000004	1.4091322638254238
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.037557703000000005	1.409020428181577
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.037557703000000005	1.409020428181577
3MC SYNDROME 1	0.037509219999999996	1.407201532669795
SCIMITAR SYNDROME	0.03745899	1.4053170964435553
COFS SYNDROME	0.037276659000000004	1.3984767392552904
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.037147134	1.3936174598962672
COFFIN-SIRIS SYNDROME 3; CSS3	0.037099813	1.3918421581510572
COFFIN-SIRIS SYNDROME 4; CSS4	0.037099813	1.3918421581510572
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.3894856562064262
KIKUCHI-FUJIMOTO DISEASE	0.037037	1.3894856562064262
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
CERVICAL VERTEBRAE, AGENESIS OF	0.037037	1.3894856562064262
CARCINOMA OF ESOPHAGUS	0.037037	1.3894856562064262
PAROTIDOMEGALY, HEREDITARY BILATERAL	0.037037	1.3894856562064262
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
PULMONARY ARTERIAL HYPERTENSION	0.037037	1.3894856562064262
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.037037	1.3894856562064262
BRANCHIAL CLEFT ANOMALIESBRANCHIAL CYSTS, INCLUDED	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.037037	1.3894856562064262
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
VON HIPPEL-LINDAU DISEASE	0.037037	1.3894856562064262
MALAKOPLAKIA	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.037037	1.3894856562064262
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.03701214900000001	1.3885533423569683
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03701214900000001	1.3885533423569683
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.03701214900000001	1.3885533423569683
CORNELIA DE LANGE SYNDROME	0.036922049000000005	1.3851731372209097
CARDIOFACIOCUTANEOUS SYNDROME	0.036804904	1.38077830780178
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.036709953	1.3772161118209374
NEURONAL CEROID LIPOFUSCINOSIS	0.036587399	1.372618357545194
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.372618357545194
15Q13.3 MICRODELETION SYNDROME	0.036361043	1.3641263518428892
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.036353194	1.3638318875797046
COFFIN-SIRIS SYNDROME 2; CSS2	0.036343383	1.3634638166297615
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.036273684	1.3608489784746212
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.036273684	1.3608489784746212
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036255719000000006	1.3601750008356726
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.036123223999999995	1.355204298510455
ALPERS-HUTTENLOCHER SYNDROME	0.036122034	1.355159654291677
MARFANOID HYPERMOBILITY SYNDROME	0.0361111	1.3547494527050215
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346006
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	1.3523064010018013
TETRASOMY X	0.035856794000000004	1.3452088706036842
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.035784784	1.3425073326253538
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.035728130000000004	1.3403818926500124
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.035569773	1.3344409476474504
HYDRANENCEPHALY	0.035569773	1.3344409476474504
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.035551613999999995	1.333759691875356
PYCNODYSOSTOSIS	0.0355013	1.3318721042924968
CHROMOSOME 18Q DELETION SYNDROME	0.035430398999999994	1.3292121717247753
DOWN SYNDROME	0.03531124	1.3247417847790752
NON-DISTAL TRISOMY 13Q	0.035279279999999996	1.3235427686176053
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.035064822999999995	1.3154971675869316
JAWAD SYNDROME	0.035028354	1.314128991104058
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.035024219	1.3139738618228416
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.035024219	1.3139738618228416
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.035024219	1.3139738618228416
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457726
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.034801279000000004	1.3056100112897353
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.034660294	1.3003207968490338
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.0344828	1.2936619052794491
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	0.0344828	1.2936619052794491
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0344828	1.2936619052794491
CERVICAL VERTEBRAL BRIDGE	0.0344828	1.2936619052794491
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0344828	1.2936619052794491
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0344828	1.2936619052794491
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	1.2936619052794491
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	1.2936619052794491
FRYNS MICROPHTHALMIA SYNDROME	0.0344828	1.2936619052794491
SPINAL INTRADURAL ARACHNOID CYSTS	0.0344828	1.2936619052794491
ACROCRANIOFACIAL DYSOSTOSIS	0.0344828	1.2936619052794491
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0344828	1.2936619052794491
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.0344828	1.2936619052794491
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.0344828	1.2936619052794491
BRACHYDACTYLY, TYPE A6	0.0344828	1.2936619052794491
COFFIN-LOWRY SYNDROME; CLS	0.034455749	1.2926470558994767
ACROCALLOSAL SYNDROME; ACLS	0.034380999	1.2898427236695058
MEIER-GORLIN SYNDROME 5; MGORS5	0.03430153	1.286861352726582
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.034101503	1.2793571097437808
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.03409065399999999	1.278950097029895
SANDHOFF DISEASE	0.034086518999999996	1.2787949677486787
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.034048984	1.277386799049656
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.034044849	1.2772316697684396
LEIGH SYNDROME	0.034044849	1.2772316697684396
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.034044849	1.2772316697684396
SECKEL SYNDROME 9; SCKL9	0.034040074000000003	1.2770525301510736
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0338384	1.2694864980688374
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.033560084	1.2590451532003883
ATYPICAL RETT SYNDROME	0.033555949	1.258890023919172
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.033555948999999995	1.2588900239191718
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.033545099999999994	1.2584830112052863
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	1.2569197132250471
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03350343	1.2569197132250471
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.033390993	1.2527015098412178
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.033350794	1.2511933981179726
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.250978768222485
17Q12 MICRODUPLICATION SYNDROME	0.033284149	1.2486931342856458
GAPO SYNDROME	0.033233399999999996	1.2467892271774346
MYELOPEROXIDASE DEFICIENCY	0.033199679999999995	1.2455241825915533
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	1.2455241825915533
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	1.2455241825915533
SECKEL SYNDROME 2; SCKL2	0.03301453	1.2385780673757796
SECKEL SYNDROME	0.03301453	1.2385780673757796
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.032937614000000004	1.2356924751644027
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.03286257	1.2328771131862628
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.2306668116790926
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.2306668116790926
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
DEND SYNDROME	0.032799519	1.2305116823978763
FLYNN-AIRD SYNDROME	0.032799519	1.2305116823978763
LOEYS-DIETZ SYNDROME 5	0.03264813	1.224832149930143
WIEDEMANN-STEINER SYNDROME	0.032611079	1.2234421390478334
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.032563	1.2216384000607463
DUBOWITZ SYNDROME	0.032442489000000005	1.21711729127993
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.032325443	1.2127261759596737
HUNTINGTON DISEASE	0.0322581	1.2101997258544839
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.2101997258544839
DIENCEPHALIC SYNDROME	0.0322581	1.2101997258544839
MILD CANAVAN DISEASE	0.0322581	1.2101997258544839
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.2101997258544839
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.2101997258544839
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.2101997258544839
LESCH-NYHAN SYNDROME	0.0322581	1.2101997258544839
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.2101997258544839
DENT DISEASE	0.0322581	1.2101997258544839
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
DYSTONIA, JUVENILE-ONSET	0.0322581	1.2101997258544839
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.2101997258544839
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.2101997258544839
KAGAMI-OGATA SYNDROME	0.032217632999999996	1.2086815598029756
CONGENITAL DISORDER OF GLYCOSYLATION	0.032190703	1.2076712498771818
HELSMOORTEL-VAN DER AA SYNDROME	0.032134122999999994	1.2055485860969573
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.032129244	1.2053655447999672
EPILEPSY, PYRIDOXINE-DEPENDENT	0.032129244	1.2053655447999672
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.03210905	1.2046079436621473
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.03201384	1.2010360309983945
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03199932	1.2004912964970007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.031940384	1.1982802446668261
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.03178286	1.1923705506174092
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.031752599	1.1912352743951864
MEIER-GORLIN SYNDROME 7	0.031623574	1.1863947531112802
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.031610043	1.1858871220824674
RAMON SYNDROME	0.031556419	1.1838753560423343
RING CHROMOSOME 12 SYNDROME	0.031515664	1.182346385339559
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.031462002999999995	1.1803332312018668
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0313726	1.1769791748225213
KEPPEN-LUBINSKY SYNDROME	0.031268858999999996	1.1730872118811246
NAVAJO NEUROHEPATOPATHY	0.031244354	1.1721678786196474
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.031214043	1.1710307265899131
FATCO SYNDROME	0.031130659999999998	1.1679025174349742
DISTAL MONOSOMY 7Q36	0.031114579000000003	1.1672992202230659
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.031060203	1.165259242037957
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.031040214000000003	1.1645093317109352
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.030987783999999997	1.1625423599541809
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.030917759000000003	1.1599152915340645
ZIMMERMANN-LABAND SYNDROME 1	0.030917759000000003	1.1599152915340645
4Q21 MICRODELETION SYNDROME	0.030827469	1.1565279583294614
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030657129999999998	1.150137494814799
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.030657129999999998	1.150137494814799
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.030621653000000002	1.1488065343529574
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.030467402999999997	1.1430196681794054
KABUKI SYNDROME 1	0.030455123	1.1425589698545353
WARBURG MICRO SYNDROME 3; WARBM3	0.030446719000000004	1.1422436841279713
20P13 MICRODELETION SYNDROME	0.030427548999999998	1.1415244995279905
ALG1-CDG	0.030414803	1.1410463186771116
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.030325114	1.137681532678799
MUCOPOLYSACCHARIDOSIS, TYPE II	0.030303319000000002	1.1368638681844552
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.030264433	1.1354050151664665
TRANSIENT NEONATAL DIABETES MELLITUS	0.030038864	1.1269425346743955
PERMANENT NEONATAL DIABETES MELLITUS	0.030038864	1.1269425346743955
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	1.124696667856804
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.029957354	1.1238845932688448
TOWNES-BROCKS SYNDROME	0.02989872	1.1216848713160408
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.02982123	1.1187777448344296
PETERS PLUS SYNDROME	0.029760514000000005	1.116499914256839
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029658373000000002	1.112667977155816
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.029627039	1.1114924461043925
RECOMBINANT CHROMOSOME 8 SYNDROME	0.029585593000000004	1.1099375517418055
MYHRE SYNDROME	0.029430863	1.1041326778161413
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.1034175074442358
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.1034175074442358
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.1034175074442358
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.1034175074442358
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.1034175074442358
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.1034175074442358
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.1034175074442358
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.1034175074442358
RAGWEED SENSITIVITY	0.0294118	1.1034175074442358
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.1034175074442358
IMMUNE SUPPRESSION	0.0294118	1.1034175074442358
MONOMELIC AMYOTROPHY	0.0294118	1.1034175074442358
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.1034175074442358
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.1034175074442358
OROFACIODIGITAL SYNDROME TYPE 4	0.029360094	1.1014776973802511
BRAIN-LUNG-THYROID SYNDROME	0.029199683999999997	1.0954597317212593
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.029188803	1.0950515184905663
PROPIONIC ACIDEMIA	0.029116954	1.0923560206124234
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.029079784	1.090961545308236
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	1.090961545308236
MENKES DISEASE	0.029075649000000002	1.0908064160270197
EDINBURGH MALFORMATION SYNDROME	0.029064800000000002	1.090399403313134
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.029064800000000002	1.090399403313134
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.02905676	1.0900977734652548
DUANE RETRACTION SYNDROME	0.029006113	1.0881976930043673
TRISOMY 20P	0.02882295	1.0813261223791077
RENPENNING SYNDROME 1; RENS1	0.028819699	1.081204157374698
ALKAPTONURIA	0.028787880000000002	1.080010430990411
HOOFT DISEASE	0.028787880000000002	1.080010430990411
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02865274	1.0749404984478257
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
48,XXYY SYNDROME	0.028581173	1.0722555801240488
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	1.0718889347878144
ALG12-CDG	0.0285714	1.0718889347878144
ALPHA-THALASSEMIA	0.0285714	1.0718889347878144
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.0718889347878144
CHEILITIS GLANDULARIS	0.0285714	1.0718889347878144
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.0718889347878144
COG7-CDG	0.0285714	1.0718889347878144
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0718889347878144
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.0718889347878144
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.0718889347878144
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.0704944594836272
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02853423	1.0704944594836272
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.02853423	1.0704944594836272
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.028372483	1.0644263347317728
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	1.0636766495016525
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.0625832037869403
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02831885	1.0624142310462876
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.028084744	1.0536314751796716
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.027987973	1.0500009998054038
JACOBSEN SYNDROME	0.027977092999999998	1.049592824090861
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.027962943	1.0490619705650537
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.027959189	1.0489211349370764
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.02791536	1.0472768395884824
MONOSOMY X	0.027855989999999997	1.045049505749106
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.027855989999999997	1.045049505749106
TURNER SYNDROME	0.027855989999999997	1.045049505749106
MOSAIC MONOSOMY X	0.027855989999999997	1.045049505749106
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.02778486	1.0423809819829817
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623315
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0421161179623315
CLEFT CHIN	0.027777800000000002	1.0421161179623315
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623315
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623315
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623315
MENINGIOMA	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0421161179623315
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623315
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623315
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0421161179623315
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623315
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623315
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623315
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623315
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623315
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623315
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623315
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623315
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623315
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0277778	1.0421161179623313
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.02769053	1.0388420835314345
CARTILAGE-HAIR HYPOPLASIA	0.02769053	1.0388420835314345
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0342609489102441
PRADER-WILLI SYNDROME; PWS	0.027567783000000002	1.0342370886386956
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027519154	1.0324127157689797
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.027441620000000003	1.0295039385767584
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02740741	1.0282205110772624
11Q22.2Q22.3 MICRODELETION SYNDROME	0.027371733000000002	1.026882047385374
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.02736639	1.0266815985946751
BALLER-GEROLD SYNDROME	0.027364100000000002	1.02659568661064
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.027299654000000003	1.0241779207926773
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.026992323999999998	1.012648082341347
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.026983783999999997	1.0123276944183508
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.026906103	1.0094134023520451
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.02690456	1.0093555149322344
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.02690456	1.0093555149322344
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.026828419000000003	1.0064989977372885
MEND SYNDROME	0.026778773	1.004636470942785
JOUBERT SYNDROME WITH OCULAR DEFECT	0.026722503	1.0025254371691334
LATERAL MENINGOCELE SYNDROME	0.026715554	1.0022647374411593
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02669808	1.001609180231975
ANGELMAN SYNDROME	0.026575603000000003	0.9970143146997994
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.026560483000000003	0.9964470705082656
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.026494883999999996	0.9939860485690833
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.02648081	0.9934580462706941
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.026397870000000004	0.9903464567703092
FLOATING-HARBOR SYNDROME	0.02630463	0.9868484509225166
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02628886	0.9862568212333308
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.026233603	0.984183791319866
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.026222754	0.9837767786059803
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.026218619000000002	0.9836216493247639
FG SYNDROME TYPE 1	0.026211853	0.9833678150522823
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02621118	0.9833425666831751
WERNER SYNDROME; WRN	0.02621118	0.9833425666831751
OSTEOGLOSPHONIC DYSPLASIA	0.0262002	0.9829306393536088
DISTAL TRISOMY 17Q	0.025977103	0.9745608987849158
MOWAT-WILSON SYNDROME; MOWS	0.025898749	0.9716213583495025
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.025816033	0.9685181724667699
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.025813534	0.9684244196073357
PEHO-LIKE SYNDROME; PEHOL	0.025738453999999997	0.9656077070477878
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.025688049	0.963716705495257
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.025620498999999998	0.9611824895469687
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.025596763	0.9602920062050213
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.025550389000000003	0.9585522322540827
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025545554	0.9583708416677026
ZUNICH NEUROECTODERMAL SYNDROME	0.025541419000000003	0.9582157123864862
MAPLE SYRUP URINE DISEASE; MSUD	0.025541419000000003	0.9582157123864862
KLIPPEL-TRÉNAUNAY SYNDROME	0.02547172	0.9556008742313457
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.025430914000000002	0.9540699902049085
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.025375054	0.9519743380528526
KOOLEN-DE VRIES SYNDROME; KDVS	0.025346433	0.9509005883170132
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.025272969	0.9481445018562429
BARBER-SAY SYNDROME; BBRSAY	0.02526451	0.9478271527414159
JUBERG-HAYWARD SYNDROME	0.02514663	0.9434047489518645
SPONDYLOOCULAR SYNDROME; SOS	0.02506266	0.9402545178167387
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.9379037558430937
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.9379037558430937
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.9379037558430937
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.9379037558430937
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.9379037558430937
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.9379037558430937
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.9379037558430937
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.9379037558430937
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	0.9379037558430937
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	0.9379037558430937
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.9379037558430937
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	0.9379037558430937
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.9379037558430937
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	0.9379037558430937
CONGENITAL TOXOPLASMOSIS	0.024952663	0.9361278538394798
HURLER SYNDROME	0.024935754	0.9354934932551777
DERMOTRICHIC SYNDROME	0.024931619000000002	0.9353383639739613
GALACTOSIALIDOSIS	0.024931619000000002	0.9353383639739613
DISTAL MONOSOMY 13Q	0.024908930000000003	0.9344871600413085
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.024880463	0.9334191877926048
DISTAL MONOSOMY 10Q	0.024802743	0.9305034325964399
WIEDEMANN-STEINER SYNDROME; WDSTS	0.024795973000000002	0.9302494482593577
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.024788854000000003	0.9299823707858439
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.024783544	0.9297831600281028
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.024749244	0.928496356075086
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9277824237361383
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.02471529	0.9272225327100502
OMODYSPLASIA 1; OMOD1	0.02471529	0.9272225327100502
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.02471529	0.9272225327100502
JUVENILE POLYPOSIS OF INFANCY	0.02471529	0.9272225327100502
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.024675049	0.9257128453084948
OSTEOGENESIS IMPERFECTA, TYPE V	0.02462118	0.9236918878115544
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02462118	0.9236918878115544
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.02462118	0.9236918878115544
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.024475933	0.9182427795385566
PELIZAEUS-MERZBACHER DISEASE	0.024407109	0.9156607680148708
STÜVE-WIEDEMANN SYNDROME	0.024404799999999997	0.9155741432239812
GM1 GANGLIOSIDOSIS	0.024392149	0.9150995264073742
HOLT-ORAM SYNDROME	0.0243902	0.9150264074305688
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0243902	0.9150264074305688
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.0243902	0.9150264074305688
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.0243902	0.9150264074305688
MESOMELIA-SYNOSTOSES SYNDROME	0.0243902	0.9150264074305688
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0243902	0.9150264074305688
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.0243902	0.9150264074305688
SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA	0.0243902	0.9150264074305688
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.0243902	0.9150264074305688
HURLER-SCHEIE SYNDROME	0.0243902	0.9150264074305688
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.9139838336155738
ZTTK SYNDROME; ZTTKS	0.024318943	0.9123531191133645
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.024313749	0.9121582602290503
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.024294644	0.9114415141788351
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.024263183	0.9102612185763319
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.024180624	0.907163922729186
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.024179759	0.9071314712592338
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.0241525	0.9061088185200128
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0241525	0.9061088185200128
GAUCHER DISEASE, PERINATAL LETHAL	0.024104439000000002	0.9043057548236298
TRANSKETOLASE DEFICIENCY	0.024101013999999997	0.9041772620090791
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0240999	0.9041354690177188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.024088054	0.9036910527020502
ADRENOCORTICAL CARCINOMA	0.02406828	0.9029492083473286
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.02406828	0.9029492083473286
RING CHROMOSOME 7 SYNDROME	0.024045829999999997	0.9021069707745812
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0240143	0.9009240865577121
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.024005733999999997	0.9006027232148099
POSTERIOR FUSION OF LUMBOSACRAL VERTEBRAE-BLEPHAROPTOSIS SYNDROME	0.0239943	0.9001737635530376
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.023991389999999998	0.9000645915558573
HAREL-YOON SYNDROME; HAYOS	0.023945534	0.8983442509707399
17Q24.2 MICRODELETION SYNDROME	0.023923989000000003	0.8975359655139544
N-ACETYLASPARTATE DEFICIENCY; NACED	0.023850863	0.894792559511963
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.023833033	0.8941236465532958
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.023713089000000003	0.889623809429662
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.023667173000000003	0.8879012178755304
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.023654814	0.8874375557747916
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.023654814	0.8874375557747916
EVEN-PLUS SYNDROME	0.023603984	0.8855306098584115
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.02355546	0.8837101761844703
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0235425	0.8832239668774413
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0235425	0.8832239668774413
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.023541763	0.8831963174747189
EDINBURGH MALFORMATION SYNDROME	0.023540739	0.8831579009368796
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.023525849	0.8825992854598995
16P13.2 MICRODELETION SYNDROME	0.023509783	0.8819965509902444
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02336563	0.8765884853856024
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.023325044	0.8750658549122166
CLASSICAL EHLERS-DANLOS SYNDROME	0.02328435	0.8735391726946053
SILVER-RUSSELL SYNDROME; SRS	0.023272854	0.8731078870315184
COWDEN SYNDROME 5; CWS5	0.023268719	0.8729527577503022
COWDEN SYNDROME 6; CWS6	0.023268719	0.8729527577503022
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.8729527577503022
PYRUVATE DEHYDROGENASE DEFICIENCY	0.023120003	0.8673735059521437
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.023120003	0.8673735059521437
AICARDI-GOUTIERES SYNDROME 7	0.023120003	0.8673735059521437
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.023120003	0.8673735059521437
CEDNIK SYNDROME	0.023120003	0.8673735059521437
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.023109154	0.8669664932382579
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.023065033	0.8653112431737957
PRADER-WILLI-LIKE SYNDROME	0.023043653	0.8645091478817989
BRANCHIO-OCULO-FACIAL SYNDROME	0.02298443	0.862287328916507
BUSCHKE-OLLENDORFF SYNDROME	0.02298443	0.862287328916507
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02297619	0.8619781958385812
MONOSOMY 9P	0.022888153	0.8586753865204547
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02280507	0.8555584322105863
MARSHALL-SMITH SYNDROME; MRSHSS	0.02279743	0.8552718088228007
OROFACIODIGITAL SYNDROME TYPE 6	0.022753353	0.8536182094689488
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.022746910000000002	0.853376492912993
ARTERIES, ANOMALIES OF	0.0227273	0.8526408012069097
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.8526408012069097
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.8526408012069097
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.8526408012069097
LARSEN SYNDROME	0.0227273	0.8526408012069097
COCAINE EMBRYOFETOPATHY	0.0227273	0.8526408012069097
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8526408012069097
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.8526408012069097
BETHLEM MYOPATHY 1	0.0227273	0.8526408012069097
SIRENOMELIA	0.0227273	0.8526408012069097
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8526408012069097
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8526408012069097
THUMB DEFORMITY	0.0227273	0.8526408012069097
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8526408012069097
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8526408012069097
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8526408012069097
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.8526408012069097
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.8526408012069097
WATSON SYNDROME	0.0227273	0.8526408012069097
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8526408012069097
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.022718734	0.8523194378640075
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.022676703	0.8507425965535338
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.022661709000000002	0.8501800793969295
SPINAL ARACHNOIDITIS	0.02265578	0.8499576461421937
NEPHROSIALIDOSIS	0.02265578	0.8499576461421937
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	0.8499576461421937
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	0.8499576461421937
PITT-HOPKINS-LIKE SYNDROME	0.022631049	0.8490298342307636
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.022605399999999998	0.8480675824934187
DYSTONIA 28, CHILDHOOD-ONSET	0.022578584	0.8470615494087511
RAVINE SYNDROME	0.0225636	0.846499407413649
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.022546883000000004	0.845872249930192
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064703
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064703
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.02250458	0.8442852042268547
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.022403858999999998	0.8405065400591638
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.022380124	0.8396160942333664
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.022380124	0.8396160942333664
WYBURN-MASON SYNDROME	0.022363573	0.838995164430848
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.022363573	0.838995164430848
JOUBERT SYNDROME 30; JBTS30	0.022363573	0.838995164430848
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.022363573	0.838995164430848
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.022363573	0.838995164430848
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.022293703999999998	0.8363739485301679
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.022280519000000002	0.8358792980893364
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.022280519000000002	0.8358792980893364
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.022280519000000002	0.8358792980893364
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.022280519000000002	0.8358792980893364
SHUKLA-VERNON SYNDROME; SHUVER	0.022131632999999998	0.8302936685456379
HYPERCALCEMIA, INFANTILE, 1	0.0221203	0.8298684980150393
CHROMOSOME 10Q26 DELETION SYNDROME	0.022081703000000005	0.8284204871644685
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.022055544	0.8274391021905043
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.022001329000000003	0.8254051641055832
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.021990333	0.824992636517613
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.021906923000000002	0.8218634144266181
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.021843744	0.8194931815710016
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.021829583000000003	0.818961915367542
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.8186832078874554
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.021819703	0.8185912558032327
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.021818019	0.818528078606239
HUNTINGTON DISEASE; HD	0.021818019	0.818528078606239
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.021818019	0.818528078606239
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.021818019	0.818528078606239
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.021818019	0.818528078606239
KNOBLOCH SYNDROME	0.021786749	0.8173549485884305
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.021756653	0.8162258625309964
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021756653	0.8162258625309964
PROTEUS SYNDROME	0.0217391	0.8155673415459438
LUMBAR SYNDROME	0.0217391	0.8155673415459438
PTEN HAMARTOMA TUMOR SYNDROME	0.0217391	0.8155673415459438
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0217391	0.8155673415459438
PRIMARY MYELOFIBROSIS	0.0217391	0.8155673415459438
PROTEUS-LIKE SYNDROME	0.0217391	0.8155673415459438
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0217391	0.8155673415459438
LYMPHATIC MALFORMATION 1	0.0217391	0.8155673415459438
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.0217391	0.8155673415459438
TEMPI SYNDROME	0.0217391	0.8155673415459438
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.0217391	0.8155673415459438
COWDEN SYNDROME 7; CWS7	0.0217391	0.8155673415459438
ENCHONDROMATOSIS, MULTIPLE	0.0217391	0.8155673415459438
VERRUCOUS HEMANGIOMA	0.0217391	0.8155673415459438
ACROCEPHALOSYNDACTYLY	0.0217391	0.8155673415459438
KAPOSI SARCOMA	0.0217391	0.8155673415459438
WITTEVEEN-KOLK SYNDROME	0.021737783	0.8155179327760861
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.021716919000000005	0.8147351958176098
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.02171232	0.8145626590426848
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021679434	0.8133289029260984
CRANIOFRONTONASAL SYNDROME; CFNS	0.021669224	0.8129458630322122
SCARF SYNDROME	0.0216682	0.8129074464943727
SCARF SYNDROME	0.0216682	0.8129074464943727
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.021651563999999998	0.8122833278190845
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.021647429	0.8121281985378681
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.021641214000000002	0.8118950356641657
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.021609753000000006	0.8107147400616626
12Q14 MICRODELETION SYNDROME	0.021583914000000003	0.8097453602557733
LEIGH SYNDROME; LS	0.021476403	0.8057119614279953
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.021476403	0.8057119614279953
COFFIN-LOWRY SYNDROME	0.021444888999999998	0.8045296774695296
HYPERPROLINEMIA, TYPE I	0.021430832999999996	0.8040023504618443
BARAITSER-WINTER SYNDROME 2; BRWS2	0.021384459000000005	0.8022625765109059
RABSON-MENDENHALL SYNDROME	0.021378844	0.8020519233273435
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.8018971692076293
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.021287	0.7986062900252774
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.7982161220628465
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.7982161220628465
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.7982161220628465
KURU, SUSCEPTIBILITY TO	0.0212766	0.7982161220628465
NEUROFERRITINOPATHY	0.0212766	0.7982161220628465
SUSAC SYNDROME	0.0212766	0.7982161220628465
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.7982161220628465
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.7982161220628465
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.7982161220628465
X-LINKED RETINOSCHISIS	0.0212766	0.7982161220628465
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.7982161220628465
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02124533	0.797042992045038
DISTAL MONOSOMY 3P	0.021205259000000004	0.7955396823890227
JUNG SYNDROME	0.021179299999999998	0.7945658006451053
CRANIOFACIAL DYSSYNOSTOSIS	0.02115274	0.7935693716948975
SALT-AND-PEPPER SYNDROME	0.021125533999999998	0.7925487073116388
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.021125533999999998	0.7925487073116388
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.021106009999999998	0.7918162419944755
X SMALL RINGS	0.021062034	0.7901664317717975
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870421
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870421
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870421
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870421
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870421
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.020998584	0.7877860320394676
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.020945833000000004	0.7858070175984886
CYSTINOSIS, NEPHROPATHIC; CTNS	0.020917079999999998	0.7847283157308182
LOWRY-MACLEAN SYNDROME	0.020900359	0.7841010081827601
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642369
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642369
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642369
GAUCHER DISEASE, TYPE I	0.0208333	0.7815852126642369
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7815852126642369
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642369
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642369
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7815852126642369
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642369
IMINOGLYCINURIA	0.0208333	0.7815852126642369
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642369
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642369
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642369
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642369
STICKLER SYNDROME, TYPE III	0.0208333	0.7815852126642369
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642369
DERMOIDS OF CORNEA	0.0208333	0.7815852126642369
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642369
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642369
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7815852126642369
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642369
CRANDALL SYNDROME	0.0208333	0.7815852126642369
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642369
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642369
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642369
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642369
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751291
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
COPPER DEFICIENCY, FAMILIAL BENIGN	0.020696319	0.7764462128890712
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.020669680000000003	0.7754468201629952
MOEBIUS SYNDROME; MBS	0.020669680000000003	0.7754468201629952
WOLCOTT-RALLISON SYNDROME	0.020610059	0.7732100697699101
FRYNS SYNDROME	0.020607029000000002	0.773096395834702
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.02056531	0.7715312595631013
CONGENITAL HYPOTHYROIDISM	0.020545554	0.7707900904990838
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.7707900904990838
WEBB-DATTANI SYNDROME; WEDAS	0.020542583000000003	0.7706786300167395
GYRATE ATROPHY OF CHOROID AND RETINA	0.020541419	0.7706349612178675
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.020502064	0.7691585131254192
ICHTHYOSIS, X-LINKED	0.02045458	0.767377096247721
CHOROIDAL OSTEOMA, BILATERAL	0.02045458	0.767377096247721
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.02045458	0.767377096247721
ONCOCYTOMA	0.02045458	0.767377096247721
DISTAL MONOSOMY 15Q	0.020334263000000005	0.7628632656000502
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.020322824000000003	0.7624341183575266
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.020231073000000002	0.7589919740574322
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.020207014	0.7580893729989588
PRIMARY HYPEROXALURIA TYPE 1	0.0201549	0.7561342563456787
CORNELIA DE LANGE SYNDROME 1	0.020148419	0.7558911141760138
SMITH-FINEMAN-MYERS SYNDROME	0.020143928999999998	0.7557226666614644
PALLISTER-KILLIAN SYNDROME	0.020111469000000003	0.754504892424878
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.020073544000000002	0.7530820924272639
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.020016614	0.7509462979944579
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.7503230046744749
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.7503230046744749
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	0.7503230046744749
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.7503230046744749
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	0.7503230046744749
CATATRICHY	0.02	0.7503230046744749
TRICHODENTOOSSEOUS SYNDROME	0.02	0.7503230046744749
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.7503230046744749
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.7503230046744749
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	0.7503230046744749
VAN BOGAERT-HOZAY SYNDROME	0.02	0.7503230046744749
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02	0.7503230046744749
MIDPHALANGEAL HAIR	0.02	0.7503230046744749
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.7503230046744749
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.7503230046744749
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.7503230046744749
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.7503230046744749
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.7503230046744749
FAMILIAL MELANOMA	0.02	0.7503230046744749
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	0.7503230046744749
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.7503230046744749
HAIRY NOSE TIP	0.02	0.7503230046744749
HAIR WHORL	0.02	0.7503230046744749
DARIER DISEASE	0.02	0.7503230046744749
DISSECTING CELLULITIS OF THE SCALP	0.02	0.7503230046744749
RINGED HAIR	0.02	0.7503230046744749
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.019997029000000003	0.7502115441921307
BAND HETEROTOPIA; BH	0.019954873	0.7486300133628777
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.019946624	0.7483205426395997
BARDET-BIEDL SYNDROME 1; BBS1	0.019906863999999996	0.7468289005063067
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.019897659999999998	0.7464836018595554
BOHRING-OPITZ SYNDROME	0.019851923	0.7447677256963158
GERMAN SYNDROME	0.019825424	0.7437735852312723
WIEACKER-WOLFF SYNDROME	0.019785633	0.7422807800973221
ATAXIA-TELANGIECTASIA	0.019740449	0.7405856503651617
49,XXXXY SYNDROME	0.019731613000000002	0.7402541576616966
48,XXXY SYNDROME	0.019731613000000002	0.7402541576616966
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.019731613	0.7402541576616963
BAKER-GORDON SYNDROME; BAGOS	0.019687904	0.7386143642511306
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.019580753	0.7345944712374369
ADENYLOSUCCINASE DEFICIENCY	0.019543603	0.733200746256254
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.019466383	0.7303037491352059
WARBURG MICRO SYNDROME 2; WARBM2	0.01945561	0.7298995876487381
HHHH SYNDROME	0.019409319	0.7281629275382687
FANCONI ANEMIA	0.01940107	0.7278534568149907
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.01936908	0.7266533151690139
22Q11.2 DELETION SYNDROME	0.019256723	0.7224381130772034
HOYERAAL-HREIDARSSON SYNDROME	0.019255684	0.7223991337971105
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.019237914000000002	0.7217324718074574
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.019227729	0.7213503698173268
OHDO SYNDROME	0.019190469	0.7199525180596184
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.019174189	0.7193417551338133
BARAITSER-WINTER SYNDROME 1; BRWS1	0.019147183	0.7183285939806013
TIMOTHY SYNDROME; TS	0.019093203	0.7163034721909848
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395407
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.01907494	0.7156183147392663
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.018944073000000002	0.7107086887066297
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.018941173	0.7105998918709517
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.01890914	0.709398137030515
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.01890503	0.7092439456530544
POLAND SYNDROME	0.01887237	0.708018668186421
PUBIC BONE DYSPLASIA	0.0188679	0.7078509709948763
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7078509709948763
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7078509709948763
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7078509709948763
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7078509709948763
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7078509709948763
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7078509709948763
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7078509709948763
TOE, MISSHAPEN	0.0188679	0.7078509709948763
VAN DEN BOSCH SYNDROME	0.0188679	0.7078509709948763
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7078509709948763
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7078509709948763
VESICOURETERAL REFLUX 1	0.0188679	0.7078509709948763
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7078509709948763
THROMBOCYTOPENIA 3	0.0188679	0.7078509709948763
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7078509709948763
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7078509709948763
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7078509709948763
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7078509709948763
TRACHEOBRONCHOMEGALY	0.0188679	0.7078509709948763
RAYNAUD DISEASE	0.0188679	0.7078509709948763
CARPAL DISPLACEMENT	0.0188679	0.7078509709948763
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7078509709948763
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7078509709948763
MONOPHALANGY OF GREAT TOE	0.0188679	0.7078509709948763
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7078509709948763
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7078509709948763
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7078509709948763
KNUCKLE PADS	0.0188679	0.7078509709948763
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7078509709948763
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7078509709948763
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7078509709948763
LETTERER-SIWE DISEASE	0.0188679	0.7078509709948763
19P13.12 MICRODELETION SYNDROME	0.018848673000000003	0.7071296479743325
2Q31.1 MICRODELETION SYNDROME	0.018848673000000003	0.7071296479743325
SAETHRE-CHOTZEN SYNDROME	0.018775558999999997	0.7043866921661438
CAMPOMELIC DYSPLASIA	0.018686309999999998	0.7010384132739342
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.018686309999999998	0.7010384132739342
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.01861353	0.6983079878599239
ADDUCTED THUMBS SYNDROME	0.01861353	0.6983079878599239
BLOOM SYNDROME	0.01861353	0.6983079878599239
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.018518193000000002	0.6947313106450915
CONGENITAL ADRENAL HYPERPLASIA	0.018493779999999998	0.6938154288694354
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.018408359999999995	0.6906107993164706
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.018402654	0.6903967321632373
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.018402654	0.6903967321632373
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.018402654	0.6903967321632373
HEREDITARY COPROPORPHYRIA	0.018398519000000002	0.6902416028820209
TENORIO SYNDROME; TNORS	0.018398519000000002	0.6902416028820209
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01830672	0.6867976578067151
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.018179383	0.6820204637844034
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.01815574	0.6811334694444275
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.018146659	0.680792785284155
INTELLECTUAL DISABILITY, WOLFF TYPE	0.018122729	0.6798950238090621
PERIPARTUM CARDIOMYOPATHY	0.018115979999999997	0.6796418273111345
AFRICAN IRON OVERLOAD	0.018115979999999997	0.6796418273111345
2Q37 MICRODELETION SYNDROME	0.018100373	0.6790563127544369
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.018085902999999997	0.6785134540605549
9Q SUBTELOMERIC DELETION SYNDROME	0.01803757	0.6767001859713083
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017970094000000002	0.6741687462181377
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.017968684	0.674115848446308
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017968684	0.674115848446308
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0179537	0.6735537064512059
X-LINKED AGAMMAGLOBULINEMIA	0.0179537	0.6735537064512059
AASE-SMITH SYNDROME	0.01791203	0.6719904084709667
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.017893569999999998	0.671297860337652
PORPHYRIA CUTANEA TARDA, TYPE I	0.0178571	0.6699296463386283
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0178571	0.6699296463386283
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0178571	0.6699296463386283
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.0178571	0.6699296463386283
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0178571	0.6699296463386283
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0178571	0.6699296463386283
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0178571	0.6699296463386283
PAPILLON-LEFÈVRE SYNDROME	0.0178571	0.6699296463386283
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0178571	0.6699296463386283
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.0178571	0.6699296463386283
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2	0.0178571	0.6699296463386283
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.017836303	0.6691494229622176
COHEN SYNDROME	0.017794633	0.6675861249819783
ADENYLOSUCCINATE LYASE DEFICIENCY	0.017752719	0.666013673061082
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01774999	0.6659112914870942
COFFIN-SIRIS SYNDROME 7; CSS7	0.017749414	0.6658896821845595
ACROCRANIOFACIAL DYSOSTOSIS	0.01774524	0.6657330897734839
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.017680833	0.6633167870853804
GAUCHER DISEASE	0.017546839999999998	0.6582898855671131
AYMÉ-GRIPP SYNDROME	0.017544484	0.6582014975171625
FOUNTAIN SYNDROME	0.017412059	0.6532334213224616
14Q24.1Q24.3 MICRODELETION SYNDROME	0.01739999	0.6527806389052908
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.017399309999999998	0.6527551279231318
FRANK-TER HAAR SYNDROME; FTHS	0.017399309999999998	0.6527551279231318
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.017399309999999998	0.6527551279231318
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.017399309999999998	0.6527551279231318
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.017399309999999998	0.6527551279231318
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.017399309999999998	0.6527551279231318
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.017362040000000002	0.6513569010039211
8P11.2 DELETION SYNDROME	0.017319593	0.6497644529749501
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.017317903	0.6497010506810551
COCKAYNE SYNDROME	0.017249079	0.6471190391573693
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
TRISOMY 17P	0.017223014	0.6461411807015273
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.017212254	0.6457375069250124
HEREDITARY METHEMOGLOBINEMIA	0.017179839	0.6445214209151862
SALLA DISEASE	0.017069953	0.6403989212306033
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.017045503	0.6394816513573888
1Q21.1 MICRODELETION SYNDROME	0.017033933000000005	0.6390475894991847
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.016996013999999997	0.6376250145984719
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.016988853999999998	0.6373563989627984
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.01698881	0.6373547482521883
CHST3-RELATED SKELETAL DYSPLASIA	0.01698881	0.6373547482521883
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.01698881	0.6373547482521883
LATERAL MENINGOCELE SYNDROME	0.016858230000000002	0.6324558893546687
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.016798388999999997	0.6302108854085322
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.016793279	0.630019177880838
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.016772424	0.6292367785677138
DUPLICATION/INVERSION 15Q11	0.016769079	0.6291112870451819
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.016757954	0.6286939198738317
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01672152	0.6273270564562162
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016716283999999998	0.6271306218935924
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.01670766	0.6268070826139769
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.016679644	0.6257560301490288
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0166667	0.6252704211004035
NASOPHARYNGEAL CARCINOMA	0.0166667	0.6252704211004035
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	0.6252704211004035
N SYNDROME	0.0166667	0.6252704211004035
HEPATOCELLULAR CARCINOMA	0.0166667	0.6252704211004035
ANTISYNTHETASE SYNDROME	0.0166667	0.6252704211004035
ACQUIRED PURPURA FULMINANS	0.0166667	0.6252704211004035
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0166667	0.6252704211004035
PRIMARY PERITONEAL CARCINOMA	0.0166667	0.6252704211004035
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0166667	0.6252704211004035
ADAMANTINOMA OF LONG BONES	0.0166667	0.6252704211004035
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0166667	0.6252704211004035
PERITONEAL CYSTIC MESOTHELIOMA	0.0166667	0.6252704211004035
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.0166667	0.6252704211004035
MALIGNANT PERITONEAL MESOTHELIOMA	0.0166667	0.6252704211004035
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.6252704211004035
HURIEZ SYNDROME; HRZ	0.0166667	0.6252704211004035
TRIGEMINAL NEURALGIA	0.0166667	0.6252704211004035
THYMOMA, FAMILIAL	0.0166667	0.6252704211004035
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.6252704211004035
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.6252704211004035
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0166667	0.6252704211004035
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0166667	0.6252704211004035
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0166667	0.6252704211004035
117600 CEREBRAL SARCOMA	0.0166667	0.6252704211004035
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.6252704211004035
CHYLOUS ASCITES	0.0166667	0.6252704211004035
GALACTOSEMIA	0.016549303	0.6208661376114151
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.016538453999999998	0.6204591248975292
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.016534319	0.6203039956163129
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.016534319	0.6203039956163129
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.016499949	0.6190145655327798
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.016496784	0.6188958269172902
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.01648744	0.6185452760095062
HALLERMANN-STREIFF SYNDROME; HSS	0.01645142	0.6171939442780875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.016435503000000004	0.6165967997148174
OGDEN SYNDROME; OGDNS	0.016428064	0.6163177170732286
VASCULAR EHLERS-DANLOS SYNDROME	0.016356324	0.6136263084554612
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01633598	0.6128630798951064
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.01628788	0.6110585530688644
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016287583999999997	0.611047448288395
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.016267203	0.6102828316304816
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.016246633	0.6095111244201739
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.016214684	0.6083125209363567
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.01613409	0.6052889443244199
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.01613409	0.6052889443244199
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.016072573	0.602981063310492
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.016072573	0.602981063310492
KLEEFSTRA SYNDROME	0.016069303	0.6028583854992277
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.016062384	0.6025988112557605
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.016030903	0.6014177653302527
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.016021744	0.6010741549102621
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.016007884	0.6005541810680226
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.016007884	0.6005541810680226
HARDIKAR SYNDROME	0.015992899999999997	0.5999920390729204
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.015967962999999998	0.599056498834542
COSTELLO SYNDROME	0.01595123	0.5984287410926812
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.015930693000000003	0.5976582719153313
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01590154	0.5965645635875674
14Q12 MICRODELETION SYNDROME	0.015894539	0.5963019130197811
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01589181	0.5961995314457933
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01588199	0.5958311228504981
FREE SIALIC ACID STORAGE DISEASE	0.015792873	0.5924877960901193
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.015792873	0.5924877960901193
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.015788603000000002	0.5923276021286215
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.015772473999999998	0.5917225041415016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.015750683999999997	0.5909050272279087
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.015746933	0.5907643041483821
KOOLEN-DE VRIES SYNDROME	0.015746933	0.5907643041483821
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.015746549	0.5907498979466923
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.015742029999999997	0.5905803624637861
MONOSOMY 18P	0.015725064	0.5899438634589208
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.015716844	0.5896354807039996
TOLUENE EMBRYOPATHY	0.015701854	0.5890731136119961
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01569499	0.5888156027567918
DERMATITIS, ATOPIC	0.015692679999999997	0.5887289404497519
BARATELA-SCOTT SYNDROME	0.015606894	0.5855105799858017
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.015565809000000002	0.5839692289534493
CEREBROFACIOTHORACIC DYSPLASIA	0.01555024	0.5833851400104604
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015531153999999998	0.5826691067670994
2Q23.1 MICRODELETION SYNDROME	0.015523748999999998	0.5823912996746186
KLEEFSTRA SYNDROME	0.015523748999999998	0.5823912996746186
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.015485348999999997	0.5809506795056436
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230292
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.015356238999999999	0.5761069693489675
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.015328613999999999	0.575070585698761
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.015328613999999999	0.575070585698761
BRANCHIOSKELETOGENITAL SYNDROME	0.015326929	0.5750073709856172
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01531241	0.5744626740003738
OSTEOMESOPYKNOSIS	0.01528218	0.5733285607788083
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.015251454	0.5721758395467269
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.015251454	0.5721758395467269
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.015251454	0.5721758395467269
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.015251454	0.5721758395467269
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.015247318999999999	0.5720207102655105
ADAMS-OLIVER SYNDROME 5; AOS5	0.015247318999999999	0.5720207102655105
HYPOPHOSPHATASIA	0.015247318999999999	0.5720207102655105
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.015247184000000002	0.572015645585229
BOHRING-OPITZ SYNDROME	0.015246583	0.5719930983789384
OCULOCEREBRORENAL SYNDROME OF LOWE	0.015223638999999999	0.5711323278279758
AMISH LETHAL MICROCEPHALY	0.01520609	0.5704739569075243
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.015136933000000002	0.5678794525058107
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.015043179	0.5643621633567981
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.015001303	0.5627911370496107
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.015001303	0.5627911370496107
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.015001303	0.5627911370496107
19P13.3 MICRODUPLICATION SYNDROME	0.015000583999999999	0.5627641629375927
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.015000583999999999	0.5627641629375927
DISTAL MONOSOMY 1Q	0.014997942999999998	0.5626650827848253
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.014941288999999998	0.560539642809484
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
MEHMO SYNDROME	0.014916439	0.5596073664761759
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.014905313000000002	0.5591899617886755
DISTAL MONOSOMY 10P	0.014903679999999999	0.5591286979153438
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.014898980000000001	0.5589523720092454
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.014898980000000001	0.5589523720092454
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.014898980000000001	0.5589523720092454
KERATOSIS, FAMILIAL ACTINIC	0.014898980000000001	0.5589523720092454
GLOMUVENOUS MALFORMATIONS	0.014898980000000001	0.5589523720092454
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.014880989999999998	0.5582774564665406
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.014832303	0.5564509076601114
MONOSOMY 22Q13.3	0.014832303	0.5564509076601114
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014785572999999998	0.5546977779596893
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.014785572999999998	0.5546977779596893
PEHO SYNDROME; PEHO	0.014785572999999998	0.5546977779596893
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.014785572999999998	0.5546977779596893
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014785572999999998	0.5546977779596893
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014785572999999998	0.5546977779596893
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.014785572999999998	0.5546977779596893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014785572999999998	0.5546977779596893
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014785572999999998	0.5546977779596893
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014785572999999998	0.5546977779596893
DESMOSTEROLOSIS	0.014783059999999999	0.5546034998741521
SHPRINTZEN-GOLDBERG SYNDROME	0.014783059999999999	0.5546034998741521
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0147059	0.5517087537221179
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0147059	0.5517087537221179
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0147059	0.5517087537221179
LAMBERT SYNDROME	0.0147059	0.5517087537221179
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.0147059	0.5517087537221179
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.0147059	0.5517087537221179
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0147059	0.5517087537221179
HIRSCHSPRUNG DISEASE	0.0147059	0.5517087537221179
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0147059	0.5517087537221179
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0147059	0.5517087537221179
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0147059	0.5517087537221179
COMMON VARIABLE IMMUNODEFICIENCY	0.0147059	0.5517087537221179
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0147059	0.5517087537221179
GLYCOGEN STORAGE DISEASE VI	0.0147059	0.5517087537221179
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0147059	0.5517087537221179
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.0147059	0.5517087537221179
FIBROCHONDROGENESIS 1; FBCG1	0.0147059	0.5517087537221179
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0147059	0.5517087537221179
TRICUSPID ATRESIA	0.0147059	0.5517087537221179
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0147059	0.5517087537221179
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0147059	0.5517087537221179
FLOATING-HARBOR SYNDROME	0.014692804	0.5512174422186571
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0146757	0.5505757659850595
DIAMOND-BLACKFAN ANEMIA 1	0.01466831	0.5502985216348323
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.014659960000000001	0.5499852617803808
SCHISIS ASSOCIATION	0.014654300000000002	0.549772920370058
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.014627152999999999	0.5487544694396629
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.014574634	0.546784158745538
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.014569073	0.5465755314340882
DUBOWITZ SYNDROME	0.01450176	0.5440502068134057
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.014501603000000002	0.5440443167778191
OTOPALATODIGITAL SYNDROME TYPE 2	0.014490754000000002	0.5436373040639333
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.014470489999999999	0.542877076795597
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.014470489999999999	0.542877076795597
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.014459884000000001	0.5424791805062182
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.014459884000000001	0.5424791805062182
DUPLICATION OF THE PITUITARY GLAND	0.014459884000000001	0.5424791805062182
ALAZAMI SYNDROME; ALAZS	0.014459884	0.5424791805062181
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.014459884	0.5424791805062181
FORSYTHE-WAKELING SYNDROME; FWS	0.014459884	0.5424791805062181
COSTELLO SYNDROME; CSTLO	0.014457434	0.5423872659381457
MENTAL RETARDATION, X-LINKED 102	0.014455749	0.5423240512250018
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.014455749	0.5423240512250018
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.014455749	0.5423240512250018
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01444966	0.5420956153862286
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.014423080000000001	0.5410984361130163
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.014423080000000001	0.5410984361130163
HEART-HAND SYNDROME TYPE 2	0.014423080000000001	0.5410984361130163
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.014422173000000002	0.5410644089647543
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.014422173000000002	0.5410644089647543
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.014422173000000002	0.5410644089647543
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.014422173000000002	0.5410644089647543
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.014422173000000002	0.5410644089647543
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.014399869999999999	0.5402276862660915
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.014380503000000001	0.539501110984515
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.014380503000000001	0.539501110984515
20Q11.2 MICRODUPLICATION SYNDROME	0.014343403	0.5381092618108438
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.01430491	0.5366651526398971
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.01430491	0.5366651526398971
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.014278772999999998	0.5356845930212382
MIRAGE SYNDROME; MIRAGE	0.014244873	0.534412795528315
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.014244873	0.534412795528315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.014241512999999999	0.5342867412635297
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.014240018999999998	0.5342306921350805
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.014240018999999998	0.5342306921350805
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.014240018999999998	0.5342306921350805
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.014240018999999998	0.5342306921350805
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.014240018999999998	0.5342306921350805
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.014212203	0.5331871429001792
BOWEN-CONRADI SYNDROME	0.014199769000000001	0.5327206670881732
%608572 BURN-MCKEOWN SYNDROME	0.01417148	0.5316593727142114
PMM2-CDG	0.014148883000000001	0.5308116202673799
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.014083284	0.5283505983281979
MARDEN-WALKER SYNDROME	0.014083283999999998	0.5283505983281978
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.014083283999999998	0.5283505983281978
FUMARASE DEFICIENCY; FMRD	0.014083283999999998	0.5283505983281978
ACROOSTEOLYSIS DOMINANT TYPE	0.01407075	0.5278803709011683
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.014038503	0.5266705876045815
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.014038503	0.5266705876045815
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.014038503	0.5266705876045815
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.014034643	0.5265257752646793
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.014027654	0.5262635748906958
PRIMARY PULMONARY HYPOPLASIA	0.013948229999999999	0.5232838921745325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.013945200000000001	0.5231702182393244
WEAVER-WILLIAMS SYNDROME	0.01391433	0.5220120946816094
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01391433	0.5220120946816094
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01391433	0.5220120946816094
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.01391433	0.5220120946816094
MEIER-GORLIN SYNDROME 8; MGORS8	0.01391433	0.5220120946816094
SECKEL SYNDROME 4	0.01391433	0.5220120946816094
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.013910969999999998	0.521886040416824
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.013906559999999998	0.5217205941942932
HYDROLETHALUS	0.01389787	0.5213945788487622
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.013876619000000001	0.5205973231401454
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.013850920000000001	0.5196331955952889
MENTAL RETARDATION, X-LINKED 1	0.013834949000000001	0.519034025159906
JOUBERT SYNDROME	0.013826603	0.5187209153700554
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.013814534	0.5182681329528845
TRISOMY 9P	0.013801984	0.5177973052674514
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.01374533	0.51567186529211
NETHERTON SYNDROME; NETH	0.013737353999999998	0.5153726364778457
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.013733218999999998	0.5152175071966293
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.013711853	0.5144159371307356
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.013703454	0.5141008389849225
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
CONGENITAL HYDROCEPHALUS	0.013691548999999997	0.5136542092163899
NOONAN SYNDROME 7; NS7	0.013691509	0.5136527085703807
MONOSOMY 5P	0.01365835	0.5124087105447807
TRISOMY 18P	0.01365835	0.5124087105447807
MONOSOMY 22	0.013540179999999999	0.5079754270716615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.013497084	0.506358631061189
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01344043	0.5042331910858476
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01344043	0.5042331910858476
GENITOPALATOCARDIAC SYNDROME	0.013414630000000002	0.5032652744098176
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.013414630000000002	0.5032652744098176
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.013414630000000002	0.5032652744098176
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.013337703	0.5003792695207878
8P INVERTED DUPLICATION/DELETION SYNDROME	0.013325169	0.49990904209375836
ADAMS-OLIVER SYNDROME 1; AOS1	0.013294173000000001	0.49874619150111393
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.013294173000000001	0.49874619150111393
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.013282073	0.49829224608328576
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.013282073	0.49829224608328576
ELEJALDE DISEASE	0.013282073	0.49829224608328576
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.013256430000000001	0.49733021944284245
BLOOM SYNDROME	0.013256430000000001	0.49733021944284245
TRISOMY 4P	0.013243399999999999	0.496841384005297
OCULO-PALATO-CEREBRAL SYNDROME	0.013206784	0.495467692648339
TONNE-KALSCHEUER SYNDROME; TOKAS	0.013206784	0.495467692648339
CEREBROFACIOARTICULAR SYNDROME	0.013206784	0.495467692648339
LOWRY-MACLEAN SYNDROME	0.013206784	0.495467692648339
CHOPS SYNDROME; CHOPS	0.013203754000000002	0.4953540187131309
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.013203754000000002	0.4953540187131309
CHROMOSOME 15Q25 DELETION SYNDROME	0.013203754000000002	0.4953540187131309
NOONAN SYNDROME 2; NS2	0.013203754000000002	0.4953540187131309
NOONAN SYNDROME 9; NS9	0.013203754000000002	0.4953540187131309
OCULOFACIOCARDIODENTAL SYNDROME	0.013203754000000002	0.4953540187131309
OROFACIODIGITAL SYNDROME I; OFD1	0.013202648999999999	0.4953125633671225
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.013202648999999999	0.4953125633671225
CASPASE 8 DEFICIENCY	0.013191799999999998	0.4949055506532368
CYSTIC FIBROSIS	0.013191799999999998	0.4949055506532368
LYSINURIC PROTEIN INTOLERANCE	0.013191799999999998	0.4949055506532368
IMMUNODEFICIENCY 58; IMD58	0.013191799999999998	0.4949055506532368
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.013191799999999998	0.4949055506532368
GRANGE SYNDROME; GRNG	0.0131579	0.49363375316031366
FG SYNDROME 2; FGS2	0.0131579	0.49363375316031366
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0131579	0.49363375316031366
SHORT STATURE DUE TO GHSR DEFICIENCY	0.0131579	0.49363375316031366
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0131579	0.49363375316031366
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0131579	0.49363375316031366
MACS SYNDROME	0.0131579	0.49363375316031366
OROFACIODIGITAL SYNDROME XVII	0.0131579	0.49363375316031366
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0131579	0.49363375316031366
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0131579	0.49363375316031366
OVARIAN DYSGENESIS 4; ODG4	0.0131579	0.49363375316031366
RUIJS-AALFS SYNDROME; RJALS	0.0131579	0.49363375316031366
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0131579	0.49363375316031366
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0131579	0.49363375316031366
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.01315454	0.4935076988955283
CRANIOECTODERMAL DYSPLASIA 4	0.01315454	0.4935076988955283
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.013150129999999998	0.4933422526729975
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.013135173000000002	0.4927811236139518
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.013135173000000002	0.4927811236139518
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.013135173000000002	0.4927811236139518
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.013135173000000002	0.4927811236139518
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.013135173000000002	0.4927811236139518
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.013135173000000002	0.4927811236139518
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.013135173000000002	0.4927811236139518
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.013135173000000002	0.4927811236139518
LISSENCEPHALY 1; LIS1	0.013135173000000002	0.4927811236139518
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.013135173000000002	0.4927811236139518
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01312523	0.4924081005321779
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.013105144	0.49165455113858336
AU-KLINE SYNDROME; AUKS	0.013045554000000001	0.4894189637461558
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.013045554000000001	0.4894189637461558
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.013045554000000001	0.4894189637461558
MECKEL SYNDROME, TYPE 10; MKS10	0.013041419	0.48926383446493926
ROIFMAN SYNDROME; RFMN	0.013005674000000002	0.48792281967483486
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.012991772999999998	0.4874013076704357
ALSTRÖM SYNDROME	0.012991772999999998	0.4874013076704357
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.012991772999999998	0.4874013076704357
NETHERTON SYNDROME	0.012991772999999998	0.4874013076704357
RECOMBINANT 8 SYNDROME	0.012991733	0.4873998070244264
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.012985330000000002	0.48715959111448
NEONATAL ADRENOLEUKODYSTROPHY	0.012982038999999999	0.4870361254640607
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.012951530000000001	0.4858915452365801
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.012951530000000001	0.4858915452365801
FACIOCARDIOMELIC SYNDROME	0.012951530000000001	0.4858915452365801
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.012926779	0.48496298300214513
16P12.1P12.3 TRIPLICATION SYNDROME	0.012915929999999999	0.4845559702882594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012796283999999998	0.4800673129773953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012796283999999998	0.4800673129773953
RING CHROMOSOME 14 SYNDROME	0.012796283999999998	0.4800673129773953
BETA-UREIDOPROPIONASE DEFICIENCY	0.012796283999999998	0.4800673129773953
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.01278375	0.47959708555036595
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.012781299999999999	0.4795051709822932
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.012757573	0.4786150252856977
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012740654	0.47798028953989335
LERI PLEONOSTEOSIS	0.012739629999999998	0.47794187300205393
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.012736519	0.47782516025867683
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.012728263	0.4775154269223473
MILLER-DIEKER SYNDROME (MDS)	0.012661229999999999	0.4750006068237301
TRIPLOIDY	0.012658200000000001	0.47488693288852196
ATRIAL SEPTAL DEFECT-ATRIOVENTRICULAR CONDUCTION DEFECTS SYNDROME	0.012658200000000001	0.47488693288852196
CONGENITAL LARYNGEAL WEB	0.012658200000000001	0.47488693288852196
AUTOSOMAL RECESSIVE AMELIA	0.012658200000000001	0.47488693288852196
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.012658200000000001	0.47488693288852196
CONGENITAL PULMONARY VENOUS RETURN ANOMALY	0.012658200000000001	0.47488693288852196
MELNICK-NEEDLES SYNDROME	0.012658200000000001	0.47488693288852196
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.012658200000000001	0.47488693288852196
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.012658200000000001	0.47488693288852196
CONGENITAL PERICARDIUM ANOMALY	0.012658200000000001	0.47488693288852196
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.012658200000000001	0.47488693288852196
TRACHEAL AGENESIS	0.012658200000000001	0.47488693288852196
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.012658200000000001	0.47488693288852196
DIPROSOPUS	0.012658200000000001	0.47488693288852196
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.012658200000000001	0.47488693288852196
NOONAN SYNDROME 10; NS10	0.012658200000000001	0.47488693288852196
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.012658200000000001	0.47488693288852196
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.012657598999999999	0.4748643856822314
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.012593754000000002	0.4724691670705594
HYPERMANGANESEMIA WITH DYSTONIA 2	0.012593754000000002	0.4724691670705594
RETT SYNDROME; RTT	0.012589619000000002	0.4723140377893429
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.012589619000000002	0.4723140377893429
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.012589619000000002	0.4723140377893429
XP22.3 MICRODELETION SYNDROME	0.0125	0.46895187792154686
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0125	0.46895187792154686
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.0125	0.46895187792154686
ISOTRETINOIN SYNDROME	0.0125	0.46895187792154686
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0125	0.46895187792154686
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0125	0.46895187792154686
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.012493139	0.46869447961479327
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.012493139	0.46869447961479327
JOHANSON-BLIZZARD SYNDROME; JBS	0.01247613	0.4680563674154678
KAGAMI-OGATA SYNDROME	0.012466523	0.4676959497601724
ERYTHROKERATODERMIA VARIABILIS	0.01246212	0.46753076615069333
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.012450353999999999	0.4670893511270433
IMMUNODEFICIENCY 23; IMD23	0.012450353999999999	0.4670893511270433
48,XYYY SYNDROME	0.012450353999999999	0.4670893511270433
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.012450353999999999	0.4670893511270433
ALSTROM SYNDROME; ALMS	0.012450353999999999	0.4670893511270433
7P22.1 MICRODUPLICATION SYNDROME	0.012450353999999999	0.4670893511270433
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.012450314	0.467087850481034
RITSCHER-SCHINZEL SYNDROME 1	0.012450314	0.467087850481034
9Q21.13 MICRODELETION SYNDROME	0.012446218999999998	0.4669342218458268
47,XYY SYNDROME	0.012446218999999998	0.4669342218458268
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.012446218999999998	0.4669342218458268
BERNARD-SOULIER SYNDROME	0.012446218999999998	0.4669342218458268
KAPUR-TORIELLO SYNDROME	0.012446179	0.4669327211998175
CAMOS SYNDROME	0.012408949	0.465535994926616
COFFIN-SIRIS SYNDROME 6; CSS6	0.012371304	0.4641236994510674
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01235643	0.46356568423249106
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012347993	0.46324916047296916
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.012316329	0.46206124909196855
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.012282263	0.4607832239181065
FEINGOLD SYNDROME	0.01225073	0.4596002271527865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.4596002271527865
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01221733	0.45834718773498007
11P15.4 MICRODUPLICATION SYNDROME	0.012210443	0.45808881400832047
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.4575132037152844
CATARACT 48; CTRCT48	0.0121951	0.4575132037152844
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.4575132037152844
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.4575132037152844
JUBERG-MARSIDI SYNDROME	0.0121951	0.4575132037152844
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.4575132037152844
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0121951	0.4575132037152844
RHYNS SYNDROME; RHYNS	0.0121951	0.4575132037152844
LOEYS-DIETZ SYNDROME 3; LDS3	0.0121951	0.4575132037152844
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.4575132037152844
LELIS SYNDROME	0.0121951	0.4575132037152844
ACHROMATOPSIA	0.0121951	0.4575132037152844
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0121951	0.4575132037152844
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.012174484	0.4567397707620659
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.012136193	0.4553032398534665
WAARDENBURG SYNDROME TYPE 1	0.01211618	0.454552429138839
MCDONOUGH SYNDROME	0.01211618	0.454552429138839
GAUCHER DISEASE, TYPE II	0.012093883	0.4537159315370776
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.4520020812459505
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.4520020812459505
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.012048200000000002	0.4520020812459505
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609965
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45168897145609965
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45168897145609965
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.45168897145609965
COLE-CARPENTER SYNDROME	0.012039854	0.45168897145609965
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.012035718999999999	0.4515338421748833
MUCOPOLYSACCHARIDOSIS TYPE 3	0.012035718999999999	0.4515338421748833
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.012035718999999999	0.4515338421748833
SIALIDOSIS TYPE 1	0.012035718999999999	0.4515338421748833
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.011979963	0.44944209170245175
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.011979962999999998	0.4494420917024517
XQ28 (MECP2) DUPLICATION	0.011979962999999998	0.4494420917024517
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011938292999999999	0.4478787937222125
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.011938292999999999	0.4478787937222125
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.011938292999999999	0.4478787937222125
TYSHCHENKO SYNDROME	0.011925104	0.44738399321677996
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.011904799999999998	0.4466222653024344
NF1-MICRODELETION SYNDROME	0.011904799999999998	0.4466222653024344
AA AMYLOIDOSIS	0.011904799999999998	0.4466222653024344
ICHTHYOSIS VULGARIS	0.011904799999999998	0.4466222653024344
MASTOCYTOSIS	0.011904799999999998	0.4466222653024344
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	0.4466222653024344
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	0.4466222653024344
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	0.4466222653024344
FIBULAR HEMIMELIA	0.011904799999999998	0.4466222653024344
SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.4466222653024344
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	0.4466222653024344
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.011904799999999998	0.4466222653024344
CUTANEOUS MASTOCYTOSIS	0.011904799999999998	0.4466222653024344
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.011904799999999998	0.4466222653024344
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	0.4466222653024344
MYOTONIA PERMANENS	0.011904799999999998	0.4466222653024344
YAO SYNDROME	0.011904799999999998	0.4466222653024344
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.011904799999999998	0.4466222653024344
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	0.4466222653024344
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	0.4466222653024344
AORTIC ARCH DEFECTS	0.011904799999999998	0.4466222653024344
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	0.4466222653024344
CARCINOID SYNDROME	0.011904799999999998	0.4466222653024344
CHILBLAIN LUPUS	0.011904799999999998	0.4466222653024344
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	0.4466222653024344
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	0.4466222653024344
CAT-EYE SYNDROME (TYPE I)	0.011904799999999998	0.4466222653024344
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.011904799999999998	0.4466222653024344
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.011904799999999998	0.4466222653024344
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	0.4466222653024344
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	0.4466222653024344
TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	0.011904799999999998	0.4466222653024344
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.4466222653024344
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	0.4466222653024344
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	0.4466222653024344
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	0.4466222653024344
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	0.4466222653024344
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	0.4466222653024344
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	0.4466222653024344
MICROTRIPLICATION 11Q24.1	0.0118799	0.4456881131616147
SAY SYNDROME	0.011867530000000001	0.44522403838322355
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.011765403	0.4413926265083041
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.011664889	0.43762172818371153
CURRY-JONES SYNDROME	0.011656654	0.4373127826865368
HYPERTELORISM, TEEBI TYPE	0.011628929999999999	0.43627268493745697
ACROMEGALY	0.01158752	0.4347191411562786
PRIMROSE SYNDROME; PRIMS	0.01158752	0.4347191411562786
SOMATOMAMMOTROPINOMA	0.01158752	0.4347191411562786
DIASTROPHIC DWARFISM	0.011494299999999999	0.4312218856314908
MULTIPLE EPIPHYSEAL DYSPLASIA	0.011494299999999999	0.4312218856314908
ACHONDROPLASIA	0.011494299999999999	0.4312218856314908
RADIO-RENAL SYNDROME	0.011494299999999999	0.4312218856314908
MUCOPOLYSACCHARIDOSIS TYPE 1	0.011494299999999999	0.4312218856314908
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.011494299999999999	0.4312218856314908
SHORT RIB-POLYDACTYLY SYNDROME	0.011494299999999999	0.4312218856314908
SOLITARY BONE CYST	0.011494299999999999	0.4312218856314908
MUCOLIPIDOSIS TYPE III	0.011494299999999999	0.4312218856314908
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.011494299999999999	0.4312218856314908
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.011494299999999999	0.4312218856314908
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.011494299999999999	0.4312218856314908
KUSKOKWIM SYNDROME	0.011494299999999999	0.4312218856314908
ISOLATED CLOVERLEAF SKULL SYNDROME	0.011494299999999999	0.4312218856314908
SPONDYLOENCHONDRODYSPLASIA	0.011494299999999999	0.4312218856314908
FRONTOMETAPHYSEAL DYSPLASIA	0.011494299999999999	0.4312218856314908
METATROPIC DYSPLASIA	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
HYPOCHONDROPLASIA	0.011494299999999999	0.4312218856314908
FAMILIAL SCHEUERMANN DISEASE	0.011494299999999999	0.4312218856314908
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.011494299999999999	0.4312218856314908
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
WEISMANN-NETTER SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
KYPHOMELIC DYSPLASIA	0.011494299999999999	0.4312218856314908
CENANI-LENZ SYNDROME	0.011494299999999999	0.4312218856314908
PELVIS-SHOULDER DYSPLASIA	0.011494299999999999	0.4312218856314908
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
FIBROCHONDROGENESIS	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
MYCETOMA	0.011494299999999999	0.4312218856314908
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.011494299999999999	0.4312218856314908
ADAMS-OLIVER SYNDROME	0.011477109	0.4305769454928229
BRANCHIOOCULOFACIAL SYNDROME	0.011471749	0.4303758589275701
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.011470573	0.43033173993489526
RETT SYNDROME	0.011434408999999998	0.42897500587784276
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.011396874	0.42756683717882005
19P13.13 MICRODELETION SYNDROME	0.011379763000000001	0.42692489833217084
INDOMETHACIN EMBRYOFETOPATHY	0.01137955	0.42691690739217103
EBSTEIN MALFORMATION	0.01137955	0.42691690739217103
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.011237589	0.4215910771888413
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.011237589	0.4215910771888413
WAARDENBURG SYNDROME, TYPE 1; WS1	0.01112347	0.417309771640319
PSEUDOATROPHODERMA COLLI	0.0111111	0.41684569686192785
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.41684569686192785
PILONIDAL SINUS	0.0111111	0.41684569686192785
PRENATAL BOWING	0.0111111	0.41684569686192785
PIGMENTED PURPURIC ERUPTION	0.0111111	0.41684569686192785
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.41684569686192785
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	0.41684569686192785
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	0.41684569686192785
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.41684569686192785
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.41684569686192785
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.41684569686192785
TRICHILEMMAL CYST 1	0.0111111	0.41684569686192785
PARANA HARD-SKIN SYNDROME	0.0111111	0.41684569686192785
SYRINGOMAS, MULTIPLE	0.0111111	0.41684569686192785
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	0.41684569686192785
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.41684569686192785
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.41684569686192785
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.41684569686192785
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.41684569686192785
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.41684569686192785
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.41684569686192785
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.41684569686192785
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.41684569686192785
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.41684569686192785
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.41684569686192785
DERMAL RIDGES, PATTERNLESS	0.0111111	0.41684569686192785
CAROTENEMIA, FAMILIAL	0.0111111	0.41684569686192785
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.41684569686192785
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.41684569686192785
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.41684569686192785
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.41684569686192785
131600 EPIDERMOID CYSTS	0.0111111	0.41684569686192785
FUTCHER LINE	0.0111111	0.41684569686192785
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.41684569686192785
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.41684569686192785
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.41684569686192785
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.41684569686192785
LENTIGINES	0.0111111	0.41684569686192785
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.41684569686192785
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.41684569686192785
LICHEN PLANUS, FAMILIAL	0.0111111	0.41684569686192785
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	0.41684569686192785
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.41684569686192785
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.41684569686192785
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.41684569686192785
KYRLE DISEASE	0.0111111	0.41684569686192785
ACROMIAL DIMPLES	0.0111111	0.41684569686192785
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.011091814	0.4161221603885203
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.011063564000000001	0.4150623291444176
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.011059429	0.4149071998632012
DESANTO-SHINAWI SYNDROME	0.011008973000000002	0.4130142849870085
PEDIATRIC-ONSET GRAVES DISEASE	0.010992344000000001	0.4123904289247718
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.010971999999999999	0.4116272003644169
ZECHI-CEIDE SYNDROME	0.010929154	0.4100197833915028
FETAL TRIMETHADIONE SYNDROME	0.010899844	0.40892018502815236
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.010890863	0.4085832524829033
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.010890863	0.4085832524829033
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.010848553	0.4069959441665144
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.010838344	0.4066129417887783
SMITH-KINGSMORE SYNDROME; SKS	0.010834209000000001	0.4064578125075619
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075855
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.010806883	0.40543264618627517
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.010777333	0.4043240439468686
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.010777333	0.4043240439468686
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.010777333	0.4043240439468686
INFANTILE SIALIC ACID STORAGE DISEASE	0.010777333	0.4043240439468686
KBG SYNDROME	0.010771973	0.4041229573816159
MALAN OVERGROWTH SYNDROME	0.010715319	0.40199751740627443
LOWE OCULOCEREBRORENAL SYNDROME	0.010677978999999999	0.40059666435654717
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.010640443999999999	0.39918849565752434
5Q14.3 MICRODELETION SYNDROME	0.010636308999999998	0.3990333663763079
15Q14 MICRODELETION SYNDROME	0.010566722999999998	0.39642276754614403
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.010537813	0.3953381756428871
DISTAL MONOSOMY 6P	0.010514204	0.3944524568520191
GAUCHER DISEASE TYPE 3	0.01050459	0.39409177658367206
GAUCHER DISEASE TYPE 2	0.01050459	0.39409177658367206
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.010496143	0.3937748776626478
8P23.1 MICRODELETION SYNDROME	0.010496143	0.3937748776626478
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010496143	0.3937748776626478
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.01047634	0.3930319453395694
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0103836	0.3895526975668938
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.010317983000000001	0.3870910003370076
OROFACIODIGITAL SYNDROME VI	0.010307134	0.38668398762312195
JOUBERT SYNDROME 2	0.010307134	0.38668398762312195
XIA-GIBBS SYNDROME	0.010307134	0.38668398762312195
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010235914	0.38401208740347614
PELVISCAPULAR DYSPLASIA	0.0101739	0.38168556086288197
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.0101739	0.38168556086288197
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0101739	0.38168556086288197
HOLMES-GANG SYNDROME	0.010151543999999998	0.3808468498082568
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.010147409	0.38069172052704037
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.010147409	0.38069172052704037
CYSTINOSIS	0.01013656	0.3802847078131547
SIALURIA	0.010134433	0.38020491096160763
MAN1B1-CDG	0.010134433	0.38020491096160763
PELGER-HUET ANOMALY; PHA	0.010120134	0.3796684675294156
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.010094889999999999	0.37872140983291547
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.010057064000000001	0.3773023239341747
ISOLATED COMPLEX I DEFICIENCY	0.010045494	0.37686826207597046
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.3757501307344046
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.3757501307344046
PAINE SYNDROME	0.01001569	0.3757501307344046
MENTAL RETARDATION, X-LINKED 91; MRX91	0.010015543	0.3757446158603202
HALL-RIGGS SYNDROME	0.009992259	0.37487108981827816
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.009992258999999998	0.3748710898182781
ALAZAMI-YUAN SYNDROME	0.009978654	0.3743606825943484
2Q32Q33 MICRODELETION SYNDROME	0.009954724	0.3734629211192554
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.009950589	0.37330779183803886
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.009936532999999999	0.37278046483035365
NIEMANN-PICK DISEASE, TYPE C2	0.009936532999999999	0.37278046483035365
MUCOPOLYSACCHARIDOSIS TYPE 2	0.009936532999999999	0.37278046483035365
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.009936532999999999	0.37278046483035365
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.009936532999999999	0.37278046483035365
MENTAL RETARDATION, X-LINKED 72	0.009936532999999999	0.37278046483035365
EMANUEL SYNDROME	0.009852803	0.369639237571284
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
KRABBE DISEASE	0.009804814	0.36783887503771784
BIOTINIDASE DEFICIENCY	0.009804814	0.36783887503771784
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36783887503771784
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36783887503771784
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36783887503771784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36783887503771784
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36783887503771784
VERVERI-BRADY SYNDROME; VERBRAS	0.00980389	0.36780421011490183
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.009776564000000001	0.3667790437936152
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.009752073	0.365860235758241
BARDET-BIEDL SYNDROME 2	0.009732924	0.3651418389974155
EPILEPSY-TELANGIECTASIA	0.009705639	0.36411821083828827
PEMPHIGOID GESTATIONIS	0.00969036	0.3635450015788672
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00969036	0.3635450015788672
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00969036	0.3635450015788672
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00969036	0.3635450015788672
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00969036	0.3635450015788672
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.009685000000000001	0.36334391501361446
CRANIOFRONTONASAL DYSPLASIA	0.009685000000000001	0.36334391501361446
RING CHROMOSOME 6 SYNDROME	0.009685000000000001	0.36334391501361446
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.009685000000000001	0.36334391501361446
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.009685000000000001	0.36334391501361446
MCDONOUGH SYNDROME	0.00959786	0.3600747576822477
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.009593014	0.3598929544182151
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009593014	0.3598929544182151
AYME-GRIPP SYNDROME; AYGRP	0.009588879	0.3597378251369987
2P15P16.1 MICRODELETION SYNDROME	0.009581444	0.3594588925600109
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00956528	0.35885248150763305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.009561553	0.35871265881571196
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.009561553	0.35871265881571196
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009561553	0.35871265881571196
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.009561553	0.35871265881571196
CHROMOSOME 5Q12 DELETION SYNDROME	0.009561553	0.35871265881571196
XP21 MICRODELETION SYNDROME	0.009561553	0.35871265881571196
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.009561553	0.35871265881571196
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009561553	0.35871265881571196
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009561553	0.35871265881571196
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00955127	0.3583268802428586
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.35604075859606615
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.009474124	0.35543265931692775
OCULOSKELETODENTAL SYNDROME; OCSKD	0.009474124	0.35543265931692775
19Q13.11 MICRODELETION SYNDROME	0.009450839999999999	0.35455913327488564
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00940917	0.35299583529464645
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.009395114	0.3524685082869612
HYDROXYKYNURENINURIA	0.009395114	0.3524685082869612
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.009395114	0.3524685082869612
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.009390978999999999	0.3523133790057447
CHILDHOOD DISINTEGRATIVE DISORDER	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.009390978999999999	0.3523133790057447
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.009390978999999999	0.3523133790057447
AUTISM	0.009390978999999999	0.3523133790057447
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.009390978999999999	0.3523133790057447
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.009390978999999999	0.3523133790057447
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.009365253	0.351348238524832
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.009365253	0.351348238524832
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.009365253	0.351348238524832
PRADER-WILLI SYNDROME	0.009284928999999999	0.3483347912734583
TRISOMY 18-LIKE SYNDROME	0.00928239	0.3482395377680149
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.009268874	0.3477324694814559
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.009264739	0.34757734020023945
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.009264739	0.34757734020023945
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.009250813	0.34705489029208464
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.009250813	0.34705489029208464
FILIPPI SYNDROME	0.009250812999999998	0.3470548902920846
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.009250812999999998	0.3470548902920846
17Q11.2 MICRODUPLICATION SYNDROME	0.009250812999999998	0.3470548902920846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.009250812999999998	0.3470548902920846
RUVALCABA SYNDROME	0.009250812999999998	0.3470548902920846
XQ27.3Q28 DUPLICATION SYNDROME	0.009239964	0.346647877578199
2Q24 MICRODELETION SYNDROME	0.009235829	0.34649274829698246
CONO-SPONDYLAR DYSPLASIA	0.009235829	0.34649274829698246
ADRENOMYODYSTROPHY	0.009235829	0.34649274829698246
ACHALASIA-MICROCEPHALY SYNDROME	0.009231010000000001	0.34631195796900627
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.009231010000000001	0.34631195796900627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.009218089	0.3458272117918363
QAZI-MARKOUIZOS SYNDROME	0.009194158999999999	0.3449294503167432
1Q41Q42 MICRODELETION SYNDROME	0.009194158999999999	0.3449294503167432
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00918737	0.34467475317280655
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00918737	0.34467475317280655
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.009159790000000001	0.3436400577493604
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009159790000000001	0.3436400577493604
RENAL TUBULAR DYSGENESIS	0.009159790000000001	0.3436400577493604
GMS SYNDROME	0.009159790000000001	0.3436400577493604
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.009159790000000001	0.3436400577493604
227320 FACIOTHORACOGENITAL SYNDROME	0.00904746	0.33942586859360624
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00904746	0.33942586859360624
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009020134	0.3384007022723195
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009020134	0.3384007022723195
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.3384007022723195
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.009020134	0.3384007022723195
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.009020134	0.3384007022723195
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.009020134	0.3384007022723195
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.009015999	0.338245572991103
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.009015999	0.338245572991103
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.009015999	0.338245572991103
PACHYGYRIA, FRONTOTEMPORAL	0.009015999	0.338245572991103
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009015999	0.338245572991103
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.009015999	0.338245572991103
CONGENITAL MYASTHENIC SYNDROME	0.009015999	0.338245572991103
CINCA SYNDROME	0.008948914	0.3357288020526737
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714572
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00892857	0.3349655734923188
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00892857	0.3349655734923188
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.3349655734923188
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00892857	0.3349655734923188
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00892857	0.3349655734923188
LEGIUS SYNDROME	0.00892857	0.3349655734923188
EMERY-NELSON SYNDROME	0.00892857	0.3349655734923188
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00892857	0.3349655734923188
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.00892857	0.3349655734923188
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00892857	0.3349655734923188
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00892857	0.3349655734923188
THORACOMELIC DYSPLASIA	0.00892857	0.3349655734923188
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00892857	0.3349655734923188
WILDERVANCK SYNDROME	0.00892857	0.3349655734923188
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00892857	0.3349655734923188
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00892857	0.3349655734923188
RING CHROMOSOME 8 SYNDROME	0.00892857	0.3349655734923188
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00892857	0.3349655734923188
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00892857	0.3349655734923188
PTERYGIUM COLLI, ISOLATED	0.00892857	0.3349655734923188
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00892857	0.3349655734923188
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.008877532999999998	0.33305086173284015
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.008877532999999998	0.33305086173284015
TURNPENNY-FRY SYNDROME; TPFS	0.008865504	0.33259957996167877
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.00884956	0.33200142246235226
PRIMARY DYSTONIA, DYT13 TYPE	0.00884956	0.33200142246235226
SMITH-MAGENIS SYNDROME	0.00884956	0.33200142246235226
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.00884956	0.33200142246235226
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00884956	0.33200142246235226
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.00884956	0.33200142246235226
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00884956	0.33200142246235226
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.00884956	0.33200142246235226
15Q24 MICRODELETION SYNDROME	0.008835863	0.33148756375260097
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008796029	0.32999314542419084
RENPENNING SYNDROME	0.008754359	0.32842984744395154
LIG4 SYNDROME	0.008709393999999999	0.3267429337486921
CROME SYNDROME	0.008705259	0.3265878044674757
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.008705259	0.3265878044674757
SANJAD-SAKATI SYNDROME	0.008705259	0.3265878044674757
SECKEL SYNDROME 7; SCKL7	0.008705259	0.3265878044674757
DPM1-CDG	0.008705259	0.3265878044674757
TETRASOMY 18P	0.008705259	0.3265878044674757
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.008705259	0.3265878044674757
TEMPLE-BARAITSER SYNDROME	0.008705259	0.3265878044674757
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00869441	0.32618079175359005
ATYPICAL WERNER SYNDROME	0.00869441	0.32618079175359005
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.008676670000000001	0.3255152552484438
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.008676670000000001	0.3255152552484438
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.008652739999999999	0.32461749377335075
6Q25 MICRODELETION SYNDROME	0.008624913	0.32357353186079696
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.008624913	0.32357353186079696
COFFIN-SIRIS SYNDROME	0.008583242999999999	0.3220102338805576
AARSKOG-SCOTT SYNDROME	0.008572394	0.32160322116667206
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.008494383	0.31867654877078894
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.31867654877078894
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00847458	0.3179336164477106
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	0.3179336164477106
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.3179336164477106
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00847458	0.3179336164477106
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00847458	0.3179336164477106
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.3179336164477106
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.3179336164477106
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00847458	0.3179336164477106
SCLEROSTEOSIS 1; SOST1	0.00847458	0.3179336164477106
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.3179336164477106
HYPEREKPLEXIA 2; HKPX2	0.00847458	0.3179336164477106
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00847458	0.3179336164477106
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.3179336164477106
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.008465073	0.31757695040743855
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806476
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.31526171622806476
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806476
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.31526171622806476
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.31526171622806476
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.31526171622806476
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.31526171622806476
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.31526171622806476
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31526171622806476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31526171622806476
TEMPLE SYNDROME	0.00840336	0.31526171622806476
OMPHALOCELE	0.00840336	0.31526171622806476
RETINOPATHY OF PREMATURITY	0.00840336	0.31526171622806476
NEMALINE MYOPATHY 10	0.00840336	0.31526171622806476
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31526171622806476
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.31526171622806476
HEC SYNDROME	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806476
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806476
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.31526171622806476
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31526171622806476
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.31526171622806476
TEMPLE SYNDROME	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806476
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008344233999999999	0.31304353632934556
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.008344233999999999	0.31304353632934556
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00816384	0.30627584792408324
CAREY-FINEMAN-ZITER SYNDROME	0.00816384	0.30627584792408324
DISTAL TRISOMY 5Q	0.00816384	0.30627584792408324
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.30627584792408324
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.30627584792408324
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00816384	0.30627584792408324
COFFIN-SIRIS SYNDROME 5	0.008119923000000001	0.30462825115426884
17P11.2 MICRODUPLICATION SYNDROME	0.008083494	0.30326157531740444
AICARDI-GOUTIÈRES SYNDROME	0.008054583	0.3021769458979973
6Q16 MICRODELETION SYNDROME	0.008041824	0.3016982773371652
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.008039599	0.3016148039028952
ALEXANDER DISEASE	0.008039599	0.3016148039028952
RAMON SYNDROME	0.008039599	0.3016148039028952
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00802684	0.3011361353420631
17Q21.31 MICRODUPLICATION SYNDROME	0.007965324	0.29882829184428533
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.007952964	0.29836459222739653
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.29836459222739653
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.29836459222739653
300270 ADRENOMYODYSTROPHY	0.007952964	0.29836459222739653
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.29820946294618
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.007948829	0.29820946294618
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.007948829	0.29820946294618
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.29820946294618
LISSENCEPHALY 5; LIS5	0.007948829	0.29820946294618
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.29820946294618
RING CHROMOSOME 10 SYNDROME	0.007948829	0.29820946294618
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.007948829	0.29820946294618
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.29820946294618
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.29820946294618
MOSAIC TRISOMY 14	0.007868483	0.2951951903395013
JOUBERT SYNDROME WITH RENAL DEFECT	0.007826813	0.293631892359262
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.007826813	0.293631892359262
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00779868	0.2925764505047367
MELAS	0.00779868	0.2925764505047367
OLIVER SYNDROME	0.00779868	0.2925764505047367
MEIER-GORLIN SYNDROME 2; MGORS2	0.007790559999999999	0.2922718193648388
GLASS SYNDROME	0.007590533	0.28476757638203776
MULTIPLE SULFATASE DEFICIENCY	0.007590533	0.28476757638203776
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.28466519480804997
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28466519480804997
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
%300712 CRANIOFACIOSKELETAL SYNDROME	0.007578504	0.2843162946108763
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.007575548999999999	0.28420543438693563
MOMO SYNDROME	0.007533879	0.2826421364066964
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.007513164	0.2818649893546048
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.007513164	0.2818649893546048
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.007509029	0.2817098600733884
KEARNS-SAYRE SYNDROME; KSS	0.007509029	0.2817098600733884
CUSHING DISEASE	0.00749818	0.2813028473595027
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00749818	0.2813028473595027
ACTH-INDEPENDENT CUSHING SYNDROME	0.00749818	0.2813028473595027
ACTH-DEPENDENT CUSHING SYNDROME	0.00749818	0.2813028473595027
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00749818	0.2813028473595027
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00749818	0.2813028473595027
HALLERMANN-STREIFF SYNDROME	0.00749627	0.2812311915125563
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00740741	0.2778975064027876
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2778975064027876
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00740741	0.2778975064027876
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00740741	0.2778975064027876
KID SYNDROME	0.00740741	0.2778975064027876
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2778975064027876
CHARLIE M SYNDROME	0.00740741	0.2778975064027876
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.2778975064027876
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00740741	0.2778975064027876
TETRALOGY OF FALLOT	0.00740741	0.2778975064027876
TRISOMY XQ28	0.00740741	0.2778975064027876
RHINY	0.00740741	0.2778975064027876
FETAL VALPROATE SYNDROME	0.00740741	0.2778975064027876
TARP SYNDROME; TARPS	0.007327064	0.27488323379610885
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.007327064	0.27488323379610885
CUTIS LAXA	0.007309624	0.27422895213603266
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.007298153	0.27379860437670167
17Q12 MICRODELETION SYNDROME	0.007298153	0.27379860437670167
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.007219743000000001	0.2708569630368754
MENTAL RETARDATION, X-LINKED 21	0.007163089	0.268731523061534
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0070491139999999996	0.2644556198386453
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0070491139999999996	0.2644556198386453
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
FACIOCARDIORENAL SYNDROME	0.0070341299999999995	0.26389347784354317
PSEUDODIASTROPHIC DYSPLASIA	0.0070341299999999995	0.26389347784354317
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00699246	0.2623301798633039
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00696761	0.26139790352999587
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00696761	0.26139790352999587
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.006834102999999999	0.2563892348607421
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.006834102999999999	0.2563892348607421
CHROMOSOME 9P DELETION SYNDROME	0.006822074000000001	0.25593795308958067
HADZISELIMOVIC SYNDROME	0.006810504	0.25550389123137646
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.006796494	0.254978289966602
DISTAL TRISOMY 15Q	0.0067923589999999995	0.2548231606853856
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0067923589999999995	0.2548231606853856
MICROPHTHALMIA, LENZ TYPE	0.0067923589999999995	0.2548231606853856
MATTHEW-WOOD SYNDROME	0.00678151	0.2544161479714999
MARSHALL-SMITH SYNDROME	0.00678151	0.2544161479714999
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.006756734	0.25348664783330915
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.006756734	0.25348664783330915
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.006756734	0.25348664783330915
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.006752599	0.25333151855209274
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.006752599	0.25333151855209274
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.006752599	0.25333151855209274
WOLFRAM SYNDROME	0.006752599	0.25333151855209274
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00673984	0.2528528499912607
ANTLEY-BIXLER SYNDROME	0.00673984	0.2528528499912607
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00673984	0.2528528499912607
LAURENCE-MOON SYNDROME	0.00673984	0.2528528499912607
15Q26 OVERGROWTH SYNDROME	0.00673984	0.2528528499912607
MOSAIC TRISOMY 8	0.00673984	0.2528528499912607
APERT SYNDROME	0.00673984	0.2528528499912607
HOLOPROSENCEPHALY 11	0.006678324	0.2505450064934829
GOLDBERG-SHPRINTZEN SYNDROME	0.006678324	0.2505450064934829
DESBUQUOIS DYSPLASIA 2; DBQD2	0.006678324	0.2505450064934829
HOLOPROSENCEPHALY 5; HPE5	0.006678324	0.2505450064934829
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0066741890000000005	0.25038987721226647
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.0066216700000000005	0.2484195665181415
NON-DISTAL MONOSOMY 10Q	0.0066216700000000005	0.2484195665181415
GASTROCUTANEOUS SYNDROME	0.0066216700000000005	0.2484195665181415
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.0066216700000000005	0.2484195665181415
15Q11Q13 MICRODUPLICATION SYNDROME	0.006581483	0.24691190498869883
TEEBI-SHALTOUT SYNDROME; TBSH	0.006503559999999999	0.24398853401403636
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.006463313	0.24247862151557972
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.006463313	0.24247862151557972
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.006389063	0.23969304736072575
MENTAL RETARDATION, X-LINKED 107; MRX107	0.006292684	0.23607727831734968
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.006292684	0.23607727831734968
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.006292684	0.23607727831734968
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.006288548999999999	0.23592214903613318
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.006276520000000001	0.23547086726497177
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.006276520000000001	0.23547086726497177
JACOBSEN SYNDROME	0.00626495	0.23503680540676755
FAMILIAL VISCERAL MYOPATHY	0.00625094	0.23451120414199308
BARTSOCAS-PAPAS SYNDROME	0.00625094	0.23451120414199308
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00625094	0.23451120414199308
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00625094	0.23451120414199308
MONOSOMY 13Q14	0.00625094	0.23451120414199308
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00625094	0.23451120414199308
NON-DISTAL TRISOMY 10Q	0.00625094	0.23451120414199308
WOODHOUSE-SAKATI SYNDROME	0.00621118	0.23301956200870022
ATAXIA WITH VITAMIN E DEFICIENCY	0.00621118	0.23301956200870022
167755 PANCREAS, DORSAL, AGENESIS OF	0.00621118	0.23301956200870022
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00621118	0.23301956200870022
GLUCAGONOMA	0.00621118	0.23301956200870022
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.00621118	0.23301956200870022
HEMOCHROMATOSIS TYPE 2	0.00621118	0.23301956200870022
PANCREATITIS, HEREDITARY	0.00621118	0.23301956200870022
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00621118	0.23301956200870022
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00621118	0.23301956200870022
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00621118	0.23301956200870022
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.00621118	0.23301956200870022
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00621118	0.23301956200870022
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00621118	0.23301956200870022
FAMILIAL PANCREATIC CARCINOMA	0.00621118	0.23301956200870022
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00621118	0.23301956200870022
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00621118	0.23301956200870022
NEUROTROPHIC KERATOPATHY	0.00621118	0.23301956200870022
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00621118	0.23301956200870022
FRIEDREICH ATAXIA	0.00621118	0.23301956200870022
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00621118	0.23301956200870022
SPLENOPORTAL VASCULAR ANOMALIES	0.00621118	0.23301956200870022
STIFF-PERSON SYNDROME; SPS	0.00621118	0.23301956200870022
BETA-THALASSEMIA MAJOR	0.00621118	0.23301956200870022
BETA-THALASSEMIA INTERMEDIA	0.00621118	0.23301956200870022
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14	0.00621118	0.23301956200870022
VIPOMA	0.00621118	0.23301956200870022
CUSHING SYNDROME	0.00621118	0.23301956200870022
WOLFRAM-LIKE SYNDROME	0.00621118	0.23301956200870022
DYSBETALIPOPROTEINEMIA	0.00621118	0.23301956200870022
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00621118	0.23301956200870022
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00621118	0.23301956200870022
DYSTROPHIA MYOTONICA 2	0.00621118	0.23301956200870022
NEUTRAL LIPID STORAGE MYOPATHY	0.00621118	0.23301956200870022
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00621118	0.23301956200870022
BARDET-BIEDL SYNDROME 6; BBS6	0.00621118	0.23301956200870022
WOLFRAM SYNDROME 2; WFS2	0.00621118	0.23301956200870022
DIABETES MELLITUS, INSULIN-DEPENDENT, 6	0.00621118	0.23301956200870022
ACERULOPLASMINEMIA	0.00621118	0.23301956200870022
DIABETES MELLITUS, INSULIN-DEPENDENT, 2	0.00621118	0.23301956200870022
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00621118	0.23301956200870022
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00621118	0.23301956200870022
SHORT SYNDROME	0.00621118	0.23301956200870022
DIABETES MELLITUS, INSULIN-DEPENDENT, 10	0.00621118	0.23301956200870022
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00621118	0.23301956200870022
CRANIAL NERVES, RECURRENT PARESIS OF	0.00621118	0.23301956200870022
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.00621118	0.23301956200870022
HEREDITARY CHRONIC PANCREATITIS	0.00621118	0.23301956200870022
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00621118	0.23301956200870022
PREAXIAL HALLUCAL POLYDACTYLY	0.00621118	0.23301956200870022
SOMATOSTATINOMA	0.00621118	0.23301956200870022
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00621118	0.23301956200870022
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00621118	0.23301956200870022
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00621118	0.23301956200870022
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00621118	0.23301956200870022
HYPERLIPOPROTEINEMIA, TYPE V	0.00621118	0.23301956200870022
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00621118	0.23301956200870022
RCAD (RENAL CYSTS AND DIABETES)	0.00621118	0.23301956200870022
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00621118	0.23301956200870022
ACERULOPLASMINEMIA	0.00621118	0.23301956200870022
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00621118	0.23301956200870022
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00621118	0.23301956200870022
GOOD SYNDROME	0.00621118	0.23301956200870022
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00621118	0.23301956200870022
%601666 DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15;;INSULIN-DEPENDENT DIABETES MELLITUS 15	0.00621118	0.23301956200870022
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00621118	0.23301956200870022
BULLOUS PEMPHIGOID	0.00621118	0.23301956200870022
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00613277	0.23007792066887398
PIEBALDISM	0.00613277	0.23007792066887398
XYLT1-CDG	0.00613277	0.23007792066887398
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00613277	0.23007792066887398
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00613277	0.23007792066887398
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0061201829999999995	0.22960570488588206
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0061201829999999995	0.22960570488588206
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0061065930000000004	0.22909586040420576
WEAVER SYNDROME	0.006040064	0.2265999484453064
DISTAL MONOSOMY 9P	0.006040064	0.2265999484453064
TRISOMY 8Q	0.006040064	0.2265999484453064
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.006040064	0.2265999484453064
TRISOMY 12P	0.006040064	0.2265999484453064
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.006035929000000001	0.22644481916408993
ISOLATED SPINA BIFIDA	0.006035929000000001	0.22644481916408993
KALLMANN SYNDROME	0.006035929000000001	0.22644481916408993
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006035929000000001	0.22644481916408993
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0059218940000000005	0.22216666497218723
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0059218940000000005	0.22216666497218723
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.0059218940000000005	0.22216666497218723
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.005917759	0.2220115356909708
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.005917759	0.2220115356909708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.005917759	0.2220115356909708
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.005917759	0.2220115356909708
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005917759	0.2220115356909708
ZLOTOGORA-OGUR SYNDROME	0.005917759	0.2220115356909708
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.005917759	0.2220115356909708
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.005917759	0.2220115356909708
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.005847644000000001	0.21938109081733326
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.005847644000000001	0.21938109081733326
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.005847644	0.21938109081733326
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.005847644	0.21938109081733326
AREDYLD SYNDROME	0.00574713	0.21561019249274074
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.00574713	0.21561019249274074
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00574713	0.21561019249274074
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.005632633	0.21131470583943007
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.005632633	0.21131470583943007
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.005631283000000001	0.21126405903661455
HYPERLEUCINE-ISOLEUCINEMIA	0.005616299	0.21070191704151242
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.005574629	0.20913861906127315
GAPO SYNDROME; GAPOS	0.005574628999999999	0.20913861906127315
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.005565174	0.2087839038608133
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.005565174	0.2087839038608133
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.005561039	0.20862877457959683
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.005561039	0.20862877457959683
FANCONI ANEMIA	0.005523504	0.20722060588057403
CONGENITAL RUBELLA SYNDROME	0.005519369	0.2070654765993576
ALAGILLE SYNDROME 1; ALGS1	0.00550852	0.20665846388547193
ALAGILLE SYNDROME	0.00550852	0.20665846388547193
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00549451	0.20613286262069747
KEIPERT SYNDROME	0.00549451	0.20613286262069747
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.20613286262069747
LARYNX ATRESIA	0.00549451	0.20613286262069747
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00549451	0.20613286262069747
INIENCEPHALY	0.00549451	0.20613286262069747
HOLZGREVE SYNDROME	0.00549451	0.20613286262069747
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.20613286262069747
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00549451	0.20613286262069747
ACHONDROGENESIS TYPE 1B	0.00549451	0.20613286262069747
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.20613286262069747
ACHONDROGENESIS TYPE 2	0.00549451	0.20613286262069747
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00549451	0.20613286262069747
ACHONDROGENESIS	0.00549451	0.20613286262069747
ACHONDROGENESIS TYPE 1A	0.00549451	0.20613286262069747
AUROCEPHALOSYNDACTYLY	0.00549451	0.20613286262069747
ISOLATED HEMIHYPERPLASIA	0.00549451	0.20613286262069747
ACALVARIA	0.00549451	0.20613286262069747
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.20613286262069747
FRONTONASAL DYSPLASIA	0.00549451	0.20613286262069747
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.20613286262069747
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00549451	0.20613286262069747
PHENYLKETONURIA	0.00549451	0.20613286262069747
VACTERL WITH HYDROCEPHALUS	0.00549451	0.20613286262069747
NAGER SYNDROME	0.00549451	0.20613286262069747
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.20613286262069747
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.20613286262069747
CAT-EYE SYNDROME	0.00549451	0.20613286262069747
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00549451	0.20613286262069747
THALIDOMIDE EMBRYOPATHY	0.00549451	0.20613286262069747
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.20613286262069747
AXENFELD-RIEGER SYNDROME	0.00549451	0.20613286262069747
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00549451	0.20613286262069747
X-LINKED EHLERS-DANLOS SYNDROME	0.00549451	0.20613286262069747
FACIOSCAPULOHUMERAL DYSTROPHY	0.00549451	0.20613286262069747
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.2016995791475783
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.2016995791475783
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.2016995791475783
WAARDENBURG-SHAH SYNDROME	0.00537634	0.2016995791475783
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.2016995791475783
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00537634	0.2016995791475783
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00537634	0.2016995791475783
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00537634	0.2016995791475783
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.2016995791475783
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00537634	0.2016995791475783
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00537634	0.2016995791475783
ISOLATED TRIGONOCEPHALY	0.00537634	0.2016995791475783
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.2016995791475783
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.2016995791475783
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.005308492999999999	0.19915422090267082
OCULOECTODERMAL SYNDROME; OES	0.005308492999999999	0.19915422090267082
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.005308492999999999	0.19915422090267082
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.005302090000000001	0.19891400499272432
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.005302090000000001	0.19891400499272432
CHROMOSOME 1P35 DELETION SYNDROME	0.005143733	0.19297305999016254
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.005143733	0.19297305999016254
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.005132884	0.19256604727627685
POPOV-CHANG SYNDROME; POPCHAS	0.005132884	0.19256604727627685
COFFIN-SIRIS SYNDROME 8; CSS8	0.005128749	0.1924109179950604
2Q23.1 MICRODUPLICATION SYNDROME	0.005091214	0.1910027492960376
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.005091214	0.1910027492960376
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.005091214	0.1910027492960376
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.005091214	0.1910027492960376
ASPARTYLGLUCOSAMINURIA; AGU	0.005085729000000001	0.19079697321200564
XYLOSIDASE DEFICIENCY	0.005085729000000001	0.19079697321200564
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00507488	0.19038996049811996
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00507488	0.19038996049811996
GLUTATHIONURIA	0.00503321	0.18882666251788066
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00503321	0.18882666251788066
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004874853	0.1828857175153189
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0048195930000000005	0.18081257505340334
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0048195930000000005	0.18081257505340334
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.0048195930000000005	0.18081257505340334
GENITOPATELLAR SYNDROME	0.0048195930000000005	0.18081257505340334
MCKUSICK-KAUFMAN SYNDROME	0.004808744	0.18040556233951766
OROTIC ACIDURIA	0.004808744	0.18040556233951766
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.004808744	0.18040556233951766
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.004808744	0.18040556233951766
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.004804609	0.18025043305830118
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.004804609	0.18025043305830118
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0047670740000000005	0.17884226435927839
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.004767074	0.17884226435927836
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.004762939000000001	0.17868713507806197
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.004762939000000001	0.17868713507806197
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.004602314	0.17266110344677005
AL-RAQAD SYNDROME; ARS	0.004602314	0.17266110344677005
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.004598179	0.1725059741655536
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.004598179	0.1725059741655536
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004598179	0.1725059741655536
13Q12.3 MICRODELETION SYNDROME	0.004587330000000001	0.17209896145166795
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00454566	0.17053566347142868
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00454566	0.17053566347142868
TETRASOMY 12P	0.00454566	0.17053566347142868
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00454566	0.17053566347142868
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00454566	0.17053566347142868
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.17048501666861315
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00454431	0.17048501666861315
46,XX GONADAL DYSGENESIS	0.00454431	0.17048501666861315
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00454431	0.17048501666861315
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004387303	0.1645947184688669
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.004387303	0.1645947184688669
WILSON-TURNER SYNDROME	0.004387303	0.1645947184688669
MONOSOMY 18Q	0.004375733	0.16416065661066268
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.004375733	0.16416065661066268
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004375733	0.16416065661066268
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004375733	0.16416065661066268
C SYNDROME	0.004375733	0.16416065661066268
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004375733	0.16416065661066268
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.004375733	0.16416065661066268
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004375733	0.16416065661066268
PITT-HOPKINS SYNDROME	0.004375733	0.16416065661066268
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004375733	0.16416065661066268
ALG11-CDG	0.004375733	0.16416065661066268
LARSEN-LIKE SYNDROME	0.004333434	0.16257376097192638
REVESZ SYNDROME	0.004333434	0.16257376097192638
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.16257376097192638
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.16257376097192638
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004329299	0.16241863169070997
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169070997
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169070997
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.004278174	0.16050061851001085
MOSAIC TRISOMY 9	0.004278174	0.16050061851001085
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.004278174	0.16050061851001085
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.004278174	0.16050061851001085
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004278174	0.16050061851001085
GENITOPATELLAR SYNDROME; GTPTS	0.004278174	0.16050061851001085
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004278174	0.16050061851001085
TRISOMY 18	0.004278174	0.16050061851001085
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.004274039	0.1603454892287944
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.004274039	0.1603454892287944
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.004274039	0.1603454892287944
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.004274039	0.1603454892287944
OCULODENTODIGITAL DYSPLASIA; ODDD	0.004274039	0.1603454892287944
PRUNE BELLY SYNDROME	0.00426319	0.15993847651490872
CATEL-MANZKE SYNDROME	0.00426319	0.15993847651490872
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00426319	0.15993847651490872
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00426319	0.15993847651490872
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00426319	0.15993847651490872
NOONAN SYNDROME 8; NS8	0.00426319	0.15993847651490872
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00426319	0.15993847651490872
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.00426319	0.15993847651490872
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00422152	0.15837517853466945
611961 STEVENSON-CAREY SYNDROME	0.004063163	0.15243423353210767
20P12.3 MICRODELETION SYNDROME	0.004063163	0.15243423353210767
SIMPSON-GOLABI-BEHMEL SYNDROME	0.004063163	0.15243423353210767
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004063163	0.15243423353210767
CHÉDIAK-HIGASHI SYNDROME	0.004063163	0.15243423353210767
CODAS SYNDROME	0.004063163	0.15243423353210767
SHASHI-PENA SYNDROME; SHAPNS	0.004063163	0.15243423353210767
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.004063163	0.15243423353210767
ROIFMAN SYNDROME	0.00405676	0.15219401762216114
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00405676	0.15219401762216114
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00405676	0.15219401762216114
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.003845884	0.1442827619254744
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.003845884	0.1442827619254744
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.003845884	0.1442827619254744
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.003845884	0.1442827619254744
AICA-RIBOSIDURIA	0.003841749	0.14412763264425796
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.003841749	0.14412763264425796
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.003834314	0.1438487000672702
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.003834314	0.1438487000672702
MARINESCO-SJOGREN SYNDROME; MSS	0.003834314	0.1438487000672702
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.003830179	0.14369357078605377
XERODERMA PIGMENTOSUM	0.003830179	0.14369357078605377
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14210667514731748
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14210667514731748
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14210667514731748
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14210667514731748
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14210667514731748
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14210667514731748
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14210667514731748
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14210667514731748
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14210667514731748
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14210667514731748
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14210667514731748
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14210667514731748
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14210667514731748
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14210667514731748
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14210667514731748
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.14210667514731748
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14210667514731748
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14210667514731748
ZINC, ELEVATED PLASMA	0.00378788	0.14210667514731748
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14210667514731748
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14210667514731748
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14210667514731748
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14210667514731748
MYOPATHY, SPHEROID BODY	0.00378788	0.14210667514731748
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14210667514731748
GONADOBLASTOMA	0.00378788	0.14210667514731748
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.14210667514731748
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14210667514731748
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14210667514731748
DERMATOLEUKODYSTROPHY	0.00378788	0.14210667514731748
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14210667514731748
HYPOASCORBEMIA	0.00378788	0.14210667514731748
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.14210667514731748
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14210667514731748
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14210667514731748
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14210667514731748
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14210667514731748
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14210667514731748
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14210667514731748
ETHANOLAMINOSIS	0.00378788	0.14210667514731748
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14210667514731748
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14210667514731748
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14210667514731748
SCHIZOPHRENIA 4	0.00378788	0.14210667514731748
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14210667514731748
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14210667514731748
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14210667514731748
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14210667514731748
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14210667514731748
ACETYLATION, SLOW	0.00378788	0.14210667514731748
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14210667514731748
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14210667514731748
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14210667514731748
AREDYLD	0.00378788	0.14210667514731748
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14210667514731748
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14210667514731748
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.14210667514731748
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14210667514731748
XM SYSTEM	0.00378788	0.14210667514731748
DELETED IN AZOOSPERMIA	0.00378788	0.14210667514731748
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14210667514731748
LYMPHOKINE DEFICIENCY	0.00378788	0.14210667514731748
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14210667514731748
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14210667514731748
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14210667514731748
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14210667514731748
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14210667514731748
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14210667514731748
CEPHALIN LIPIDOSIS	0.00378788	0.14210667514731748
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.14210667514731748
MACROCYTOSIS, FAMILIAL	0.00378788	0.14210667514731748
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.14210667514731748
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14210667514731748
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14210667514731748
APOLIPOPROTEIN(A)	0.00378788	0.14210667514731748
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14210667514731748
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.14210667514731748
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14210667514731748
PITUITARY DWARFISM IV	0.00378788	0.14210667514731748
LARON SYNDROME	0.00378788	0.14210667514731748
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.14210667514731748
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.14210667514731748
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14210667514731748
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14210667514731748
CALVARIAL HYPEROSTOSIS	0.00378788	0.14210667514731748
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14210667514731748
PENDRED SYNDROME	0.00378788	0.14210667514731748
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14210667514731748
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14210667514731748
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14210667514731748
OSTEOGENIC SARCOMA	0.00378788	0.14210667514731748
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731748
COUMARIN RESISTANCE	0.00378788	0.14210667514731748
PROGESTERONE RESISTANCE	0.00378788	0.14210667514731748
OVARIAN CANCER	0.00378788	0.14210667514731748
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14210667514731748
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14210667514731748
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14210667514731748
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14210667514731748
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.14210667514731748
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14210667514731748
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14210667514731748
ALAND ISLAND EYE DISEASE	0.00378788	0.14210667514731748
FLOOD FACTOR DEFICIENCY	0.00378788	0.14210667514731748
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14210667514731748
GLUTATHIONE REDUCTASE	0.00378788	0.14210667514731748
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14210667514731748
HEINZ BODY ANEMIAS	0.00378788	0.14210667514731748
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
HYPERPROGLUCAGONEMIA	0.00378788	0.14210667514731748
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14210667514731748
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14210667514731748
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14210667514731748
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.14210667514731748
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14210667514731748
PACMAN DYSPLASIA	0.00378788	0.14210667514731748
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14210667514731748
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14210667514731748
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14210667514731748
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14210667514731748
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.14210667514731748
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14210667514731748
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.14210667514731748
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14210667514731748
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14210667514731748
BARTTER SYNDROME	0.00378788	0.14210667514731748
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14210667514731748
PARAOXONASE 1	0.00378788	0.14210667514731748
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731748
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14210667514731748
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14210667514731748
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14210667514731748
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.14210667514731748
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14210667514731748
FINGERPRINT BODY MYOPATHY	0.00378788	0.14210667514731748
XANTHINURIA, TYPE I	0.00378788	0.14210667514731748
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14210667514731748
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14210667514731748
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.14210667514731748
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.14210667514731748
PERRY SYNDROME	0.00378788	0.14210667514731748
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14210667514731748
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14210667514731748
CARBOXYLESTERASE 1	0.00378788	0.14210667514731748
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14210667514731748
BEETURIA	0.00378788	0.14210667514731748
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14210667514731748
T-SUBSTANCE ANOMALY	0.00378788	0.14210667514731748
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14210667514731748
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14210667514731748
REFSUM DISEASE	0.00378788	0.14210667514731748
MECKEL SYNDROME, TYPE 4; MKS4	0.00373262	0.14003353268540192
CHARGE SYNDROME	0.00373262	0.14003353268540192
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00373262	0.14003353268540192
WAARDENBURG SYNDROME TYPE 3	0.00373262	0.14003353268540192
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00373262	0.14003353268540192
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00373262	0.14003353268540192
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00373262	0.14003353268540192
XK APROSENCEPHALY SYNDROME	0.00373262	0.14003353268540192
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0036193030000000004	0.13578231508936706
PONTINE TEGMENTAL CAP DYSPLASIA	0.0036193030000000004	0.13578231508936706
6Q TERMINAL DELETION SYNDROME	0.0036193030000000004	0.13578231508936706
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0036193030000000004	0.13578231508936706
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0036193030000000004	0.13578231508936706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0036193030000000004	0.13578231508936706
1Q21.1 MICRODUPLICATION SYNDROME	0.0036193030000000004	0.13578231508936706
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.0036193030000000004	0.13578231508936706
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0036193030000000004	0.13578231508936706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.003619303	0.13578231508936703
3C SYNDROME	0.0035217440000000003	0.1321222769887152
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0035217440000000003	0.1321222769887152
NOONAN SYNDROME 11; NS11	0.0035217440000000003	0.1321222769887152
NOONAN SYNDROME 3; NS3	0.0035217440000000003	0.1321222769887152
CHROMOSOME 15Q14 DELETION SYNDROME	0.0035217440000000003	0.1321222769887152
16P13.11 MICRODUPLICATION SYNDROME	0.0035217440000000003	0.1321222769887152
LYMPHEDEMA, HEREDITARY, III	0.0035217440000000003	0.1321222769887152
NOONAN SYNDROME 5; NS5	0.0035217440000000003	0.1321222769887152
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0035217440000000003	0.1321222769887152
SYNDROMIC DIARRHEA	0.0035217440000000003	0.1321222769887152
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0035217440000000003	0.1321222769887152
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.003517609	0.13196714770749876
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.003517609	0.13196714770749876
THANATOPHORIC DYSPLASIA TYPE 2	0.003517609	0.13196714770749876
THANATOPHORIC DYSPLASIA	0.003517609	0.13196714770749876
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.003517609	0.13196714770749876
THANATOPHORIC DYSPLASIA TYPE 1	0.003517609	0.13196714770749876
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.003517609	0.13196714770749876
FRYNS SYNDROME; FRNS	0.003517609	0.13196714770749876
ACROCARDIOFACIAL SYNDROME	0.003517609	0.13196714770749876
HUNTER-MACDONALD SYNDROME	0.00330033	0.1238156761008655
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00330033	0.1238156761008655
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00330033	0.1238156761008655
2Q37 MONOSOMY	0.00330033	0.1238156761008655
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.00330033	0.1238156761008655
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.00330033	0.1238156761008655
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00330033	0.1238156761008655
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00330033	0.1238156761008655
ATELOSTEOGENESIS TYPE II	0.00330033	0.1238156761008655
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00330033	0.1238156761008655
3Q27.3 MICRODELETION SYNDROME	0.00330033	0.1238156761008655
CHROMOSOME 13Q14 DELETION SYNDROME	0.00330033	0.1238156761008655
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00330033	0.1238156761008655
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00330033	0.1238156761008655
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00330033	0.1238156761008655
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00330033	0.1238156761008655
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.00330033	0.1238156761008655
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00330033	0.1238156761008655
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00328876	0.12338161424266131
MEIER-GORLIN SYNDROME 6; MGORS6	0.00328876	0.12338161424266131
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.003130403	0.11744066924009951
10Q22.3Q23.3 MICRODELETION SYNDROME	0.003130403	0.11744066924009951
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.003130403	0.11744066924009951
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.003130403	0.11744066924009951
RFT1-CDG	0.003130403	0.11744066924009951
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.003130403	0.11744066924009951
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.003130403	0.11744066924009951
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.003130403	0.11744066924009951
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.003130403	0.11744066924009951
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.003130403	0.11744066924009951
STT3A-CDG	0.003130403	0.11744066924009951
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.003130403	0.11744066924009951
STT3B-CDG	0.003130403	0.11744066924009951
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.003130403	0.11744066924009951
INFANTILE LIVER FAILURE SYNDROME 1	0.003130403	0.11744066924009951
LATHOSTEROLOSIS	0.003130403	0.11744066924009951
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.003130403	0.11744066924009951
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.003130403	0.11744066924009951
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.003130403	0.11744066924009951
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.003130403	0.11744066924009951
VICI SYNDROME; VICIS	0.003130403	0.11744066924009951
JABERI-ELAHI SYNDROME; JABELS	0.003130403	0.11744066924009951
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003130403	0.11744066924009951
PELIZAEUS-MERZBACHER DISEASE	0.003130403	0.11744066924009951
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.003130403	0.11744066924009951
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.003130403	0.11744066924009951
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.003130403	0.11744066924009951
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.003130403	0.11744066924009951
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.003088733	0.11587737125986024
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.003088733	0.11587737125986024
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003088733	0.11587737125986024
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.003088733	0.11587737125986024
MEHMO SYNDROME; MEHMO	0.003088733	0.11587737125986024
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.003088733	0.11587737125986024
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.003088733	0.11587737125986024
ADAMS-OLIVER SYNDROME 2; AOS2	0.003088733	0.11587737125986024
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.003088733	0.11587737125986024
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.003088733	0.11587737125986024
CK SYNDROME	0.003088733	0.11587737125986024
MATERNAL PHENYLKETONURIA	0.003088733	0.11587737125986024
CHROMOSOME 19P13.13 DELETION SYNDROME	0.003088733	0.11587737125986024
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0030887329999999998	0.11587737125986022
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0030887329999999998	0.11587737125986022
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0030887329999999998	0.11587737125986022
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0030887329999999998	0.11587737125986022
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0030887329999999998	0.11587737125986022
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0030887329999999998	0.11587737125986022
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.003077884	0.11547035854597458
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0030737489999999998	0.11531522926475811
HADDAD SYNDROME	0.0030737489999999998	0.11531522926475811
HYPERTELORISM, TEEBI TYPE; TBHS	0.00297619	0.11165519116410627
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00297619	0.11165519116410627
EISENMENGER SYNDROME	0.00297619	0.11165519116410627
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00297619	0.11165519116410627
DIAMOND-BLACKFAN ANEMIA 4	0.00297619	0.11165519116410627
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00297619	0.11165519116410627
MEACHAM SYNDROME	0.00297619	0.11165519116410627
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00297619	0.11165519116410627
PENTALOGY OF CANTRELL	0.00297619	0.11165519116410627
ATRIAL SEPTAL DEFECT 5	0.00297619	0.11165519116410627
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00297619	0.11165519116410627
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.00297619	0.11165519116410627
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00297619	0.11165519116410627
AORTIC VALVE DISEASE 3; AOVD3	0.00297619	0.11165519116410627
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.00297619	0.11165519116410627
CONGENITAL PULMONARY VALVE STENOSIS	0.00297619	0.11165519116410627
LYMPHATIC MALFORMATION 7; LMPHM7	0.00297619	0.11165519116410627
SIFRIM-HITZ-WEISS SYNDROME	0.00297619	0.11165519116410627
HOLT-ORAM SYNDROME	0.00297619	0.11165519116410627
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00297619	0.11165519116410627
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.00297619	0.11165519116410627
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00297619	0.11165519116410627
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00297619	0.11165519116410627
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00297619	0.11165519116410627
ELLIS-VAN CREVELD SYNDROME	0.00297619	0.11165519116410627
WHITE FORELOCK WITH MALFORMATIONS	0.00297619	0.11165519116410627
8P23.1 DELETION SYNDROME	0.00297619	0.11165519116410627
MEGALENCEPHALY	0.00297619	0.11165519116410627
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.11165519116410627
FAMILIAL CUTANEOUS COLLAGENOMA	0.00297619	0.11165519116410627
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00297619	0.11165519116410627
ALAGILLE SYNDROME 2	0.00297619	0.11165519116410627
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00297619	0.11165519116410627
DIAMOND-BLACKFAN ANEMIA 16	0.00297619	0.11165519116410627
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00297619	0.11165519116410627
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00297619	0.11165519116410627
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.00297619	0.11165519116410627
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.11165519116410627
ABRUZZO-ERICKSON SYNDROME	0.00297619	0.11165519116410627
EBSTEIN ANOMALY	0.00297619	0.11165519116410627
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00297619	0.11165519116410627
3Q29 MICRODELETION SYNDROME	0.002588984	0.09712871269670703
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.002588984	0.09712871269670703
EAR-PATELLA-SHORT STATURE SYNDROME	0.002588984	0.09712871269670703
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.002588984	0.09712871269670703
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.002588984	0.09712871269670703
MEVALONIC ACIDURIA; MEVA	0.002588984	0.09712871269670703
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.002588984	0.09712871269670703
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002588984	0.09712871269670703
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002588984	0.09712871269670703
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.002588984	0.09712871269670703
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.002588984	0.09712871269670703
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.002588984	0.09712871269670703
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.002588984	0.09712871269670703
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002588984	0.09712871269670703
LIG4 SYNDROME	0.002588984	0.09712871269670703
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002588984	0.09712871269670703
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002588984	0.09712871269670703
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0025848489999999997	0.09697358341549057
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0025848489999999997	0.09697358341549057
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0025848489999999997	0.09697358341549057
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0025848489999999997	0.09697358341549057
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0025848489999999997	0.09697358341549057
SYMMETRICAL THALAMIC CALCIFICATIONS	0.0025848489999999997	0.09697358341549057
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0025848489999999997	0.09697358341549057
HARROD SYNDROME	0.0025848489999999997	0.09697358341549057
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0025848489999999997	0.09697358341549057
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0025848489999999997	0.09697358341549057
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0025848489999999997	0.09697358341549057
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0025848489999999997	0.09697358341549057
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0025848489999999997	0.09697358341549057
OROFACIODIGITAL SYNDROME IX; OFD9	0.002547314	0.09556541471646778
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.002547314	0.09556541471646778
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.002547314	0.09556541471646778
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.002547314	0.09556541471646778
OPTIC ATROPHY 11; OPA11	0.002547314	0.09556541471646778
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002547314	0.09556541471646778
MUCOLIPIDOSIS IV; ML4	0.002547314	0.09556541471646778
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.002547314	0.09556541471646778
CRANIOSYNOSTOSIS 6; CRS6	0.002547314	0.09556541471646778
MIETENS SYNDROME	0.002547314	0.09556541471646778
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.002547314	0.09556541471646778
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.002547314	0.09556541471646778
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.002547314	0.09556541471646778
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002547314	0.09556541471646778
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002547314	0.09556541471646778
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002547314	0.09556541471646778
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.002547314	0.09556541471646778
MARINESCO-SJÖGREN SYNDROME	0.002547314	0.09556541471646778
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.002547314	0.09556541471646778
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.002547314	0.09556541471646778
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.002547314	0.09556541471646778
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002543179	0.09541028543525132
COG5-CDG	0.002543179	0.09541028543525132
COCKAYNE SYNDROME A; CSA	0.002543179	0.09541028543525132
ANGELMAN SYNDROME	0.002543179	0.09541028543525132
PITT-HOPKINS SYNDROME	0.002543179	0.09541028543525132
SECKEL SYNDROME 1; SCKL1	0.002543179	0.09541028543525132
MARDEN-WALKER SYNDROME	0.002543179	0.09541028543525132
PRIMARY CUTIS VERTICIS GYRATA	0.002543179	0.09541028543525132
CYCLIC VOMITING SYNDROME	0.002543179	0.09541028543525132
INCONTINENTIA PIGMENTI; IP	0.002543179	0.09541028543525132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002543179	0.09541028543525132
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.002543179	0.09541028543525132
PROGEROID SYNDROME, PETTY TYPE	0.00253233	0.09500327272136566
FREEMAN-SHELDON SYNDROME	0.00253233	0.09500327272136566
MULTIMINICORE MYOPATHY	0.00253233	0.09500327272136566
MELNICK-NEEDLES SYNDROME	0.00253233	0.09500327272136566
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0023739729999999997	0.08906232771880385
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0023739729999999997	0.08906232771880385
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0023739729999999997	0.08906232771880385
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0023739729999999997	0.08906232771880385
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0023739729999999997	0.08906232771880385
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0023739729999999997	0.08906232771880385
INFANTILE REFSUM DISEASE	0.0023739729999999997	0.08906232771880385
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.0023739729999999997	0.08906232771880385
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0023739729999999997	0.08906232771880385
FUCOSIDOSIS	0.0023739729999999997	0.08906232771880385
ARGININOSUCCINIC ACIDURIA	0.0023739729999999997	0.08906232771880385
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0023739729999999997	0.08906232771880385
PITUITARY STALK INTERRUPTION SYNDROME	0.0023739729999999997	0.08906232771880385
2P21 MICRODELETION SYNDROME	0.0023739729999999997	0.08906232771880385
NEPHROGENIC DIABETES INSIPIDUS	0.0023739729999999997	0.08906232771880385
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0023739729999999997	0.08906232771880385
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0023739729999999997	0.08906232771880385
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0023739729999999997	0.08906232771880385
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0023739729999999997	0.08906232771880385
TETRASOMY 5P	0.0023739729999999997	0.08906232771880385
FOLATE MALABSORPTION, HEREDITARY	0.0023739729999999997	0.08906232771880385
COWDEN SYNDROME	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0023739729999999997	0.08906232771880385
EAST SYNDROME	0.0023739729999999997	0.08906232771880385
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.0023739729999999997	0.08906232771880385
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0023739729999999997	0.08906232771880385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0023739729999999997	0.08906232771880385
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0023739729999999997	0.08906232771880385
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0023739729999999997	0.08906232771880385
CITRULLINEMIA, CLASSIC	0.0023739729999999997	0.08906232771880385
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.0023739729999999997	0.08906232771880385
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0023739729999999997	0.08906232771880385
GRACILE BONE DYSPLASIA; GCLEB	0.0023739729999999997	0.08906232771880385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.0023739729999999997	0.08906232771880385
HEREDITARY FOLATE MALABSORPTION	0.0023739729999999997	0.08906232771880385
PROPIONIC ACIDEMIA	0.0023739729999999997	0.08906232771880385
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.0023739729999999997	0.08906232771880385
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002332303	0.08749902973856458
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002332303	0.08749902973856458
MUENKE SYNDROME	0.002332303	0.08749902973856458
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.002332303	0.08749902973856458
SCHIZENCEPHALY	0.002332303	0.08749902973856458
MONOSOMY 9Q22.3	0.002332303	0.08749902973856458
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.002332303	0.08749902973856458
RAYNAUD-CLAES SYNDROME; MRXSRC	0.002332303	0.08749902973856458
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.002332303	0.08749902973856458
SCHINDLER DISEASE, TYPE I	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002332303	0.08749902973856458
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.002332303	0.08749902973856458
GLYCEROL KINASE DEFICIENCY; GKD	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002332303	0.08749902973856458
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002332303	0.08749902973856458
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.002332303	0.08749902973856458
POTOCKI-SHAFFER SYNDROME	0.002332303	0.08749902973856458
XQ21 MICRODELETION SYNDROME	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 90	0.002332303	0.08749902973856458
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002332303	0.08749902973856458
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002332303	0.08749902973856458
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002332303	0.08749902973856458
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.002332303	0.08749902973856458
HARTNUP DISEASE	0.002332303	0.08749902973856458
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.002332303	0.08749902973856458
OPTIC PATHWAY GLIOMA	0.002332303	0.08749902973856458
INCONTINENTIA PIGMENTI	0.002332303	0.08749902973856458
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.002332303	0.08749902973856458
WEAVER SYNDROME	0.002332303	0.08749902973856458
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.002332303	0.08749902973856458
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.002332303	0.08749902973856458
CHROMOSOME 16P13.2 DELETION SYNDROME	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002332303	0.08749902973856458
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0020434299999999997	0.0766616268720981
MEIER-GORLIN SYNDROME 3; MGORS3	0.0020434299999999997	0.0766616268720981
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.0020434299999999997	0.0766616268720981
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0020434299999999997	0.0766616268720981
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0020434299999999997	0.0766616268720981
JOHNSON NEUROECTODERMAL SYNDROME	0.0020434299999999997	0.0766616268720981
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0020434299999999997	0.0766616268720981
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0020434299999999997	0.0766616268720981
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.0020434299999999997	0.0766616268720981
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0020434299999999997	0.0766616268720981
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.0020434299999999997	0.0766616268720981
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0020434299999999997	0.0766616268720981
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0020434299999999997	0.0766616268720981
GROWTH HORMONE INSENSITIVITY SYNDROME	0.0020434299999999997	0.0766616268720981
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.0020434299999999997	0.0766616268720981
PSEUDOPROGERIA SYNDROME	0.0020434299999999997	0.0766616268720981
SEVERE COMBINED IMMUNODEFICIENCY	0.0020434299999999997	0.0766616268720981
ACROOTOOCULAR SYNDROME	0.0020434299999999997	0.0766616268720981
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00200176	0.07509832889185884
OTOMANDIBULAR SYNDROME	0.00200176	0.07509832889185884
FOCAL DERMAL HYPOPLASIA; FDH	0.00200176	0.07509832889185884
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00200176	0.07509832889185884
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00200176	0.07509832889185884
MASA SYNDROME	0.00200176	0.07509832889185884
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00200176	0.07509832889185884
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00200176	0.07509832889185884
MUCOLIPIDOSIS TYPE IV	0.00200176	0.07509832889185884
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00200176	0.07509832889185884
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00200176	0.07509832889185884
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00200176	0.07509832889185884
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00200176	0.07509832889185884
LAMBOTTE SYNDROME	0.00200176	0.07509832889185884
SECKEL SYNDROME 5; SCKL5	0.00200176	0.07509832889185884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001843403	0.06915738388929706
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001843403	0.06915738388929706
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001843403	0.06915738388929706
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001843403	0.06915738388929706
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001843403	0.06915738388929706
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001843403	0.06915738388929706
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001843403	0.06915738388929706
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001843403	0.06915738388929706
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001843403	0.06915738388929706
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001843403	0.06915738388929706
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001843403	0.06915738388929706
CLASSIC PHENYLKETONURIA	0.001843403	0.06915738388929706
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001843403	0.06915738388929706
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001843403	0.06915738388929706
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001843403	0.06915738388929706
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001843403	0.06915738388929706
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929706
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001843403	0.06915738388929706
MICRO SYNDROME	0.001843403	0.06915738388929706
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001843403	0.06915738388929706
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001843403	0.06915738388929706
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001843403	0.06915738388929706
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001843403	0.06915738388929706
MEVALONIC ACIDURIA	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001843403	0.06915738388929706
LISSENCEPHALY 4	0.001843403	0.06915738388929706
3Q29 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY 2; HPE2	0.001843403	0.06915738388929706
ALG3-CDG	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001843403	0.06915738388929706
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001843403	0.06915738388929706
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001843403	0.06915738388929706
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001843403	0.06915738388929706
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001843403	0.06915738388929706
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001843403	0.06915738388929706
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001843403	0.06915738388929706
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001843403	0.06915738388929706
DPAGT1-CDG	0.001843403	0.06915738388929706
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001843403	0.06915738388929706
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001843403	0.06915738388929706
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001843403	0.06915738388929706
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001843403	0.06915738388929706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001843403	0.06915738388929706
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001843403	0.06915738388929706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001843403	0.06915738388929706
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929706
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001843403	0.06915738388929706
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001843403	0.06915738388929706
LISSENCEPHALY 8; LIS8	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001843403	0.06915738388929706
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001843403	0.06915738388929706
WALKER-WARBURG SYNDROME	0.001843403	0.06915738388929706
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001843403	0.06915738388929706
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001843403	0.06915738388929706
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001843403	0.06915738388929706
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001843403	0.06915738388929706
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001843403	0.06915738388929706
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001843403	0.06915738388929706
RING CHROMOSOME 22 SYNDROME	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001843403	0.06915738388929706
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001843403	0.06915738388929706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001843403	0.06915738388929706
MACDERMOT-WINTER SYNDROME	0.001843403	0.06915738388929706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001843403	0.06915738388929706
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001843403	0.06915738388929706
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001843403	0.06915738388929706
HEART AND BRAIN MALFORMATION SYNDROME	0.001843403	0.06915738388929706
KLEEFSTRA SYNDROME 2; KLEFS2	0.001843403	0.06915738388929706
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001843403	0.06915738388929706
HSD10 DISEASE	0.001843403	0.06915738388929706
HOLOPROSENCEPHALY 1; HPE1	0.001843403	0.06915738388929706
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001843403	0.06915738388929706
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001843403	0.06915738388929706
SPINOCEREBELLAR ATAXIA TYPE 7	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.001832554	0.06875037117541137
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001832554	0.06875037117541137
HYPOTONIA-CYSTINURIA SYNDROME	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001832554	0.06875037117541137
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.001832554	0.06875037117541137
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001832554	0.06875037117541137
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.001832554	0.06875037117541137
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001832554	0.06875037117541137
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.001832554	0.06875037117541137
SHWACHMAN-DIAMOND SYNDROME	0.001832554	0.06875037117541137
PEROXISOME BIOGENESIS DISORDER 3B	0.001832554	0.06875037117541137
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.001832554	0.06875037117541137
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001832554	0.06875037117541137
NIEMANN-PICK DISEASE, TYPE A	0.001832554	0.06875037117541137
FARBER DISEASE	0.001832554	0.06875037117541137
GALACTOSE EPIMERASE DEFICIENCY	0.001832554	0.06875037117541137
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001832554	0.06875037117541137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.001832554	0.06875037117541137
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.001832554	0.06875037117541137
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.001832554	0.06875037117541137
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001832554	0.06875037117541137
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.001832554	0.06875037117541137
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.001832554	0.06875037117541137
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.001832554	0.06875037117541137
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.001832554	0.06875037117541137
CHROMOSOME 16Q22 DELETION SYNDROME	0.001832554	0.06875037117541137
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001832554	0.06875037117541137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.001828419	0.06859524189419494
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.001828419	0.06859524189419494
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.001828419	0.06859524189419494
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.001828419	0.06859524189419494
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.001828419	0.06859524189419494
CENTRAL DIABETES INSIPIDUS	0.001828419	0.06859524189419494
KRABBE DISEASE	0.001828419	0.06859524189419494
ADDISON DISEASE	0.001828419	0.06859524189419494
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001828419	0.06859524189419494
GLUTARIC ACIDEMIA I; GA1	0.001828419	0.06859524189419494
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.001828419	0.06859524189419494
MOGS-CDG	0.001828419	0.06859524189419494
CITRULLINEMIA TYPE I	0.001828419	0.06859524189419494
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.001828419	0.06859524189419494
HISTIOCYTOID CARDIOMYOPATHY	0.001828419	0.06859524189419494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.001828419	0.06859524189419494
HYPER-BETA-ALANINEMIA	0.001828419	0.06859524189419494
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001828419	0.06859524189419494
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.06859524189419494
ACUTE ADRENAL INSUFFICIENCY	0.001828419	0.06859524189419494
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.001828419	0.06859524189419494
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.001828419	0.06859524189419494
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.001828419	0.06859524189419494
GITELMAN SYNDROME	0.001828419	0.06859524189419494
ECTODERMAL DYSPLASIA SYNDROME	0.001828419	0.06859524189419494
RETINITIS PIGMENTOSA 59; RP59	0.001828419	0.06859524189419494
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001790884	0.06718707319517211
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	0.06718707319517211
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.06718707319517211
16P11.2P12.2 MICRODELETION SYNDROME	0.001790884	0.06718707319517211
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.06718707319517211
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.06718707319517211
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.06718707319517211
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	0.06718707319517211
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.001790884	0.06718707319517211
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.06718707319517211
ARTERIAL TORTUOSITY SYNDROME	0.001790884	0.06718707319517211
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.06718707319517211
RAHMAN SYNDROME	0.001790884	0.06718707319517211
GABRIELE-DE VRIES SYNDROME; GADEVS	0.001790884	0.06718707319517211
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.001790884	0.06718707319517211
JOUBERT SYNDROME 14	0.001790884	0.06718707319517211
CHAR SYNDROME	0.001790884	0.06718707319517211
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001790884	0.06718707319517211
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.06718707319517211
HYPERTRYPTOPHANEMIA; HYPTRP	0.001790884	0.06718707319517211
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.001790884	0.06718707319517211
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.06718707319517211
JOUBERT SYNDROME 21	0.001790884	0.06718707319517211
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.06718707319517211
SENIOR-LOKEN SYNDROME 9	0.001790884	0.06718707319517211
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.06718707319517211
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.06718707319517211
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.001790884	0.06718707319517211
NEPHRONOPHTHISIS 11; NPHP11	0.001790884	0.06718707319517211
CHAR SYNDROME	0.001790884	0.06718707319517211
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.06718707319517211
ISOLATED PLAGIOCEPHALY	0.001790884	0.06718707319517211
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.06718707319517211
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.001790884	0.06718707319517211
CODAS SYNDROME	0.001790884	0.06718707319517211
FRAGILE X SYNDROME	0.001786749	0.06703194391395567
CROUZON SYNDROME	0.001786749	0.06703194391395567
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.001786749	0.06703194391395567
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001786749	0.06703194391395567
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.001786749	0.06703194391395567
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.001786749	0.06703194391395567
DYSEQUILIBRIUM SYNDROME	0.001786749	0.06703194391395567
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001786749	0.06703194391395567
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001786749	0.06703194391395567
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001786749	0.06703194391395567
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001786749	0.06703194391395567
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.001786749	0.06703194391395567
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001786749	0.06703194391395567
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001786749	0.06703194391395567
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001786749	0.06703194391395567
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.001786749	0.06703194391395567
MUSCLE-EYE-BRAIN DISEASE	0.001786749	0.06703194391395567
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.001786749	0.06703194391395567
LINEAR VERRUCOUS NEVUS SYNDROME	0.001786749	0.06703194391395567
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001786749	0.06703194391395567
CHIME SYNDROME	0.001786749	0.06703194391395567
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001786749	0.06703194391395567
GAUCHER DISEASE, TYPE IIIC	0.001786749	0.06703194391395567
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.04884542734590457
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.04884542734590457
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.04884542734590457
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.001301984	0.04884542734590457
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.001301984	0.04884542734590457
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.04884542734590457
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001301984	0.04884542734590457
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.04884542734590457
RIDDLE SYNDROME	0.001301984	0.04884542734590457
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.001301984	0.04884542734590457
AICARDI-GOUTIERES SYNDROME 6	0.001301984	0.04884542734590457
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.04884542734590457
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.04884542734590457
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001301984	0.04884542734590457
CONGENITAL VARICELLA SYNDROME	0.001301984	0.04884542734590457
MONOSOMY 13Q34	0.001301984	0.04884542734590457
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.04884542734590457
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.04884542734590457
RAINE SYNDROME	0.001301984	0.04884542734590457
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.04884542734590457
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.001301984	0.04884542734590457
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.04884542734590457
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.04884542734590457
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.04884542734590457
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.04884542734590457
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.04884542734590457
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.04884542734590457
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.04884542734590457
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.04884542734590457
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.04884542734590457
SECKEL SYNDROME 8; SCKL8	0.001301984	0.04884542734590457
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.04884542734590457
AICARDI-GOUTIERES SYNDROME 5	0.001301984	0.04884542734590457
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.04884542734590457
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.04884542734590457
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.04884542734590457
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.001301984	0.04884542734590457
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.04884542734590457
WARSAW BREAKAGE SYNDROME; WABS	0.001301984	0.04884542734590457
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.04884542734590457
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.04884542734590457
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001301984	0.04884542734590457
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.04884542734590457
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.04884542734590457
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.04884542734590457
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.04884542734590457
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.04884542734590457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.04884542734590457
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.04884542734590457
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.04884542734590457
BRESEK SYNDROME	0.001301984	0.04884542734590457
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.04884542734590457
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.04884542734590457
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.04884542734590457
HARTSFIELD SYNDROME; HRTFDS	0.001301984	0.04884542734590457
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001301984	0.04884542734590457
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.001301984	0.04884542734590457
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.04884542734590457
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.04884542734590457
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.04884542734590457
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.04884542734590457
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.001301984	0.04884542734590457
TRIPLE A SYNDROME	0.001297849	0.04869029806468812
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.04869029806468812
WORSTER-DROUGHT SYNDROME	0.001297849	0.04869029806468812
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.04869029806468812
SJÖGREN-LARSSON SYNDROME	0.001297849	0.04869029806468812
RENIER-GABREELS-JASPER SYNDROME	0.001297849	0.04869029806468812
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.04869029806468812
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.04869029806468812
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.001297849	0.04869029806468812
TYROSINEMIA TYPE 2	0.001297849	0.04869029806468812
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.04869029806468812
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.04869029806468812
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.001297849	0.04869029806468812
MENKES DISEASE	0.001297849	0.04869029806468812
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.001297849	0.04869029806468812
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.04869029806468812
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.04869029806468812
LISSENCEPHALY 3; LIS3	0.001297849	0.04869029806468812
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.04869029806468812
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.04869029806468812
PERRAULT SYNDROME 3	0.001297849	0.04869029806468812
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001297849	0.04869029806468812
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.04869029806468812
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.001297849	0.04869029806468812
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.04869029806468812
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.001297849	0.04869029806468812
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.04869029806468812
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001297849	0.04869029806468812
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.04869029806468812
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001297849	0.04869029806468812
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.04869029806468812
MOYNAHAN SYNDROME	0.001297849	0.04869029806468812
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.04869029806468812
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.04869029806468812
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001297849	0.04869029806468812
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001297849	0.04869029806468812
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001297849	0.04869029806468812
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.04869029806468812
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.04869029806468812
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.04869029806468812
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.04869029806468812
BANGSTAD SYNDROME	0.001297849	0.04869029806468812
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.04869029806468812
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.001297849	0.04869029806468812
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.04869029806468812
MICROPHTHALMIA, SYNDROMIC 1	0.001297849	0.04869029806468812
COHEN SYNDROME	0.001297849	0.04869029806468812
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001297849	0.04869029806468812
PSEUDO-TORCH SYNDROME 2	0.001297849	0.04869029806468812
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.001297849	0.04869029806468812
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.04869029806468812
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001297849	0.04869029806468812
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.04869029806468812
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.04869029806468812
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.04869029806468812
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001297849	0.04869029806468812
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.001297849	0.04869029806468812
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.04869029806468812
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.04869029806468812
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.04869029806468812
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.04869029806468812
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001297849	0.04869029806468812
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001297849	0.04869029806468812
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.001297849	0.04869029806468812
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001297849	0.04869029806468812
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.04869029806468812
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001297849	0.04869029806468812
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.001287	0.04828328535080245
LYSINURIC PROTEIN INTOLERANCE; LPI	0.001287	0.04828328535080245
DIARRHEA 9; DIAR9	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.001287	0.04828328535080245
APPARENT MINERALOCORTICOID EXCESS	0.001287	0.04828328535080245
MULTIPLE OSTEOCHONDROMAS	0.001287	0.04828328535080245
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.001287	0.04828328535080245
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.001287	0.04828328535080245
ENTEROKINASE DEFICIENCY	0.001287	0.04828328535080245
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.001287	0.04828328535080245
MAJEED SYNDROME	0.001287	0.04828328535080245
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.001287	0.04828328535080245
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.001287	0.04828328535080245
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.001287	0.04828328535080245
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.001287	0.04828328535080245
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.04828328535080245
ERYTHRODERMA, LETHAL CONGENITAL	0.001287	0.04828328535080245
HYPERCALCEMIA, INFANTILE 2	0.001287	0.04828328535080245
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
CRYPTOSPORIDIOSIS	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.001287	0.04828328535080245
OMENN SYNDROME	0.001287	0.04828328535080245
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.001287	0.04828328535080245
IMMUNODEFICIENCY 52; IMD52	0.001287	0.04828328535080245
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.001287	0.04828328535080245
601095 HARROD SYNDROME	0.001287	0.04828328535080245
MANNOSE-BINDING LECTIN DEFICIENCY	0.001287	0.04828328535080245
BARE LYMPHOCYTE SYNDROME, TYPE II	0.001287	0.04828328535080245
ERYTHRODERMA DESQUAMATIVUM	0.001287	0.04828328535080245
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.001287	0.04828328535080245
TRICHOHEPATOENTERIC SYNDROME 2	0.001287	0.04828328535080245
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.001287	0.04828328535080245
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.001287	0.04828328535080245
IMMUNODEFICIENCY 53; IMD53	0.001287	0.04828328535080245
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.001287	0.04828328535080245
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.001287	0.04828328535080245
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080245
HYPOTONIA-CYSTINURIA SYNDROME	0.001287	0.04828328535080245
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.001287	0.04828328535080245
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.001287	0.04828328535080245
CONGENITAL SHORT BOWEL SYNDROME	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.001287	0.04828328535080245
WILSON DISEASE	0.001287	0.04828328535080245
CLASSIC MULTIMINICORE MYOPATHY	0.001287	0.04828328535080245
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.001287	0.04828328535080245
GALACTOSEMIA	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.001287	0.04828328535080245
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080245
CLASSIC GALACTOSEMIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.001287	0.04828328535080245
IMMUNODEFICIENCY 57; IMD57	0.001287	0.04828328535080245
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.001287	0.04828328535080245
TYROSINEMIA, TYPE I; TYRSN1	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.001287	0.04828328535080245
FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.001287	0.04828328535080245
VALINEMIA	0.001287	0.04828328535080245
DOUBLE OUTLET RIGHT VENTRICLE	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.001287	0.04828328535080245
GLYCOGEN STORAGE DISEASE IV	0.001287	0.04828328535080245
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.001287	0.04828328535080245
PRIMARY HYPEROXALURIA	0.001287	0.04828328535080245
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
NEPHROPATHIC INFANTILE CYSTINOSIS	0.001287	0.04828328535080245
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.001287	0.04828328535080245
IMMUNODEFICIENCY 46; IMD46	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.001287	0.04828328535080245
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.001287	0.04828328535080245
RETICULAR DYSGENESIS	0.001287	0.04828328535080245
BARTH SYNDROME; BTHS	0.001287	0.04828328535080245
IMMUNODEFICIENCY 22; IMD22	0.001287	0.04828328535080245
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.001287	0.04828328535080245
BARBER-SAY SYNDROME	0.001287	0.04828328535080245
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.001287	0.04828328535080245
ATRESIA OF SMALL INTESTINE	0.001287	0.04828328535080245
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.001287	0.04828328535080245
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.001287	0.04828328535080245
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.001287	0.04828328535080245
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.001287	0.04828328535080245
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
HYPERLIPOPROTEINEMIA, TYPE ID	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.001287	0.04828328535080245
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.001287	0.04828328535080245
AUTOSOMAL AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.001287	0.04828328535080245
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.001287	0.04828328535080245
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.001287	0.04828328535080245
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.001287	0.04828328535080245
GRAFT VERSUS HOST DISEASE	0.001287	0.04828328535080245
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.001287	0.04828328535080245
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.001287	0.04828328535080245
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.001287	0.04828328535080245
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.001287	0.04828328535080245
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.001287	0.04828328535080245
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.001287	0.04828328535080245
ISOLATED AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
FAMILIAL DILATED CARDIOMYOPATHY	0.001287	0.04828328535080245
INFANTILE SYSTEMIC HYALINOSIS	0.001287	0.04828328535080245
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.001287	0.04828328535080245
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.001287	0.04828328535080245
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.001287	0.04828328535080245
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.001287	0.04828328535080245
HAWKINSINURIA	0.001287	0.04828328535080245
MELORHEOSTOSIS	0.001287	0.04828328535080245
HAWKINSINURIA	0.001287	0.04828328535080245
PEARSON SYNDROME	0.001287	0.04828328535080245
KAPUR-TORIELLO SYNDROME	0.001287	0.04828328535080245
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
RIGID SPINE MUSCULAR DYSTROPHY 1	0.001287	0.04828328535080245
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.001287	0.04828328535080245
JUVENILE POLYPOSIS SYNDROME	0.001287	0.04828328535080245
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.001287	0.04828328535080245
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080245
614044 TRYPSINOGEN DEFICIENCY	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.001287	0.04828328535080245
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080245
PORPHYRIA, ACUTE HEPATIC	0.001287	0.04828328535080245
CONGENITAL LETHAL ERYTHRODERMA	0.001287	0.04828328535080245
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.001287	0.04828328535080245
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.001287	0.04828328535080245
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.001287	0.04828328535080245
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.001287	0.04828328535080245
SECONDARY SHORT BOWEL SYNDROME	0.001287	0.04828328535080245
IMMUNODEFICIENCY 9; IMD9	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.001287	0.04828328535080245
MYOPATHIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080245
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.001287	0.04828328535080245
MUCOPOLYSACCHARIDOSIS TYPE 6	0.001287	0.04828328535080245
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.001287	0.04828328535080245
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.04671998737056319
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	0.04671998737056319
BENCZE SYNDROME	0.00124533	0.04671998737056319
PETERS ANOMALY	0.00124533	0.04671998737056319
MARSHALL SYNDROME	0.00124533	0.04671998737056319
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.04671998737056319
MORNING GLORY DISC ANOMALY	0.00124533	0.04671998737056319
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.04671998737056319
FETAL IODINE SYNDROME	0.00124533	0.04671998737056319
8Q21.11 MICRODELETION SYNDROME	0.00124533	0.04671998737056319
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.04671998737056319
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	0.04671998737056319
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00124533	0.04671998737056319
IVIC SYNDROME	0.00124533	0.04671998737056319
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00124533	0.04671998737056319
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.04671998737056319
ABDUCENS PALSY	0.00124533	0.04671998737056319
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.04671998737056319
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.04671998737056319
RETINOBLASTOMA	0.00124533	0.04671998737056319
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00124533	0.04671998737056319
LEBER CONGENITAL AMAUROSIS 16	0.00124533	0.04671998737056319
IVIC SYNDROME	0.00124533	0.04671998737056319
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.04671998737056319
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.04671998737056319
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.04671998737056319
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM	0.00124533	0.04671998737056319
RETINAL CONE DYSTROPHY 3B	0.00124533	0.04671998737056319
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.04671998737056319
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	0.04671998737056319
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.04671998737056319
NANCE-HORAN SYNDROME	0.00124533	0.04671998737056319
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.04671998737056319
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00124533	0.04671998737056319
X-LINKED RECESSIVE OCULAR ALBINISM	0.00124533	0.04671998737056319
HERMANSKY-PUDLAK SYNDROME	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 2	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 4	0.00124533	0.04671998737056319
COATS DISEASE	0.00124533	0.04671998737056319
OCULAR ALBINISM	0.00124533	0.04671998737056319
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.04671998737056319
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00124533	0.04671998737056319
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00124533	0.04671998737056319
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.04671998737056319
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.04671998737056319
NANOPHTHALMOS	0.00124533	0.04671998737056319
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.04671998737056319
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.04671998737056319
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00124533	0.04671998737056319
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00124533	0.04671998737056319
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00124533	0.04671998737056319
BASAL CELL NEVUS SYNDROME	0.00124533	0.04671998737056319
CHANARIN-DORFMAN SYNDROME	0.00124533	0.04671998737056319
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.04671998737056319
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.04671998737056319
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.04671998737056319
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.04671998737056319
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.04671998737056319
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.04671998737056319
ODONTOCHONDRODYSPLASIA	0.00124533	0.04671998737056319
SENGERS SYNDROME	0.00124533	0.04671998737056319
PETERS ANOMALY	0.00124533	0.04671998737056319
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.04671998737056319
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.04671998737056319
FOCAL DERMAL HYPOPLASIA	0.00124533	0.04671998737056319
MOEBIUS SYNDROME	0.00124533	0.04671998737056319
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.04671998737056319
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.04671998737056319
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056319
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.04671998737056319
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00124533	0.04671998737056319
STICKLER SYNDROME	0.00124533	0.04671998737056319
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.04671998737056319
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.04671998737056319
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.04671998737056319
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.04671998737056319
X-LINKED RETINAL DYSPLASIA	0.00124533	0.04671998737056319
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.04671998737056319
EEM SYNDROME	0.00124533	0.04671998737056319
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.04671998737056319
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	0.04671998737056319
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.04671998737056319
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.04671998737056319
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.04671998737056319
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.04671998737056319
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.04671998737056319
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00124533	0.04671998737056319
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.04671998737056319
WOOLLY HAIR	0.00124533	0.04671998737056319
SOTOS SYNDROME 2	0.00124533	0.04671998737056319
JACKSON-WEISS SYNDROME	0.00124533	0.04671998737056319
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.04671998737056319
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.04671998737056319
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.04671998737056319
ROBINOW-SORAUF SYNDROME	0.00124533	0.04671998737056319
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.04671998737056319
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.04671998737056319
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.04671998737056319
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056319
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.04671998737056319
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.04671998737056319
OPTIC ATROPHY 1; OPA1	0.00124533	0.04671998737056319
STIFF SKIN SYNDROME	0.00124533	0.04671998737056319
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00124533	0.04671998737056319
PROXIMAL SYMPHALANGISM	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.04671998737056319
HEMIFACIAL MICROSOMIA	0.00124533	0.04671998737056319
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.04671998737056319
RENAL COLOBOMA SYNDROME	0.00124533	0.04671998737056319
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.04671998737056319
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.04671998737056319
FRONTORHINY	0.00124533	0.04671998737056319
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.04671998737056319
SUMMITT SYNDROME	0.00124533	0.04671998737056319
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.04671998737056319
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.04671998737056319
COOPER-JABS SYNDROME	0.00124533	0.04671998737056319
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.04671998737056319
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040779042368001395
CRANIOPHARYNGIOMA	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
TAY-SACHS DISEASE	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040779042368001395
SULFOCYSTEINURIA	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040779042368001395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040779042368001395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040779042368001395
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
MEND SYNDROME; MEND	0.001086973	0.040779042368001395
XQ25 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.040779042368001395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.040779042368001395
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
SEVERE CANAVAN DISEASE	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
DONNAI-BARROW SYNDROME	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
SIALIDOSIS TYPE 2	0.001086973	0.040779042368001395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040779042368001395
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.040779042368001395
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
COACH SYNDROME	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
CANAVAN DISEASE	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.040779042368001395
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.028378341521295647
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.028378341521295647
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.028378341521295647
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.028378341521295647
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.028378341521295647
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.028378341521295647
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.028378341521295647
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.028378341521295647
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.028378341521295647
BOWEN-CONRADI SYNDROME	0.00075643	0.028378341521295647
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.028378341521295647
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.028378341521295647
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.028378341521295647
LOWRY-WOOD SYNDROME	0.00075643	0.028378341521295647
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.028378341521295647
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.028378341521295647
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.028378341521295647
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.028378341521295647
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.028378341521295647
MARTSOLF SYNDROME	0.00075643	0.028378341521295647
SATOYOSHI SYNDROME	0.00075643	0.028378341521295647
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.028378341521295647
FETAL METHYLMERCURY SYNDROME	0.00075643	0.028378341521295647
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.028378341521295647
ANE SYNDROME	0.00075643	0.028378341521295647
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.028378341521295647
RING CHROMOSOME 13 SYNDROME	0.00075643	0.028378341521295647
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.028378341521295647
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.028378341521295647
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.028378341521295647
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00075643	0.028378341521295647
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.028378341521295647
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.028378341521295647
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.028378341521295647
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.028378341521295647
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.028378341521295647
PAGOD SYNDROME	0.00075643	0.028378341521295647
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00075643	0.028378341521295647
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
VELOCARDIOFACIAL SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.028378341521295647
MECKEL SYNDROME	0.00075643	0.028378341521295647
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.028378341521295647
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.028378341521295647
ERMINE PHENOTYPE	0.00075643	0.028378341521295647
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.028378341521295647
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.028378341521295647
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.028378341521295647
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.028378341521295647
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.028378341521295647
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.028378341521295647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.028378341521295647
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.028378341521295647
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.028378341521295647
RUVALCABA SYNDROME	0.00075643	0.028378341521295647
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.028378341521295647
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.028378341521295647
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 1; FGLDS1	0.00075643	0.028378341521295647
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.028378341521295647
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.028378341521295647
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.028378341521295647
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.028378341521295647
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.028378341521295647
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.028378341521295647
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
HYPERREFLEXIA	0.00075643	0.028378341521295647
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.028378341521295647
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.028378341521295647
STIMMLER SYNDROME	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.028378341521295647
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.028378341521295647
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.028378341521295647
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.028378341521295647
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.028378341521295647
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.028378341521295647
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.028378341521295647
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.028378341521295647
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.028378341521295647
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.028378341521295647
MMEP SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.028378341521295647
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.028378341521295647
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.028378341521295647
MECKEL SYNDROME 12; MKS12	0.00075643	0.028378341521295647
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.028378341521295647
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.028378341521295647
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 20	0.00075643	0.028378341521295647
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.028378341521295647
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.028378341521295647
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.028378341521295647
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00075643	0.028378341521295647
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.028378341521295647
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.028378341521295647
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.028378341521295647
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.028378341521295647
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.028378341521295647
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.028378341521295647
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.028378341521295647
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.028378341521295647
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00075643	0.028378341521295647
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
WAGR SYNDROME	0.00075643	0.028378341521295647
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.028378341521295647
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00075643	0.028378341521295647
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.028378341521295647
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.028378341521295647
TETRAPLOIDY	0.00075643	0.028378341521295647
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.028378341521295647
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.028378341521295647
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.028378341521295647
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.028378341521295647
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.028378341521295647
STROMME SYNDROME; STROMS	0.00075643	0.028378341521295647
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.028378341521295647
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.028378341521295647
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.028378341521295647
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.028378341521295647
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608922
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020467085824608922
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020467085824608922
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.020467085824608922
HURLER SYNDROME	0.000545554	0.020467085824608922
PELLAGRA-LIKE SYNDROME	0.000545554	0.020467085824608922
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020467085824608922
WOLMAN DISEASE	0.000545554	0.020467085824608922
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 1	0.000545554	0.020467085824608922
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020467085824608922
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.020467085824608922
ALPHA-MANNOSIDOSIS	0.000545554	0.020467085824608922
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020467085824608922
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020467085824608922
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020467085824608922
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.020467085824608922
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608922
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020467085824608922
MEDULLOBLASTOMA	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020467085824608922
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020467085824608922
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020467085824608922
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608922
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.020467085824608922
CURRARINO SYNDROME	0.000545554	0.020467085824608922
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020467085824608922
ALG6-CDG	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608922
CDAGS SYNDROME	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020467085824608922
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020467085824608922
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020467085824608922
THYROID HYPOPLASIA	0.000545554	0.020467085824608922
THYROID HEMIAGENESIS	0.000545554	0.020467085824608922
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608922
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.020467085824608922
ATHYREOSIS	0.000545554	0.020467085824608922
ARIMA SYNDROME	0.000545554	0.020467085824608922
THYROID ECTOPIA	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020467085824608922
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608922
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020467085824608922
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020467085824608922
FRIED SYNDROME	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
JOUBERT SYNDROME 10	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608922
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020467085824608922
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020467085824608922
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020467085824608922
RIGID SPINE SYNDROME	0.000545554	0.020467085824608922
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608922
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020467085824608922
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.020467085824608922
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020467085824608922
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020467085824608922
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.020467085824608922
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020467085824608922
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608922
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020467085824608922
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020467085824608922
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608922
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020467085824608922
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.020467085824608922
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020467085824608922
OCCIPITAL HORN SYNDROME	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020467085824608922
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020467085824608922
JOUBERT SYNDROME 24	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020467085824608922
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.020467085824608922
JOUBERT SYNDROME 25	0.000545554	0.020467085824608922
JOUBERT SYNDROME 26	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608922
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020467085824608922
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020467085824608922
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608922
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020467085824608922
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608922
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608922
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020467085824608922
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020467085824608922
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608922
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020467085824608922
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608922
TEMTAMY SYNDROME	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020467085824608922
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020467085824608922
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020467085824608922
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020467085824608922
AURICULOCONDYLAR SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020467085824608922
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020467085824608922
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020467085824608922
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608922
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608922
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME	0.000545554	0.020467085824608922
DEXTROCARDIA	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020467085824608922
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020467085824608922
JOUBERT SYNDROME 27	0.000545554	0.020467085824608922
JOUBERT SYNDROME 28	0.000545554	0.020467085824608922
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020467085824608922
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020467085824608922
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020467085824608922
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020467085824608922
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.020467085824608922
MECKEL SYNDROME 13; MKS13	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608922
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020467085824608922
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608922
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
OPITZ G/BBB SYNDROME	0.000545554	0.020467085824608922
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.020467085824608922
OGDEN SYNDROME	0.000545554	0.020467085824608922
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608922
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020467085824608922
JOUBERT SYNDROME 7	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020467085824608922
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020467085824608922
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020467085824608922
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608922
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608922
JOUBERT SYNDROME 6	0.000545554	0.020467085824608922
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020467085824608922
NOONAN SYNDROME 6; NS6	0.000545554	0.020467085824608922
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608922
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608922
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020467085824608922
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020467085824608922
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020467085824608922
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 15	0.000545554	0.020467085824608922
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.020467085824608922
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
STEEL SYNDROME; STLS	0.000545554	0.020467085824608922
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020467085824608922
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020467085824608922
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020467085824608922
JOUBERT SYNDROME 8	0.000545554	0.020467085824608922
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608922
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608922
N SYNDROME	0.000545554	0.020467085824608922
USHER SYNDROME TYPE 1	0.000545554	0.020467085824608922
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020467085824608922
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020467085824608922
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020467085824608922
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020467085824608922
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020467085824608922
ICF SYNDROME	0.000545554	0.020467085824608922
RIFT VALLEY FEVER	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392476
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392476
CRYPTOCOCCOSIS	0.000541419	0.020311956543392476
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
CRISPONI SYNDROME	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392476
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392476
CADASIL	0.000541419	0.020311956543392476
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392476
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392476
TAKAYASU ARTERITIS	0.000541419	0.020311956543392476
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
MERCURY POISONING	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392476
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
LYNCH SYNDROME	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
FAMILIAL DYSAUTONOMIA	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392476
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392476
HENNEKAM SYNDROME	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
PROLACTINOMA	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
INSULINOMA	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
CHOREOACANTHOCYTOSIS	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392476
NOCARDIOSIS	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
PORPHYRIA	0.000541419	0.020311956543392476
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
FAMILIAL COLORECTAL CANCER TYPE X	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
FABRY DISEASE	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392476
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392476
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392476
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
GLIOBLASTOMA	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
ADIPOSIS DOLOROSA	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392476
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392476
WHIPPLE DISEASE	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392476
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392476
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392476
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392476
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392476
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392476
SCLERODERMA	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
